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Abstract 2
Abstract
Several factors affect the viability of biosensor design. This thesis presents the 
development of a computer-based model that will enable the sources and effects of 
noise and variations in concentrations within an evanescent field immunosensor to be 
analysed.
The model was developed as a series of modules, each representing one aspect of the 
sensor, which when linked provide a simulation of the whole sensor. A complete 
solution of the complex biochemical reactions involved in the immunoassay module 
was achieved using a Markov chain approach. More traditional methods of solving sets 
of equations, such as optimisation, genetic algorithms and simulated annealing, all 
failed to produce satisfactory results. Two alternative assays, a sandwich and a 
competitive assay, are presented. The light module details the modelling of the 
coupling into a planar monomode waveguide and calculation of fluorescence excited by 
the resulting evanescent field using standard electromagnetic formulae. However, both 
beam divergence and scattering from the immobilised antibody layer were incorporated 
into the model. Two alternative coupling techniques were modelled, prism coupling 
and coupling through a “resonant mirror” multilayer. The detection system modelled 
the amplification of the fluorescence by a photomultiplier tube.
The resulting model represents the most rigorous modelling undertaken in this area and 
the potential applications and benefits of such a model were detailed. Analysis of noise 
within the sensor allowed the impact of variation in the physical parameters defining 
the sensor to be determined and compared. The model was used to compare different 
protocols and confirmed that the sandwich assay produced the more sensitive device. A 
study of the kinetic response of the assay determined that measurements could be 
performed at half the time taken to reach equilibrium without significant loss of 
sensitivity. An analysis of the effect of scattering at the waveguide surface showed this 
to be significant noise factor. An initial study of the impact of the humectant layer 
illustrated that this is an issue that merits further consideration.
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Chapter 1 
Introduction
Simulation, the mimicking of the operation of a real system that gives information 
about the system being investigated, is currently developing as a means of 
experimentation. The complexity and interactions of the factors affecting the 
practicality of a biosensor have hindered their development in the traditional 
experimental environment. This thesis presents the development of a computer-based 
model, i.e. a simulation, of a biosensor that will enable the sources and effect of noise 
and variability within the sensor to be analysed and allow comparisons between 
different sensor arrangements to be made, thus providing the basis for a design tool to 
facilitate biosensor research and development.
1.1 Evanescent field immunosensor
A biosensor is a portable chemical sensor, which combines the selectivity and 
sensitivity of a biological molecule with the processing power of microelectronics to 
produce a powerful analytical tool for determining the presence and/or quantity of a 
particular substance, the analyte, in a biological sample. The molecule used is selected 
for its specificity to the analyte in question and incorporated within a physical 
transducer to produce a signal that can be detected. Figure 1.1 shows the schematic of a 
biosensor, illustrating the variety of biological recognition systems that have been 
combined with various different transducers in the production of biosensors [1].
A biosensor employing an antibody as the recognition molecule is designated an 
immunosensor and an evanescent field immunosensor is a device in which the physico­
chemical response is probed within the evanescent field e.g. a device where the signal 
is produced by detecting the fluorescence emitted from a fluorophore labelled molecule 
excited by the evanescent field above a guiding waveguide.
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Figure 1.1: Schematic diagram o f possible biosensor design
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1.2 Applications
The potential of biosensors has been recognised since the early seventies and 
applications have been identified in a number of areas (Table 1.1). Despite a significant 
research effort to exploit this potential, few biosensors have been developed that satisfy 
all the requirements of a commercially viable product [2]. The acknowledged exception 
is the blood glucose monitor for diabetics, patented by MediSense® in 1984 [3] and 
currently available worldwide. The less demanding category of biosensor, the 
qualitative biosensor, has achieved slightly more success. In this category, the 
biochemical reactions involved cause an observable colour change or employ a 
chemiluminescent label to indicate whether or not the analyte is present. There are a 
number of qualitative biosensors available of which the most widely recognised is the 
CLEARBLUE pregnancy test [4].
Table 1.1: Biosensors applications
Area Application Example
Medicine [5] Diagnostic tool blood sugar monitoring
Veterinary science [6] Drug testing detection of steroids
Environmental monitoring [7] Pollution control organic pollutant detection
Process control [8] Fermentation yeast quantity monitoring
Food and drink [9] Microbe detection salmonella
Military [10] Explosives detection TNT
1.3 Design criteria
Several factors affect the viability of biosensor design. The device must be capable of 
producing reliable results at the sensitivity necessary for the particular analyte. In order 
for the device to be easily used it must require addition of the sample only, with no 
further reagent addition or washing steps [11]. Any reagents incorporated within the 
device must have a realistic shelf life. The device must be self-calibrating, with the 
inclusion of either a calibration channel within the sensor [12] or with a user-friendly 
means of calibrating the device for a fixed number of uses, as employed by the glucose
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monitor [13], Finally, as a part disposable device, it needs to be cost effective both to 
manufacture and to use.
The number of design factors that need to be considered and the resulting complexity 
and interplay of these factors has impeded progress in the area of biosensors. The 
miniaturisation and lack of automation necessary to produce a portable, easy to use 
device have dramatically reduced the sensitivities achieved with immunosensors from 
those achieved by performing the immunoassay, the biochemical aspect of the sensor, 
within a laboratory environment. Non-specific binding contributions and variation in 
biomolecular immobilisations within the immunoassay; manufacturing tolerances 
within the sensor and noise within the detection elements may all contribute to 
unreliable results [14] and thus a reduction in the sensitivity achieved.
1.4 Aims o f the project
The underlying aim of this project is to develop a computer model of an evanescent 
field immunosensor, which can be used to analyse the various design criteria in a 
manner that cannot be achieved experimentally, thus providing a more rational design 
strategy for biosensor fabrication.
In order to achieve this underlying aim, the first objective of the project is to rigorously 
model each component of this type of immunosensor, that is, to produce an accurate 
model of
i) the light source;
ii) the propagation of light through the system;
iii) the complex biochemical reactions that occur when an analyte is present;
iv) the amount and detection of the resulting fluorescence and
v) the transformation of the detected signal into a readable output.
Once each component of the immunosensor has been modelled and verified against 
experimental data, the second objective is to build a complete model of the 
immunosensor. This model will be implemented in such a way to enable different
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aspects of the system to be studied and to allow the effect of noise within the system to 
be analysed. Thus the second objective of the project is to
i) implement a full model of an immunosensor;
ii) use the model to investigate certain design issues in biosensor development 
e.g. the time required to produce a reliable result and
iii) use the model to investigate some of the sources and effects of noise within 
the sensor.
The third objective of the project is to use the application of the full, rigorously tested 
model of an immunosensor to demonstrate the advantages of this type of modelling and 
the potential for such a model to become the basis of a design tool. Thus the third 
objective of the project is to
i) use the model to compare different protocols e.g. assays;
ii) use the model to study the effect of varying different parameters within the 
system e.g. the concentration of labelled molecule initially added;
iii) apply the model to a recently published configuration for an evanescent field 
optical immunosensor and to use the model to investigate the practicality of 
this arrangement and
iv) use the model to analyse aspects of the system for which experimental data 
cannot be generated e.g. the effect of a humectant layer on the 
thermodynamics of the biochemical reactions.
Briefly the three objectives of the project are to
i) model the components of an evanescent field immunosensor;
ii) implement a full model and use it to study the sensor implemented and
iii) demonstrate the potential of the model as a design tool.
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Chapter 2 
Evanescent field immunosensors
2.1 Historical evolution
2.1.1 The Clark electrode
In 1962 Clark & Lyons presented the development of an enzyme electrode based 
glucose sensor [1], which could provide a measurement of the amount of glucose in a 
blood sample without the need to send the sample for laboratory analysis. Their device, 
originally known as the oxygen electrode, was the first example of a device that we 
now know as a biosensor.
The oxygen electrode determined the concentration of glucose in a sample by using an 
electrode to monitor the decrease in the amount of oxygen due to the reaction between 
oxygen and glucose catalysed by the presence of glucose oxidase. The original 
technique proved problematic due to the need to control the ambient level of oxygen 
and the high reduction potential needed for the reaction to occur. However the 
possibilities for point of care analysis were immediately recognised and research in the 
area of biosensors began. The electrochemical detection of glucose went through a 
number of developmental stages. The second generation of glucose sensors replaced 
oxygen with a mediator, a chemical whose concentration was easier to control and 
requiring lower redox potentials [2]. Further progress was made with a technique that 
stabilised the electrode surface to enzymes, by incorporating a charge transfer complex, 
and produced directly coupled enzyme electrodes [3].
In 1984, MediSense® patented a portable glucose sensor based on this technique. This 
sensor and its derivatives have become an acknowledged success and are currently used 
worldwide for blood glucose monitoring [4]. The stability of the enzyme based 
amperometric sensor together with the relatively high concentration of glucose in 
human blood and the clear market niche for glucose sensors directed the major focus of 
biosensor research to the arena of glucose sensing.
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2.1.2 Antibodies
The biological recognition molecule used in a biosensor determines the specificity of 
the device and the concentration of analyte that it is possible to measure. The use of 
enzymes in biosensors, as in the Clark oxygen electrode, became well established due 
to their fast acting catalysing effect. However, enzymes can be expensive to extract and 
it is difficult to modify their selectivity [5].
Antibodies are extremely versatile and can be raised to be selective to a huge variety of 
antigens. Antibodies bind very strongly with their specific antigen and the addition of a 
second reactant in the form of a labelled molecule can be used to determine the amount 
of antigen in the resulting compound. This process, known as an immunoassay, has 
been used as clinical diagnostic technique since Yalow & Berson [6] proposed the first 
radio-immunoassay in 1959. The subsequent development of fluorescent dyes 
provided a safer means of labelling molecules, with labels that could be detected using 
light.
Whilst there is no direct comparison between antibody and enzyme catalysed reactions, 
each can be characterised by a transfer function from which a half saturation value may 
be determined This value, i.e. the affinity constant, for an antibody-antigen reaction is 
typically 107 M'1, whereas for an enzyme reaction the value, i.e. the Michaelis constant, 
is typically 103 NT1. Given that both these constants can be related to the concentrations 
of the species involved, it can be seen that the antibody-antigen reactions can be used to 
determine much lower concentrations of analytes than can be determined using 
enzymes.
2.1.3 Optical transducers
In the early sixties conventional waveguides consisted of hollow metal conductors and 
could be used to transmit electromagnetic waves in the microwave region between 
parts of a circuit. However, conventional guided wave transmission gave way to the 
new advances in optical communication systems. The optical fibre, proposed in 1966
[7], and the dielectric film waveguide provided a cheap, efficient means of guiding 
light, a potential that was recognised by the biosensor industry and a number of
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techniques evolved that used a combination of immunoassay with a means of using 
light to detect a change in adsorption, fluorescence, luminescence, scatter or refractive 
index caused by addition of the analyte. In 1973 Kronick & Little [8] suggested the 
exploitation of the evanescent field as a means of interrogating an immunoassay 
situated above a waveguide and the first evanescent field immunosensors began to 
appear.
2.2 Evanescent field techniques
2.2.1 Evanescent field
The power of an electromagnetic wave guided within a waveguide is not totally 
constrained within the waveguide but extends into the region beyond the boundaries. 
Figure 2.1 shows a typical distribution for a monomode waveguide. The evanescent 
field decays exponentially with increased distance from the boundary but the 
propagation of the wave is in the z-direction only.
EVANESCENT FIELD
GUIDED WAVE
WAVEGUIDE
Figure 2.1: Power distribution for an electromagnetic wave guided within a 
monomode waveguide. The evanescent field  is the exponentially decaying energy within 
the region beyond the waveguide bomdaries.
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2.2.2 Surface Plasmon Resonance
Surface plasmons are charge density waves that propagate along the surface of a metal. 
It is possible to couple light into surface plasmons by depositing a thin metal layer onto 
the surface of a prism. Light is then directed through the prism, hitting the prism -  
metal interface at an angle greater than the critical angle. Total internal reflection 
occurs and the resulting evanescent wave propagates through the metal film exciting 
the surface plasmons at the surface of the metal, which is immersed in some liquid 
(Figure 2.2). Surface plasmon resonance (SPR) occurs when the component of the light 
wave vector matches the wave vector of the surface plasmon. At this point there is a 
dramatic drop in the reflected light intensity.
SURFACE PLASMONSLIQUID
PRISM
INCIDENT 
LIGHT /
REFLECTED
LIGHT
Figure 2.2: Surface plasmons excited at the metal surface by the evanescent field 
propagating in the thin metal layer.
The frequency of incident light or the angle of incidence at which resonance occurs is 
extremely sensitive to the refractive index of the liquid above the metal. Thus if an 
immunoassay takes place within the liquid, performing an angle scan and noting the 
position of the SPR before and after the addition of a sample can be used to determine 
information relating to the sample and reactions occurring within it [9].
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2.2.3 Resonant Mirror
An adaptation of SPR involves a device known as a resonant mirror [10]. As with SPR 
light is coupled into the system via a prism. However, two layers have replaced the 
metal layer (Figure 2.3); a very thin layer of high refractive index -  the resonant layer, 
which is separated from the prism by a thicker layer of lower refractive index. This 
layer is thin enough for light to be coupled into the resonant layer via the evanescent 
field. Efficient coupling into this layer is dependent on the incident angle and is once 
again very sensitive to changes in the layer above. Thus shifts in the angle of incidence 
at which resonance occurs can be used to study reactions occurring in the sample.
EVANESCENT FIELD
SAMPLE x : :: ::
HIGH
INDEX
RESONANT
LAYER:LOW;INDEX:LAYER
PRISM
INCIDENT 
LIGHT /
REFLECTED
LIGHT
Figure 2.3: Resonant mirror configuration. The evanescent field in the low index layer 
couples light into the higher index resonant layer. This coupling achieves a maximum 
at a particular angle o f incidence -  the resonant angle.
Research has recently suggested an improvement to the resonant mirror using a 
technique known as asymmetric anti-resonant reflecting optical waveguides [11]. This 
technique suggests the inclusion of a porous polymer layer above the resonant layer, 
into which the immunoassay has diffused. This layer has a higher refractive index than 
the sample and thus the guided wave becomes trapped in this layer, allowing more 
effective monitoring of the changes in refractive index caused by the biochemical 
reactions.
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2.2.4 Commercially available devices
In the early nineties BIAcore™ produced the first in their range of instruments [12] 
using SPR. They had not achieved the miniaturisation necessaiy to become portable 
diagnostic devices but were immediately recognised as being ideal analytical tools for 
the analysis of kinetic reactions [13], determination of constants associated with 
reactions [14] and the study of molecular interactions [15].
BIAcore™ instruments cornered the market in this area and have maintained their role 
as the market leader in analytical tools for the study of molecular interactions, with 
98% of the relevant literature published in 1998 using their instruments for analytical 
purposes [16]. The remaining 2% use the IAsys™, a resonant mirror device produced 
by Affinity Sensors [17], A small number of companies produce comparable 
instruments, whilst others report devices under development [18]. Texas Instruments 
have a SPR device that is reported to be hand-held [18], but is not yet commercially 
available [19].
In terms of commercially available portable clinical diagnostic devices, the market has 
changed little in the past 10 years. There are currently a number of testing kits available 
that can be used to detect the presence of particular substances e.g. cocaine, cannabis 
etc. These operate in a similar fashion to a pregnancy test indicating only the presence, 
not the quantity of the particular analyte. A small number of “health check” kits are 
also available giving a colour-coded determination of the state of liver, kidney function 
etc. However, the vision of devices available in doctor’s surgeries for routine screening, 
in the home for drug level monitoring or in ambulances for emergency diagnosis has 
not been realised.
2.3 Design criteria.
A commercially viable biosensor needs to meet a number of criteria. It must be a 
sensitive, reliable device that is easy to use and self-calibrating. It must have a realistic 
shelf life and be cost effective to manufacture and therefore to supply. In the sense that 
portability is inherent in the definition a biosensor, it must be small enough to be used
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outside a laboratory. Table 2.1 lists the different criteria and their corresponding market 
requirements [20]. The number of design factors and the interactions between them has 
certainly contributed to the lack of commercially available biosensors [21].
Table 2.1: Design criteria and market requirements for biosensors
Criteria Requirement
Sensitivity
Assay time 
Instrumentation 
Calibration 
Assay protocol 
Operator interface 
Sample
Sample addition 
Shelf life
Must be appropriate to analyte 
e.g. ImM for glucose
1 - 2  minutes
Small, dedicated, low cost
At least dual channel for calibration
No reagent addition or washing necessary
No skill required
No preparation required
No measurement required
Minimum 6 months at room temperature (20° C)
Progress in each of the different areas represented by the design criteria varies 
according to the criteria and the sensing technique used. Since the field of biosensors is 
large, the number of variants in both biological recognition molecules and transducer 
techniques represents a vast array of different devices. Thus this review will confine 
itself to the particular arena of optical immunosensors.
2.3.1 Sensitivity
Sensitivity, that is the lowest detectable concentration of an analyte distinguishable 
from measurements made with no analyte present, is of prime importance in 
determining the viability of a biosensor. In the medical arena sensitivities range from 
concentrations of 1 mM (e.g. glucose [22]) to 1 pM (e.g. hCG [23]).
During the seventies the definition of the sensitivity of an immunoassay was the cause 
of much debate. Berson & Yalow defined sensitivity as the slope of the dose-response 
curve [24]. However, Ekins argued that if this were the case then the sensitivity would 
be dependant on the frame of reference used to plot the response curve. He further
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argued that it was the signal-to-noise ratio that was the major factor in determining 
assay sensitivity [25]; a view currently accepted by the biosensor community.
The development and refinement of different techniques have produced the sensitivities 
reported in Table 2.2, although it must be stressed that in the majority of cases these 
remain results achieved in the laboratory and not those achieved using a successful 
commercial device. When detecting analytes in human serum, immunosensors are still 
at least one magnitude less sensitive than immunoassay analysers [26], large laboratory 
based devices that use immunoassay techniques for the detection of analytes in 
samples.
Table 2.2: Sensitivities reported using optical immunosensors
Analyte Sensitivity Technique
Quoted Molar
Cocaine [27] 0.5 nM 0.5 nM Spectrophotometer
hCG [28]
(human chorionic 6.25x1c6 IU 17.25 fM Chemiluminescent
gonadatrophin)
M3G [29]
(Morphine metabolite)
0.2 ng/mL 40.9 nM Fibre-optic fluorescence
IgG [30]
(Immunoglobulin)
6.3 nM 6.3 nM Fibre-optic fluorescence
PSA [31]
(Prostate-specific antigen)
4 -1 0  ng/ml 11.8-29.4 nM
Fluorescence
capillary fill device
Noise within the sensor and detection elements of an immunosensor has a significant 
effect on the concentrations that can be detected. In 1983 Jackson and Ekins [32] 
showed that the detection limit of an immunoassay system is directly proportional to 
the relative error in the signal, supporting the by then accepted theory that noise played 
a crucial role in limiting the sensitivity of an immunosensor.
Within an immunoassay there is often a disparity between the theoretically predicted 
sensitivity and that achieved experimentally [33], suggesting that there is a degree of
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variation or “noise” within the immunoassay itself. Sources of noise in this element of 
the sensor are likely to occur due to the effects of the surface immobilisation necessary 
to secure the antibody to the surface that forms part of the physical transducer e.g. a 
waveguide in some optical immunosensors.
The optimum density and ideal orientation of the antibodies are of paramount 
importance as these can affect both the kinetic parameters of the assay and the amount 
of non-specific binding that is likely to occur [34]. Several approaches to 
immobilisation have been investigated, in many cases involving linking to an 
intermediate molecule [35,36].
23.2 User Interface
Immunoassay traditionally requires skilled technicians in a clean laboratory 
environment. The sample needs to be prepared prior to analysis and accurate 
measurements of concentrations and volumes are often required. Although modem 
immunoassay analysis has been automated to a certain extent, such automation itself 
requires the investment, space and skilled maintenance available within a laboratory 
installation.
It is normal procedure to determine results from an immunoassay once chemical 
equilibrium has been achieved and any unbound elements have been removed by 
washing. However, some immunoassays take as long as 20 minutes to reach 
equilibrium, an excessive time if one is sitting waiting for a result.
An ideal biosensor would be available in a doctor’s surgery, an ambulance or even at 
home. Thus it must be possible for an unskilled person to use the device given minimal 
instruction. In order to facilitate this, the sample must require no preparation i.e. the 
sample must use the whole blood or urine with no cleaning or removal of components 
necessary. It must be easy to add the sample to the sensor, with no accurate 
measurements necessary. Thus adding a drop of blood to a plate or point on a sensor is 
ideal. If the immunoassay requires any further reagents, e.g. a labelled component, they 
must be packaged within the system, making it appear reagent-less and the device
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should produce results within a couple of minutes. Techniques that exploit the 
evanescent field above a waveguide to excite a labelled component within the 
immunoassay have been used to provide sensor systems that address some or all of 
these requirements. In particular, the capillaiy-fill device has been developed to 
produce a user-friendly approach to immunoassay.
233  Fluorescence evanescent field techniques
An evanescent field immunosensor consists of an immunoassay where the capture 
antibody has been immobilised on the upper surface of a waveguide, either planar or 
fibre. One of the molecules taking part in the biochemical reactions has been labelled, 
for example with a fluorophore. The evanescent field produced by light propagating 
within the waveguide decays into the region above the waveguide, thus exciting those 
fluorophores that are bound near the surface and not those still free in the solution 
beyond the evanescent field. This exploitation of the evanescent field eliminates the 
need for washing away any unbound solution. The resulting fluorescence is 
proportional to the amount of analyte and the detected fluorescence can be used to 
determine the concentration of analyte present in the sample.
Recent studies have begun to look at methods of enhancing the evanescent field and 
thus producing stronger signals using this technique. Reverse-symmetry waveguides 
have been suggested [37], where the substrate material has a lower refractive index 
than the medium above the waveguide; thus allowing deeper penetration into this layer.
2.3.4 Capillary fill device
The capillary fill device (CFD) invented by Professor Shanks at Unilever and 
developed by Serono [38] exploits the evanescent field whilst seeking to address some 
of the design issues relating to the easy of use of the device. This device consists of two 
layers of glass with a narrow (approximately 100 microns) gap between them creating a 
cell of known volume. On the lower surface of the cell a waveguide has been deposited 
and on top of this the capture antibody of the immunoassay has been immobilised A 
fluorescent-labelled antibody is trapped within a water-soluble polymer inside the top
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surface of the cell. The addition of the sample causes this polymer to dissolve, thus 
adding the labelled molecule to the immunoassay without the need for any action on 
the part of the user. Thus, to the user, the device appears reagent-less. The sample to be 
tested is added at the end of the device, which fills due to capillary action. This 
eliminates any need for preparation or measurement of the sample. The addition of the 
sample causes the release of the labelled antibody and the biochemical reactions 
between the capture antibody, the analyte and the labelled antibody occur. Light is then 
coupled into the waveguide, producing an evanescent field that excites the bound 
fluorophores (Figure 2.4). The resulting fluorescence can be detected and used to 
determine the quantity of analyte present in the sample.
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Figure 2.4: Capillary fill device with immunoassay immobilised to lower surface. 
Guided light in the waveguide produces an evanescent field that excites the 
fluorophores close to the surface i.e. those that are bound.
2.3.5 Manufacturing criteria
The diagnostic market is bound by clearly defined standards, with comprehensive 
regulations being set and enforced by government institutions e.g. Food and Drug
oe
Administration [39]. Before a medical device can be marketed it musefully tested and 
classified by the appropriate authority. In the case of an immunosensor, the major 
requirements are that the device is non-harmful, sensitive, and reliable and has a 
satisfactory means of calibration.
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The issue of calibration within a portable device is one of the most stringent 
requirements that must be satisfied if an immunosensor is to become commercially 
successful. Calibration may be achieved by including a separate calibration channel 
within the sensor [40]. This would allow a calibration to be performed with each use. 
Planar waveguide sensors with multiple channels are under development [41], offering 
the potential for both within sensor calibration and multi-analyte detectioa 
Alternatively an adaptation of the calibration technique employed by the MediSense® 
glucose sensor, i.e. calibrating the device for a fixed number of uses [4], must be 
established.
Any product seeking commercial success needs to consider manufacturing costs. The 
device must be manufactured at such a cost that its purchase price is realistic for the 
intended market. Classical integrated optics involves the use of Titanium indifiused 
waveguides fabricated in crystal materials such as Lithium Niobate. Sloper & Flanagan
[42] developed a cheaper means of fabricating thin film metal phosphate waveguides 
for use in immunosensors. Developers are currently looking at fabricating waveguides 
out of polymers [37] or using a conducting oxide layer [43] as further means of 
producing inexpensive waveguide immunosensors.
2.4 Modelling
Early computer models of biosensors were developed involving a combination of two 
models: the physico-chemical model of the immunoassay and an error model 
representing the errors incurred in the measurement of the assay response [44]. 
However, these received only limited application, which Ekins [44] ascribed to the 
experimentalists reluctance to dissect their assay systems in order to identify the 
sources of error.
The emergence of Systems Biology as a field of research in the last couple of years has 
provided experimentalists with tools to facilitate the production and exchange of 
models [45] and there are a growing number of simulation packages available. The 
continued development of such tools is likely to produce an increase in the amount of 
modelling of biological and biochemical systems.
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Ezan & Grassi [46] attributed the lack of exploitation of computer models in biosensor 
development to the fact that such models are complex, do not easily take into account 
common features of assays or information on assay parameters and thus do not reflect 
reality. A review of the small amount of literature devoted to biosensor modelling 
confirms this view. Several attempts have been made to produce a mathematical model 
to determine output [47], sensitivity [48] or the detection limit [49] of different types of 
optical immunosensor. Holt et al. [50] acknowledged the potential benefit of modelling 
to biosensor design and produced a model of a continuous flow displacement 
immunosensor that they used to optimise certain parameters. However, the common 
feature of these publications is either the gross simplification involved when including 
the immunoassay element of the sensor or the complete absence of any attempt to 
model this aspect of the sensor. The intention of this project is to develop a model that 
tackles this failing i.e. a model that can be used to determine accurate values for assay 
parameters and takes into account the full complexity of the immunoassay.
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Chapter 3 
Overview of model
There are a number of biosensor techniques being used or at various stages of 
development. The model implemented during this project represents the initial stages in 
the development of a design tool that could provide an inexpensive way of studying 
and comparing different approaches to biosensing. However, in order to establish the 
reliability and usefulness of such a model, it is important that the data generated using 
the model is closely related to data obtained experimentally. Thus, the initial modelling 
is based on experimental evanescent field immunosensors previously studied in this 
group. Models of these systems can be readily tested and verified against existing 
experimental data.
3.1 Experimental model
The experimental evanescent field immunosensors previously studied [1,2] are based 
on the capillary fill device (CFD) invented by Professor Shanks at Unilever, developed 
by Serono [3] and described in chapter 2. This device consists of two layers of glass 
with a narrow (approximately 100 microns) gap between them.
Two variations of the device have been modelled. In the first, an indium phosphate 
waveguide has been deposited directly onto the lower glass surface of the CFD [4]. 
Light is coupled into the waveguide using a prism and the resulting evanescent field 
excites the fluorophore label of the immunoassay on the waveguide surface (Figure 
3.1a overleaf). The second variation involves a resonant mirror type coupling into the 
waveguide (Figure 3.1b overleaf). A buffer layer has been deposited onto the lower 
glass surface, with an iron phosphate waveguide deposited on top. Light is 
evanescently coupled into the waveguide through the buffer layer, coupling that 
achieves a maximum at a particular incident angle, the resonant angle. Guided light in 
the waveguide produces an evanescent field, once again exciting the bound 
fluorophore.
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MODEL A - PRISM COUPLING MODEL B - MULTILAYER COUPLING
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Figure 3.1 A capillary fill device used as an immunosensor
Model A - Light is coupled into the waveguide using a prism
Model B - Light is coupled through multiple layers c.f. resonant mirror
The CFD requires an exciting light and some means of detecting the resulting 
fluorescence. Several alternatives have been suggested e.g. Helium-Neon or semi­
conductor laser as light sources and photomultiplier tubes or avalanche photodiodes as 
the means of detection. The light source and detection system modelled in this project 
reflect the experimental apparatus previously used by Sloper [1] and Pampapathi [2] to 
generate data pertaining to the use of a CFD as a biosensor (Figure 3.2), data that has 
been used to verify the model.
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Figure 3.2: Experimental set-up o f a fluorescent evanescent field immunosensor. In the 
particular case illustrated the exciting light was provided by a Helium-Neon laser and 
the output fluorescence was detected using a photomultiplier tube.
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3.2 Specification o f requirements
The specification of requirements when developing a piece of software is an accurate 
determination of what the software should achieve and the type of interaction between 
the user and the software that will be appropriate and necessary.
The primary requirement of this particular model is that it provides an accurate means 
of reproducing the output from an evanescent field immunosensor. In order to do this it 
must accurately model the following components:
i) light source;
ii) propagation of light through the system;
iii) immunoassay i.e. the biochemical reactions;
iv) resulting fluorescence;
v) detection system.
The model will enable the user to study the effect of varying different parameters 
within the system by allowing the user to assign values to certain parameters. Each of 
the components listed have a number of parameters that may effect the functionality of 
the overall sensor e.g. wavelength of light source, refractive indices, thickness of any 
materials etc. A comprehensive list of the parameters that can be varied is given in the 
chapters relating to the development of the model of each of the relevant components.
Developing the model to allow the analysis of the noise within the system requires the 
facility for the user to assign a variance to the value of certain parameters and the 
model to determine both the output from the sensor and the error in this output caused 
by the specified variances. This will allow the sensitivity of the specified device to be 
calculated, a key factor in establishing the viability of a sensor.
One of the potential benefits of the model is that it will allow the impact of certain 
characteristics within the system to be studied, e.g. scattering of light. It must therefore 
be possible to examine data at various key points within the model.
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It will be possible to use the model to compare different protocols by allowing the user 
to replace a particular component with an alternative variant of that component without 
the remainder of the system being altered e.g. coupling might be via a prism or the 
multilayer. Thus, where a number of variants are available, the user must be able to 
specify the required variant.
In summaiy, the model should
i) allow the user to specify the design of the system:
a) choose component variants where available
e.g. prism or multilayer coupling;
b) assign values and variances to certain design parameters,
discussed in detail in Chapters 4 -6 ;
c) choose the point in the model at which to output intermediate data.
ii) accurately calculate the output and corresponding variance where necessary, 
at the point specified given the parameters entered.
A model that meets these requirements will demonstrate the potential of this type of 
modelling to the field of biosensor design and allow data pertaining to some elements 
of the system that cannot be produced experimentally to be generated and analysed.
3.3 System analysis and design
The analysis and design of a piece of software involves precise determination of the 
functionality of the system and decisions regarding how this functionality and the 
requirements specified can be implemented [5].
3.3.1 Overall model
In the case of the immunosensor model, analysis suggested that the best approach to 
modelling would be to divide the system into a number of modules each representing 
one component of the system e.g. the immunoassay element. Each module could then 
be modelled separately, providing the opportunity for testing each component
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independently and the potential for analysis of data from within a particular element of 
the sensor.
Linking the modules together provides a model of the sensor in its entirety, which can 
then be used to study the overall effect of changing any particular parameter. Figure
3.3 illustrates the modules, the possible variants and the flow of data through the 
model. Substitution of modules will facilitate the direct comparison of different 
variants of each component, although not all of the variants shown have been modelled.
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Figure 3.3: Data flow through the computer model o f the immunosensor.
The blocks denote each module representing a component o f the sensor, with the 
module variants listed to the right.
Data from each module can be output or fed  into the next module in the sensor model. 
33.2  Modules within the model
Analysis of each particular module required the development of a mathematical model 
that accurately represented the physical system being described. Once the mathematical 
model had been established, it was possible to identify both parameters that could be 
variable and points at which useful intermediate data could be accessed. This enabled 
decisions regarding how to proceed with the implementation to be taken.
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3.4 Implementation
3.4.1 Timescale
Software development can be time consuming and it is necessary to closely monitor the 
time spent on any one aspect of the development to avoid becoming trapped within an 
infinite loop of writing and testing code which will never produce a satisfactory result. 
Figure 3.4 illustrates the time scale for development of the immunosensor model.
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Figure 3.4: Time scale for the development o f the immunosensor model. It should be 
noted that in the case o f the immunoassay and light models the repetition o f the process 
refers to the two variants o f each o f this modules.
Development of each module of the immunosensor consisted of four main aspects. The 
first stage is the analysis of the module described above (3.3.2). Once analysis has 
begun, it is sensible to start writing code as soon as possible. Thus any immediate 
pitfalls of translating a particular mathematical model into computer code should be 
established. Testing can begin before the code is completely finished. It is often 
desirable to test functions separately and independently of the overall program. Once 
testing is complete the process of debugging, i.e. correcting any of the problems 
identified can be started. It is common practice amongst commercial software 
developers to separate the testing and debugging processes completely, as it is 
sometimes easier to isolate a bug in code with which a developer is not completely 
familiar.
3.4 Implementation 43
3.4.2 Simple overview of C++
The object oriented language C++ has been used to implement the model, as it is 
particularly appropriate for the modelling approach adopted. In C++ it is possible to 
create new data types i.e. classes, that encapsulate f all the information and 
capabilities of the data type into a single entity. Object orientation enables the 
developer to create instances of the new class with which to interact. A simple example 
would be a class Animal. An Animal may contain information such as Weight and Age 
(the variables) and have the capability to Walk or Speak (the methods). In order to 
interact with an Animal the developer creates an instance of the Animal i.e. Animal 
Fang (the object), to which a Weight and Age can be assigned. It is also possible to get 
Fang to Walk or Speak.
Inheritance in C++ allows further classes to be derived from a base class. A developer 
might wish to have a class Dog. Since a Dog is also an Animal and will have several 
attributes and methods in common with an Animal, it is possible to derive a class Dog 
from the base class Animal. An instance of the class Dog will automatically have a 
Weight and Age and be able to Walk and Speak. Similarly a Cat class may also be 
derived. The polymorphism of C++ means that a pointer to an instance of class Animal 
can be assigned to any of its derived class i.e. either Dog or Cat.
It is possible to change the functionality of a method from the base class by declaring 
the method to be virtual. Thus if the Speak method is declared virtual in the Animal 
base class and Speak is redefined for both a Dog and a Cat then a call to the Speak 
method could output “Woof!” if the object is a Dog and “Meow” if it is a Cat.
3.4.3 Physical objects in the immunosensor model
Application of an object oriented approach to the immunosensor model allowed a basic 
set of data and functions to be determined for each component of the model and 
developed as a base class representing that particular component. Each base class was 
extended and customised for each particular variant of the module e.g. an immunoassay 
base class with derived classes for each of the immunoassay types. This facilitates the 
substitution of module variants.
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In some cases the main class is composed of a number of instances of other classes. A 
class detailing its physical properties represents each biochemical species. A second 
class representing a chemical reaction includes the rate constants governing the 
particular reaction and three instances of the species class, referring to the constituent 
and product species involved. The immunoassay class contains arrays of both the 
species and reactions relevant to the particular assay. Figure 3.5 illustrates part of the 
composition of the immunoassay class and its relation to the physical assay object.
PHYSICAL OBJECT REPRESENTATION IN CODE
Competitive immunoassay class CAssay{
public:
U Constructor
II creates an instance of the class 
CAssayQ;
Labelled an
Reactions in competitive a ssay
II Variables
II attributes or the assay
U Three biochemical species initially present 
ecles* m Capture; 
ecies" m Label;
CSpecies* m_Analyte;
II Array of all species p resen t during a s sa y  p ro cess  
m_nN um berSpecies;
CSpecies* m aSpeciesArray{NUMBER];
// Array of all reactions that take place 
Tnt m_nNumberReactions;
CReaction* m_aReactionArray[NUMBER];
Figure 3.5: Illustration o f a competitive assay as a physical object and its 
corresponding implementation as a C++ class.
3.4.4 Mathematical objects
In addition to creating classes that represent physical objects, it is also possible to 
develop classes to represent mathematical objects. Two mathematical classes of 
particular use in the immunosensor model were a complex class; a type consisting of 
two variables representing the real and imaginary parts of a complex number; and an 
error class; a type consisting of two variables, one representing a measured or 
calculated value, the other an estimate of its associated variance. The development of
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these classes facilitated the development of a “complexerror” class, a type 
representing complex numbers were both the real and imaginary parts had a value and 
an associated variance.
3.4.4.1 Operator overloading
Operator overloading in C++ facilitates the use of mathematical classes such as the 
complex and error classes described above. Code can be written that allows the 
functionality of the arithmetic operators to be reassigned when applied to the developed 
class e.g. the code for overloading the ‘+’ operator for the error class is:
CError::CError operator + (CError & rhs)
{
newValue = value + rhs.getValueO;
newError = square_root( square(error) + square(rhs.getError()) ); 
return CError(newValue, newError);
}
Thus, applied to the line of code
Error3 = Errorl + Error2
value represents the measurement of object Errorl 
error represents the error associated with Errorl 
rhs refers to the object Error2 of type error 
getValue() accesses the value variable within the error class 
getError() accesses the error variable within the error class 
and Error3 is the returned object of type error with variables newValue and newError 
as calculated within the function.
The overloading of the arithmetic operators within the error class allows the 
propagation of errors through a module to be accomplished with minimal effort. Any 
parameters that have an associated variance and any calculated values are declared to
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be of type Error. The code is unchanged from the code in which all values are real, but 
the end result is of type Error and therefore has a value and a variance. Figure 3.6 
shows the declaration of the class Error and illustrates the full range of operator 
overloaded functions.
class Error
t
public: // constructor & destructor
ErrorO;
Error(double, double);
-ErrorO;
// functions to get values
double getValueO;
double getErrorO;
void Initialise(double, double);
// arithmetic operators
Error operator*- (Error &);
Error operator*- (const double &);
Error operator- (Error &);
Error operator- (const double &);
Error operator* (Error &);
Error operator* (const double &);
Error operator/ (Error &);
Error operator/ (const double &);
// assignment operators
Error& operator^ (Error & );
Error& operator+= (Error &);
Error& operator+= (const double &);
Error& operator— (Error &);
Error& operator— (const double &);
Error& operator*= (Error &);
Error& operator*= (const double &);
Error& operator/= (Error &);
Error& operator/= (const double &);
// output functions
void PrintO;
void Print(ofstream&);
// friend functions
friend Error operator*- (const double, Error);
friend Error operator- (const double, Error);
friend Error operator* (const double, Error);
friend Error operator/ (const double, Error);
private:
double value;
1;
double error;
Figure 3.6: Error class member variables andfunctions
Similarly a complex class consisting of two variables, one representing the real part and 
the other the imaginary part, facilitates the use of complex numbers, necessary for
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modelling of light through absorbing materials. The complex error class allows 
variances to be assigned to both the real and imaginary parts of any complex number 
and the calculations to proceed with only a change in the data type of certain variables 
necessary.
3.4.5 Monte Carlo simulation
“Stochastic methods attempt to mimic or replicate the behaviour of a system 
by exploiting randomness to obtain a statistical sample of possible outcomes.”
Heath [6]
A Monte Carlo procedure is a stochastic procedure in which random sampling is used 
to generate mean and standard deviation values that are difficult to determine 
analytically [7]. Whilst error propagation could be used to determine deviations in parts 
of the model, other parts, in particular the optimisation methods used to determine the 
concentrations of biochemicals within the immunoassay module, described in detail in 
Chapter 4, did not provide suitable procedures within which to apply the propagation of 
error technique. Thus, in order to determine values for the errors in these parts of the 
model a Monte Carlo simulation was adopted.
3.4.5.1 Details of Monte Carlo procedure
In order to determine a mean and standard deviation of the output from a particular 
element of the model a value and associated error must be determined for each of the 
input variables. An array of normally deviated random numbers, using the desired 
value as mean and the error as standard deviation was generated for each variable 
concerned. The simulation could then be performed for each combination of array 
values and the mean and standard deviation of the output results calculated.
3.4.5.2 Random Numbers
A  computer must use some sort of algorithm to produce a supposedly random number. 
These random number generators have merited much discussion [8] and the general 
conclusion is that the majority of standard number generating functions produce 
sequences that are pseudo-random at best, totally inadequate at worst.
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Random numbers generated for use within the Monte Carlo procedures were generated 
using a Knuth algorithm [9]. This subtractive method produced a set of random 
deviates between zero and one. These numbers were then corrected to normal deviates 
for a Gaussian distribution of zero mean and unit standard deviation using a Box- 
Muller transform [9]. The resulting sequence was then scaled to the required mean and 
standard deviation.
Any random number generator uses a seed to produce the sequence of numbers. Use of 
the same seed will produce the same set of numbers. Thus, to further randomise the 
process, the number used to seed the random number generator was produced using the 
C++ time function and was therefore variable. In addition, the first 1000 numbers 
generated were discarded before a final set of random numbers was produced.
3.4.6 Integration of modules
Each module within the immunosensor model was implemented as a stand-alone 
program using a class defining the module and a test routine. The classes were linked 
together to produce a model of a complete evanescent field immunosensor with the 
resulting class structure as shown in Figure 3.7.
ASSAY
SPECIES
LAYER
REACTION
PMT DETECTOR SANDWICH ASSAY
LIGHT
SOURCE
FLUORESCENCE
MULTILAYER BIOSENSOR
Figure 3.7: Structure diagram o f the fu ll model o f the multilayer coupled capillary fill 
device containing a sandwich immunoassay.
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3.5 Testing and verification
“Bugs lurk in comers and congregate at boundaries.”
Beizer [10]
Testing and verification play a crucial role in the development of any software. Not 
only is it vital to check that the resulting software meets the user requirements 
specified, but it is also important to check that the code is functioning correctly for a 
range of situations, including those that are outside the intended use of the software. 
For example, if the software expects the user to enter a number and he enters a letter a 
good software implementation would inform the user of his mistake and request an 
appropriate entry.
3.5.1 White box testing
Testing involves the systematic checking of all algorithms, interfaces, data handling 
and error trapping within the computer code, a process that is usually more time 
consuming than the original implementation. Testing at this level is known as white 
box testing i.e. the testing of the internal computer code. It should ensure that all 
statements within the code are executed, thus eliminating redundant code. Both paths of 
any logical test should be checked to ensure that the output is valid. Any loops should 
be tested both within the loop and at their boundary conditions and all internal data 
should be validated to ensure that accidental stack overwriting does not occur.
Testing of the code implemented in the development of the immunosensor model 
followed a procedure known as “basic path testing” [11]. This involves producing a 
low level flow chart of the route that is taken through a particular piece of code. 
Analysis of this flow chart enables all the possible routes to be identified and test cases 
involving both the acceptable and non-acceptable routes can then be derived. These test 
cases are then used to test the code within and at the extremes of its operating limits. 
Figure 3.8 shows an example of the flow chart for a particular piece of code.
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Value = CalculateValue;
if (Value < 0)
{
Flag = 1; 
Value *=-1;
}
while (Value > 0)
{
Beta = Recalculate; 
Value = CalculateValue;
}
Calculate
value
YESValue < 0
NO Flag = 1 
Value *=-1
While Value >IT>*
Change beta 
Calculate Value
Figure 3.8: Flow chart illustrating the basic paths through the code for calculating the 
propagation constant o f the guided light within the waveguide. Code includes both an 
4i f  statement (logical decision) and a while loop.
3.5.2 Black box testing
Verification refers to the process of determining whether the output of the software is 
as expected for a particular input and is known as black-box testing [12], a process that 
has no interest in the internal workings of the software. Verification of the model of the 
immunosensor includes fitting the model to experimental data in order to determine 
whether the output from the model is equivalent to the output generated by experiment. 
Details of the verification process are included in the relevant chapter for each 
component of the model.
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C h a p te r  4 
Im m unoassay  m odule
4.1 Immunoassay
Immimotechniques provide sophisticated biochemical tools that can be used to 
investigate and manipulate minute concentrations of complex molecules [1], One 
example, the immunoassay, allows the concentrations of biochemicals to be 
determined. The majority of immunoassay techniques involve an antibody chosen for 
it’s specificity to the substance to be detected, the analyte. This antibody, known as the 
capture antibody, is usually immobilised on a surface. The sample containing the 
analyte is added to the capture antibody, together with a second antibody/analyte that 
has been labelled with a molecule that can be used to generate a signal e.g. a 
radioactive isotope or a fluorophore. Following the biochemical reactions, the signal 
generated can be used to determine the quantity of analyte present in the sample. 
Immunosensors have incorporated competitive (Figure 4.1) [2], displacement [3] and 
sandwich [4] immunoassays.
V W V V i V CAPTUREANTIBODY
SURFACE
Figure 4.1: Competitive assay
a) sample containing the analyte and the labelled analyte is added to the capture 
antibody immobilised on a surface
b) at equilibrium
4.1.1 Competitive assay
In a competitive assay the sample added contains the analyte to be detected and a 
known quantity of the analyte that has been labelled with, for example, a fluorophore 
(Figure 4.1). The analyte and the labelled analyte compete for the antibody binding 
sites as the system comes to equilibrium. Thus, the bound analyte is inversely
SURFACE
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proportional to the amount of bound labelled analyte and can be measured by detecting 
the light emitted by the fluorescent label.
4.1.2 Displacement assay
A displacement assay involves a capture antibody that has already been exposed to a 
known concentration of labelled analyte. The sample containing the analyte is added 
and this analyte once again competes with the labelled analyte for the binding sites, in 
this case displacing some of the previously bound labelled analyte. At equilibrium the 
displacement assay (Figure 4.2) resembles the competitive assay and the amount of 
bound analyte can be determined by measuring the reduction in signal resulting from 
addition of the sample.
s u r f a c e
LABELLED 
ANALYTE ;
ANTIBODY
ANALYTE
c)
Figure 4.2: Displacement assay
a) capture antibody is bound with a known concentration o f labelled analyte
b) the sample containing the analyte is added
c) at equilibrium
4.1.3 Sandwich assay
A sandwich or immunometric assay involves a capture antibody, the analyte and a 
labelled antibody. The analyte may bind with the capture antibody, the labelled 
antibody or both and thus becomes bound within an antibody-analyte-labelled antibody 
sandwich. The bound analyte is proportional to the bound labelled antibody and can 
thus be measured by detecting the amount of bound label e.g. the light emitted by a
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fluorescent label. Figure 4.3 illustrates a sandwich immunoassay being performed 
within a capillary-fill device (CFD).
' a n t i b o d y -
-ANALYTE
-LABELLED
ANTIBODY
SANDWICH
JLBELLEO 
ANTIBODY 
N W ATER- 
SOLUBLE 
POLYMER
H W H .S -fji;
SAMPLE
CONTAINING
A N .U V TE;:
Figure 4.3: Sandwich assay inside a capillary fill device
a) Capture antibody immobilised on lower surface; labelled antibody trapped 
within water soluble polymer on upper surface; analyte in sample placed at end 
o f capillary
b) Sample added by capillary action
c) Polymer dissolves adding labelled antibody and sandwich assay reactions 
occur
CAPTUREW
ANTI8O0Y ! 1 . I
(l o w e r  g l a s s  s u r f a c e
4.1.4 Immunoassay within an evanescent field immunosensor
Traditionally the bound label has been separated from the unbound label by washing 
any excess solution from the assay. Development of a biosensor requires the 
elimination of this washing step. Optical sensors that utilise the effects of the 
evanescent field provide a means of probing the immunoassay without the removal of 
the unbound label i.e. the washing step becomes unnecessary. The capture antibody is 
immobilised onto a waveguide into which light is coupled. The light within the 
evanescent field excites the fluorophores. The rapid decay of this field away from the 
surface ensures that the fluorophores excited are predominately those that are bound, 
hence eliminating the need for washing. This technique has been further adapted by
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incorporating the immunoassay into the lower surface of a capillary-fill device [5], 
This provides a means by which the amount of label and solution containing analyte 
may be controlled without the need for specialist equipment or experience.
4.1.5 Modelling considerations
Initial biosensor modelling concentrated on the radioimmunoassay, an immunoassay in 
which the molecule used as the label was a radioisotope, and established that using a 
sandwich assay produced a more sensitive device than one using a competitive assay
[6]. Current practice has replaced the radioisotope labels with fluorescent labels and 
the need to perform a washing step with the exploitation of the evanescent field. 
However, no in depth modelling has been undertaken to establish whether the 
sandwich assay is still superior in this type of system.
Figures 4.1 -  4.3 illustrate different immunoassay techniques where the size of the 
analyte shown is small compared to the size of the antibody. However, in reality this is 
often not the case and it is obvious that should a large molecule become bound to an 
antibody this may hinder the binding of a second molecule. The amount by which 
binding is prevented is known as steric hindrance and may range in value from 0 - 1 ,  
where a value of 0 indicates that no hindrance occurs and a value of 1 indicates that 
there is total steric hindrance (Figure 4.4). The model needs to take account of such 
steric hindrance.
ANTIE
ANALYTE
No steric 
hindrance 
s = 0
Partial steric 
hindrance
s = 0.5
Total steric 
hindrance 
s = 1
Figure 4.4: A single molecule bound to an antibody may interfere with the binding o f a 
second molecule. This phenomenon is known as steric hindrance (s); where s may take 
values between 0 (no steric hindrance) and 1 (total steric hindrance).
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The time required for the immunoassay to come to equilibrium, typically 1 0 - 1 5  
minutes, is often greater than the acceptable operation time of a biosensor [7]. Few 
appointments with a doctor would allow time for a test that required 10 minutes of 
waiting time. Thus, it has become necessary for the biosensor industry to explore the 
feasibility of determining results during the kinetic phase of the immunoassay. 
Modelling provides the ideal vehicle with which to undertake preliminary studies. 
Therefore the model of the immunoassay element of the biosensor will need to 
establish both the equilibrium and transient concentrations of each of the species 
involved.
4.2 Optimisation applied to immunoassay
The equilibrium equations that characterise a competitive assay are listed in Table 4.1. 
In order to determine the concentrations of each of the species present at equilibrium it 
is necessary to solve the set of equilibrium equations. There are no good, general 
methods for solving systems of more than one non-linear equation [8]. The most 
common approach is to cast the equations into a form that allows an optimisation 
procedure to be used. The function derived below is applicable to any set of reactions 
although will be exemplified in relation to a competitive assay.
Table 4.1: Equilibria for a competitive assay.
Equilibrium
equation Forward rate equation [AJ [BJ [ABJ
1 c + a  ^ca d[ca]/dt = k\ [c][a] - £_i[ca] c a ca
2 ca + a ^  ca2 d[ca2]/dt = £2[ca][a] - £_2[ca2] ca a ca2
3 c +1 cl d[cl]/dt =£3[c][l]-£_3[cl] c 1 cl
4 cl + 1 ch d[cl2]/dt = *4[cl][l]-Mcl2] cl 1 cl2
5 ca +1  ^cal d[cal]/dt = &5[ca][l] - £.5[cal] ca 1 cal
6 cl + a  ^cal d[cal]/dt = *6[cl][a] - ^ [cal] cl a cal
Each equation produces both forward (shown) and reverse rate equations; 
with rate constants for creation (k+i) and depletion (k.i) of each species.
At equilibrium the rate of change in concentration is zero and the 
association constant K* = ki/Li = [ABJ/[Aj][Bi] can be derived, 
c -  capture antibody; a -  analyte; 1 -  labelled analyte
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4.2.1 Optimisation function
Each equilibrium equation has a corresponding association constant, Kh defined by
k  - M l
''[AilBj
where i denotes the equation
[XJ denotes the concentration of species X, 
and [XY] denotes a compound species.
Rearranging produces a set of equations
/ / = ^ [ M B i]-[ABi] (4.1)
where all.// = 0 at equilibrium
and Si is a steric hindrance factor.
The concentrations of the initial species are limited by the equality constraints imposed 
by mass conservation. In the case of the competitive assay the mass conservation 
equations are
gi = fclo -  [c]- [ca]- [ca2 ] -  [cl]- [cl2 ] -  [cal]
S i  = [a]o -  [ca]- 2[ca2] -  [cal] (4.2)
g3 =[l]o-[d]-2[cl2]-[cal]
where [Xj]0 is the initial concentration of species Xi
and all g, = 0 at equilibrium.
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The concentrations of the all other species are limited in that they cannot exceed an 
amount dictated by the constraints of mass conservation e.g.
0£[ca]^ Mw(]c]o>[a]o)
where Min{a,b) is the minimum value of a and b.
The standard method of recasting to a single sum of squares was adopted and the 
optimisation function, F, which could be minimised to determine the concentration 
values at equilibrium, was developed.
N
F  = E r f
1=1
M
+
• (4.3)
+ X  “ #/ V; ~ f
/=1
+ X  ^ max  ^" V/ (^ max^  ~ f 
/=1
where f  as defined by equation (4.1)
gt as defined by equation (4.2)
Ai are the Lagrangian multipliers 
h() is the Heaviside function 
Yi are the weighting factors 
0i are the concentrations of species Xi
9min i are the minimum allowed concentration values of species Xi 
0max, i are the maximum allowed concentration values of species Xi 
N is the number of equilibrium equations 
M is the number of initial species 
and L is the number of species created by the reactions.
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4.2.1.1 Lagrangian multipliers
A common technique for imposing equality constraints on the optimisation of a 
function is to introduce a Lagrangian multiplier [9]. In a simple two variable system a 
typical Lagrange equation would be of the form
A {x,y)-A ,(C -B (x,y))
where A(x,y) is the function to be optimised
B(x,y) = C is the constraint 
and X is the Lagrangian multiplier.
Differentiating the Lagrange equation with respect to x, y and X produces a set of 
simultaneous equations which can be solved for x and y, and also as a by-product of 
the procedure, X. The complexity of equation (4.3) means that the values of Xi cannot 
be established in this fashion. However, by including the Lagrangian multipliers as 
variables within the optimisation, it is possible to impose the equality constraints 
necessary to conserve mass within an immunoassay system.
4.2.1.2 Penalty functions
Penalty functions provide an ideal method of imposing inequality constraints within an 
optimisation procedure [10]. A penalty function erects a barrier within the search 
surface that forces the optimisation to return to the realistic parameter space. A 
constant, with a value large enough to be beyond the possible scope of the function 
being optimised, is used as a multiplier with the Heaviside function
0 jc <0
1 x> 0
and added to the optimisation function. Thus, variables values exceeding the limits 
imposed by the inequality should quickly be abandoned by the optimisation procedure.
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4.2.1.3 Search surface
Inspection of equation (4.3) indicates that the surface, F, over which an optimisation 
search is to be performed, has a large dimensionality and is likely to be complex. This 
suggests that the optimisation may be troubled by the well-known problems of ill- 
conditioning and false minima, with consequent difficulties in choosing initial 
estimates.
The search surface described by F  for a competitive assay has at least 8  dimensions and 
is obviously difficult to visualise. A subsystem of chemical reactions
a + 1  al 
al + a ^  a2l
was considered and an examination of the surface represented by the function, F, was 
undertaken for this subsystem. The functions £ for this subsystem are
fj = s,K,[a]P] -  [al] 
f2 = s2K2[al][a] -  [a2l]
The mass conservation equations, gi, are
gi = [ a ]o - [a ] - [a l] - 2 [a2l] 
g2 = [l]o -  [al] -  [a2l]
Assuming values for the initial concentrations of
[a] 0 = 10 nM 
[l]o> lOnM
the inequality constraints on the species produced within the system are
0 <[a / ] < 1 0  
0 < [fl2/]< 5
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Figure 4.5 shows the surface calculated for all pairs of values of al and a2l, using 
equation (4.3), in which both g t were included, all yt were set equal to zero and all A,- 
were set to equal to unity, i.e. one in which the conservation equations are included 
within the optimisation but the inequality constraints have been excluded. A long 
valley around the minimum, typical of ill conditioning can be seen, thus indicating that 
it is necessary to impose the inequality constraints within the optimisation.
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Figure 4.5: Optimisation search surface (F) plotted for the subsystem of equilibrium 
equations a + I z? al and al + a a2l for all pairs of values of [al] and [a2l]
N = M  =  L = 2; A/ =  /  and yt = 0 for all i in equation (4.3)
Figure 4.6 illustrates the search surface for F  in which the weighting factors, yt, are set 
equal to a constant large value i.e. in which penalty functions have been used to impose 
the inequality constraints on the species concentrations. Figure 4.6 now represents a 
correctly constrained surface but one in which there are several comparable local 
minima, a consequence of collapsing a set of non-linear equations into a single 
function [8],
1.00-r 
090
i|  0  80-
0 0.70 
|  0.60 
S  0.50in
|  0.40
1 0 30- 
0.20 
0.10 
000
.Concentration of
Concentration of [al] (nM)
Figure 4.6: Optimisation search surface (F) plotted for the subsystem of equilibrium 
equations a + I ^  al and al + a t*a2l for all pairs of values of [al] and [a2l]
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A review of Table 4.1 shows there to be one redundant equation, i.e. both equations 
numbered 5 and 6 lead to the production of the species cal, and therefore one may be 
eliminated. The choice of the set of equilibrium equations to be used will not alter the 
global minimum but may affect the surface, F, over which the optimisation search is 
operating. The equations describing the subsystem were reviewed and whilst neither of 
the equilibrium conditions is redundant it was found that if the second mass 
conservation equation, g2, was removed from the calculation a much better conditioned 
search surface was achieved (Figure 4.7). It should be noted that removing one of the 
conservation equations adds another variable to the optimisation procedure and the 
search surface is now three-dimensional. Figure 4.7 represents a two-dimensional snap­
shot for a fixed value of the concentration of species a.
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Figure 4.7: Optimisation search surface (F) plotted for the subsystem of equilibrium equations 
a ^ I ft al and al + a ft a j  for all pairs of values of [al] and [a2l]
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4.2.2 Optimisation techniques
Optimisation techniques vary in the methodology used to find a solution. Given the 
complexity of the immunoassay equations and the resulting search surface, two classes 
of optimisation, classical regression and intelligent optimisation techniques, were 
implemented in an attempt to calculate the concentrations of the species X, at 
equilibrium. As this calculation may be repeated many times both accuracy and speed 
of computation are major determinants of the most appropriate method.
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4.2.2.1 Classical regression techniques
Preliminary work on all major regression procedures identified three that proved most 
promising when applied to an immunoassay; the simplex method of Nelder-Mead [11], 
the secant method of Broyden [12] and the quasi-Newton method of Davidon-Fletcher- 
Powell [13]. These techniques vary slightly in their approach to the minimisation of a 
particular function. The simplex method of Nelder-Mead expands and then contracts 
the region of search until it converges onto the minimum. This approach, whilst robust 
can be time consuming. Broyden’s secant method avoids the need for determining the 
partial derivatives of the function by using an approximation to the Jacobian matrix and 
deriving a formula that uniquely determines the change in this matrix resulting from a 
multidimensional “step” towards the minimum. Davidon-Fletcher-PowelPs quasi- 
Newton method does require the first derivatives of the function but then uses an 
approximation to the inverse Hessian matrix that ensures that this matrix remains 
symmetric and positive definite. This matrix is then updated to the point where it 
converges to the true inverse Hessian and a solution is found. These three methods 
were fully implemented.
4.2.2.2 Intelligent optimisation techniques
Intelligent optimisations, those that can make decisions about the validity of a solution, 
are often considered to be better at finding a global minimum than are the classical 
procedures [8 ]. Simulated annealing is a general optimisation method, which 
stochastically simulates the slow cooling of a physical system. A cost function defines 
a value that establishes the state of the system at a particular point or “temperature”. 
The algorithm works by iteratively changing the temperature, and hence the state of the 
system, and either accepting or rejecting each change according to the resulting cost. A 
simulated annealing procedure with a stepwise cooling schedule [14] was implemented 
to determine the equilibrium concentrations of the immunoassay.
A genetic algorithm is an optimisation technique that uses an algorithm that is 
analogous to the genetic selection of nature. A set of solutions i.e. a population is 
proposed and each is allocated a fitness value. New solutions are generated by 
selecting members of the previous generation based on their fitness and reproducing a
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new population by crossing these members. A small amount of mutation is also 
allowed. Selection, reproduction and mutation of each population should result in a 
population that has the highest fitness value, i.e. the optimum solution. A genetic 
algorithm was implemented to optimise the function, F  (equation 4.3) using a 
combination of elitist and steady state selection [15]. The encoding of multiple 
floating-point numbers as bit strings was compared with the approach of Davis [16] 
using real numbers in a hybrid genetic algorithm.
4.2.3 Application to a competitive assay
Although this multidimensional problem cannot be graphed in the same way as 
illustrated above for the subsystem (Figures 4.5 -  4.7), varying the choice of redundant 
equation to eliminate from the search function F  demonstrated a similar pattern when 
applied to a competitive assay. This and the dependence of the regression techniques 
on a suitable starting point indicate the importance of good initial estimates.
4.2.3.1 Initial estimates
The technique developed by Flanagan et al [17] for simpler multiple antibody-hapten 
equilibria was considered. This involved starting with the lowest analyte concentration 
and making all initial complex concentration estimates zero. The results for each 
analyte concentration were then used as the estimates for the next highest analyte 
concentration. Unfortunately no such simple technique could be found that would work 
with the competitive assay reactions (Table 4.2).
Table 4.2: Reactions within a competitive assay
Index Reaction
1 c + a <±ca
2 ca + a <± ca2
3 c + 1  cl
4 cl + 1  ^  CI2
5 ca + 1  ^  cal
6 cl + a ^  cal
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The technique adopted for calculating the initial estimates of the concentrations within 
a competitive assay, where the reaction number and index of K refer to Table 4.2, was
i) assume that species c will be distributed between ca and cl in proportion to 
the ratio of the rate constant for each reaction over the sum of the rate 
constants for the two reactions:
i.e. [c\ = \c \ ———  and [c\ = [c\ ———
LJ L]0k 1+k 3 ljz  1 * k 1+k 3
ii) calculate [ca] resulting from reaction 1 using
[ca]
iii) calculate [cl] resulting from reaction 3 using
m i
iv) calculate concentrations of a and 1 remaining after reactions 1 and 3 have 
occurred using
H = [4 -M  and [/]=[/l  ~[c/]
v) divide the concentrations of a, 1, cl and ca in the ratio of the rate constants 
of their subsequent reactions
e.g. divide [ca] in the ratio K2:K5 to get [ca]2 and [ca]s 
divide [cl] in the ration K+'fa etc...
vi) calculate concentrations resulting from remaining reactions assuming that 
the concentrations calculated in (v) are the initial concentrations for these 
reactions
e.g. [c a l\m  = Ki[ca \\l\
and [4  « .= [ /i - M ] 5  etc -
vii) total the concentration values for each species from each of the reactions 
e.g. [cal] = [cal] 5 new  [cal] 6 new*
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Table 4.3: Equilibria for a sandwich assay
Equilibrium
equation
Forward rate equation
1 c + a ca d[ca]/dt = £i[c][a] - £_i[ca]
2 1 + a «± al d[al]/dt = &2[l][a] - A.2[al]
3 c + al cal d[cal]/dt = £3[c][al]-£.3[cal]
4 ca + 1  <± cal d[cal]/dt = >k4[ca][l] - ^4 [cal]
5 ca + a *±ca2 d[ca2]/dt = &s[ca][a] - £-s[ca2]
6 a + al «♦ a2l d[a2l]/dt = ^ [a ][a l] -^ [a 2l]
7 ca + al 4±ca2l(l) d[ca2l(l)]/dt = *7[ca][al] - A.7[ca2l(l)]
8 ca+ al ca2l(2 ) d[ca2l(2 )]/dt = *8[ca][al] - A.8[ca2l(2 )]
9 c + a2l ca2l(2 ) d[ca2l(2 )]/dt = *9[c][a2l] - Ar.9[ca2l(2 )]
1 0 ca2 + l «±ca2l(l) d[ca2l(l)]/dt = £70[ca2] [ l ] - ^ c a 2l(l)]
11 ca2l(l)+ l +*ca2l2 d[ca2l2]/dt = &77[ca2l(l)][l] - £.77[ca2l2]
12 cal + a «±ca2l(l) d[ca2l(l)]/dt = *72[cal][a] - £_72[ca2l(l)]
13 cal + a ^  ca2l(2 ) d[ca2l(2 )]/dt = A7i[cal][a] -  £_7j[ca2l(2 )]
14 ca + a2l ca3l d[ca3l]/dt = ^7^[ca][a2l] - £.7*[ca3l]
15 cal + al «±ca2l2 d[ca2l2]/dt = A:7J[cal][al] - &.7j[ca2l2]
16 ca2 + al ^  ca2l d[ca3l]/dt = £7tf[ca2][al] - £.7<y[ca3l]
17 ca2l(l) + al ca3l2 d[ca3l2]/dt = Ar77[ca2l(l)][al] - £_77[ca3l2]
18 ca2l(2 ) + al <±ca3l2 d[ca3l2]/dt = Ar7«[ca2l(2 )] [al] - k.i8[ ca3l2]
19 cal + a2l ** ca3l2 d[ca3l2]/dt = £7p[cal][a2l] - £.7p[ca3l2]
20 ca2l(2 ) + a2l ^  ca4l2 d[ca4l2]/dt = £20[ca2l(2 )][a2l] - ^.2o[ca4l2]
21 ca2l2 + a «± ca3l2 d[ca3l2]/dt = £27[ca2l2][a] - k.21 [ca3l2]
22 ca3l + 1  ^  ca3l2 d[ca3l2]/dt = £22[ca3l][l] - k.22 [ca3l2]
23 ca3l + al ^  ca4l2 d[ca4l2]/dt = ^ 5[ca3l][al] - £_23[ca4l2]
24 ca3l2 + a ca4l2 d[ca4l2]/dt = ^ [ c a 3l2][a] - £.24[ca4 2]
25 ca2l(l) + a ca3l d[ca3l]/dt = *25[ca2l(l)][a] - ^ 5[ca3l]
26 ca2l(2 ) + a ^ ca 3l d[ca3l]/dt = £2<*[ca2l(2 )][a] - £ 26[ca3l]
Each equation produces both forward (shown) and reverse rate equations; 
with rate constants for creation (k+ 0  and depletion (k_i) of each species. 
These equations can be combined to produce an overall rate of change 
equation for each species involved.
At equilibrium the rate of change in concentration is zero and the 
association constant Ki = ki/k_i can be derived, 
c -  capture antibody; a -  analyte; 1 -  labelled antibody
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4.2.4 Application to a sandwich assay
The equilibrium equations describing a sandwich assay are listed in Table 4.3. 
Comparison of the complexity of these with the corresponding competitive assay 
equations (Table 4.1) indicates that the demands on an optimisation procedure will be 
greatly increased for the sandwich assay. The competitive assay has six equilibrium 
equations compared with the twenty-six that describe a sandwich assay. All the 
reactions within a competitive assay occur at the surface, whilst within the sandwich 
assay it is possible for the analyte to bind to the labelled antibody while in the solution 
above the surface. The fourteen species that may occur during the sandwich assay 
reactions dictate that the search surface F, (equation 4.3), for a sandwich assay 
optimisation procedure has at least fourteen dimensions.
Early investigation showed that finding an optimisation technique that would produce 
an accurate result from a set of crude initial estimates was unlikely in the case of a 
sandwich assay. Analysis indicated that the optimisation could be simplified into a 
number of stages that would each provide an initial estimate for the subsequent stage.
Initially the equilibrium concentrations within the solution containing only analyte and 
labelled antibody were easily calculated by applying the optimisation procedure to the 
subsystem of equations:
a + 1  ^  al 
al + a a2l.
The resulting concentrations of a, 1, al and a2l could then be divided between double the 
capture antibody concentration assuming each capture antibody to be monovalent, i.e. a 
situation with twice as many antibodies each having only a single binding site which 
preserves the number of binding sites available. Thus concentrations for c, ca, cal and 
ca2l assuming monovalent capture antibodies were calculated.
4.2 Optimisation applied to immunoassay 68
For each of these species the ratio of the number of binding sites occupied by the 
species to the total number of binding sites available was calculated e.g.
[ca]:2 [c] 0
where [c]o is the actual concentration of bivalent capture antibodies.
A nearest neighbour analysis was then used to estimate concentrations for the bivalent 
species. The analysis is detailed for the species ca2l which is formed from a 
monovalent ca and a monovalent cal. The probability of a bivalent capture antibody 
being found in the form ca2l is given by
A m  A -O -M  M  _ [caI ca/] 
^ l)- 2 2 [c \2 [c \ -  2[cl
where [cX] is the concentration of [cX] calculated for monovalent c (above)
and [c] 0 is the actual concentration of bivalent capture antibodies.
The estimated concentration of ca2l is thus
[ca2/]= p{ca2l \ c \  = ^ j j j ^
Similar calculations were made for each of the species possibly present within a 
sandwich immunoassay and these concentrations provided an initial estimate for the 
optimisation procedure.
In summary, the process of optimising a sandwich immunoassay involved
i) calculating the equilibrium of the solution containing only the analyte and
the labelled antibody
ii) distributing the resulting species assuming monovalent capture antibodies,
i.e. only one-site capture
iii) performing a nearest neighbour statistical analysis to estimate
concentrations of the bivalent antibody species
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iv) using these values as the initial estimate for the optimisation of the 
equations that describe a full sandwich immunoassay.
The process is illustrated by Figure 4.8.
STEP 1: REACTIONS WITHIN SOLUTION
STEP 2: DISTRIBUTE AMONG SINGLE-SITE CAPTURE ANTIBODIES
‘0 cT calf ca2l \ )
SURFACE
STEP 3: NEAREST NEIGHBOUR ANALYSIS TO PRODUCE BIVALENT 
CAPTURE ANTIBODY SPECIES
AND
ca
BECOMES
Figure 4.8: Three steps identified as a means o f  approaching the optimisation o f  a  
sandwich assay
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4.3 Markov chains applied to immunoassay
The application of optimisation techniques to the modelling of the immunoassay 
proved problematic. Collapsing the multiple equilibrium equations into a single 
function produced surfaces that were ill conditioned and the optimisation results were 
extremely sensitive to the initial estimates, indicating the presence of several local 
minima. In addition the approach offered no possibility for modelling the transient 
response of the chemical reactions. Consequently a second approach, one using an 
adaptation of Markov chains, was explored. Analogous to the optimisation model, the 
model presented is applicable to any set of chemical reactions but is illustrated using 
the equilibrium equations describing a competitive assay as previously listed in Table 
4.1.
4.3.1 Markov chains
A stochastic process {X(t), t e T }is a Markov process if, for any set of s+1 values 
ti < ti < ... < t s  < tg+ i e T with corresponding set of states {xi, X 2 , . . . ,  Xg, X g + i} ,  the 
probability that the process is in state x»+i depends only on state Xg i.e. the next state 
that the process will enter depends only on it’s current state and not on the previous 
history of the process [18].
Considering a discrete time set
T = { 0 , 1,2,3, . . .} 
with positive integer states Xi
i = {l ,2,3, . . . ,S} 
the transition probabilities can be defined as
l i j  =  p [X ^ \  = j \ X S =']
where qy is the probability that if the process is in state i the next state will be 
state j.
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The probability of the process being in state j at stage s+1 becomes
t
Thus the set of equations for each state can be expressed in matrix form as
P(s+1) -  p(s)Q(s) (4.4)
where p(s) is the probability vector
and Q(s) is an s x s matrix with elements qy,
known as the transition probability matrix.
43.2 Application to immunoassay
Too et al [19] proposed that Markov chains could be applied to the chemical reactions 
in continuous flow reactors by considering the number of molecules of each chemical 
species present during the reactions to be a state of the process. Antia and Lee [20] 
showed that for this application to be successful the Markov process had to be 
modified to maintain mass conservation. Such stochiometric considerations dictate that 
the sum of the row elements in the transition probability matrix need not equal unity. 
The number of molecules of a species at any stage can then be calculated using 
equation (4.4), where p(s) becomes the vector representing the number of molecules of 
each species.
The immunoassay reactions are more complex than those considered by Antia and Lee 
but their similar general form suggests that a comparable modified Markov chain 
approach may be applicable. The probability that a number of molecules of a species 
occurs at stage s+ 1  (p(s+l))can be written in terms of the number of molecules of each 
species at stage s (p(s))and the rate at which each reaction is progressing (Q(s)).
The number of molecules of a species X is given by
nX ~ If^ Avagadro
where [X] is the concentration of species X
V is the volume in which the concentration is present 
and NAvadagro is Avagadro’s constant.
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Since the volume of the capillary fill cell in which the immunoassay is performed is 
fixed then the concentration of a species is the number of molecules divided by a 
constant Thus it is possible to consider the concentrations of the species to be the 
states of the process and for a competitive assay (Table 4.4), the “probability vector” is
p(s) = flc] [a] [/] [ca] [c/] [ca2] [c/2] [ca/]) 
where [X] represents the concentration of species X.
Table 4.4: Equilibria for a competitive assay
Equilibrium
equation Forward rate equation
1 c + a ^ ca d[ca]/dt = £i[c][a] - Mca]
2 ca + a ca2 d[ca2]/dt = #2 [ca][a] - Mca2]
3 c +1 ^ cl d[cl]/dt =£3[c][l]-Mcl]
4 cl +1  ^cb d[cl2]/dt = fci[cl]P]-Mcl2]
5 ca +1  ^cal d[cal]/dt = *5[ca][l] - Meal]
6 cl + a cal d[cal]/dt = ^ [cl][a] - M[cal]
Part of Table 4.1 reproduced for reference
The rate equations are combined to produce an equation that describes the rate of 
change in concentration of each of the species involved. This equation involves 
addition of all the terms relating to the production of the species and subtraction of all 
the terms relating to its depletioa The case of the species ca is illustrated.
The reactions in a competitive assay involving ca (Table 4.4) are:
c + a ^  ca 
ca + a «± ca2 
ca + 1  cal
with corresponding rate equations
d[ca]/dt = k\ [c][a] - £_i[ca] 
d[ca2]/dt = &2[ca][a] - M ca2]
d[cal]/dt = *5[ca][l] - Meal]
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Combining these produces an equation that describes the rate of change of the 
concentration of the species ca.
~ ~ ~  -  K [cjtf]- k_x \ca\- k2 [ca \a\+  k_2 [ca2 ] - k s [c^ J/]+ k_5 [cal ]
Thus, if [X] refers to the concentration of species X at stage s and the transition to 
stage s+1 occurs in a time period At, the concentration of ca at stage s+1 will be
[ c a r  = M ( l - A l  -  A H -  AKD+ A[cI al+ A 2[co2]+ P-,\cal\
where /?, - Atkj
Similar equations can be derived for each of the species involved and the transition 
probability matrix describing the system can be written as Q(s).
c
j_
a 1 ca cl ca2 cl2 cal
c f i iM
- H U
0
1-
0 % H a ] m i ] 0 0 0
a 0 H c J
- H c a ]
- H d ]
0
1 - H e ]
W e ] 0 ftfirfca] 0 m e t ]
1 0 0 - H e i ]  
- H e a ]
0
1 -f i- i
m e ] 0 m e i j to f i e fc q ]
ca fi-j fi-i 0
i 
i
S'
0
l- f i -3
m a ] 0 m i ]
cl fi-3 0 fi-3 0 1 
1
0 m i ] m a ]
ca2 0 fi-2 0 fi-2 0 I -fi-2 0 0
cl2 0 0 fi-4 0 fi-4 0 1 — fi-4 0
cal 0 fi-5 fi-6 fi-6 fi-5 0 0 l - f i - s-fi-e
Equation (4.5)
The introduction of the Vz reflects the stochiometry of the reactions. Steric hindrance is 
included as a factor multiplying the value of the association constant prior to 
calculating the rate constants. Repeated application of equation (4.4) using the vector 
and matrix defined for the assay allows the calculation of the number of molecules and
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hence concentration of each of the species at successive intervals throughout the 
reaction; thus allowing both the transient and equilibrium values to be determined.
4.4 Diffusion included within immunoassay module
The models considered above assume that all the species involved in the immunoassay 
reactions are physically present at the capture antibody surface. Use of the CFD 
implies that this will not actually be the case; the analyte and labelled component must 
diffuse through the solution in the cell in order to reach this surface.
Diffusion of the molecules in solution can be described using a finite element approach
[21]. The capillary fill cell is divided into N+l elements of height Ax (Figure 4.9). The 
initial concentration of analyte and labelled molecule are equally distributed 
throughout the cell.
N M
N-1
element number
M0
Figure 4.9: Finite element approach to the modelling o f diffusion. The distance 
between the two surfaces is divided into N+l elements o f height Ax. M  represents the 
diffusing molecule.
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The concentration of each species within each element due to diffusion is calculated 
according to (see Appendix A):
[ * r + ^ t e - [ * r )  *=<>
(Ax)
M r  = w -  2 \ x r + )  i ^  ^  - 1 (4.6)
(A* ) 2
m t ^ I - m e m ^ )  t . N
(Ax)
where [X]k is the concentration of species X in element k
D is the diffusion coefficient 
At is the change in time 
and Ax is the height of the element.
The modified Markov model is then used to calculate the concentrations within each 
element resulting from any reactions. The bound species are converted from surface 
concentrations to volumetric concentrations for the purposes of implementing the 
reaction equations. In the case of a competitive assay, reactions will occur in element 0 
only, i.e. at the surface, but in a sandwich assay the analyte and labelled antibody may 
react in solution before reaching the surface.
4.4.1 Calculation of Ax
The factor -  in equation (4.6) is known as the model diffusion coefficient Dm. It is 
(Ax) 2
obvious that the larger the value of Dm, the smaller the value of Ax and hence the more 
accurate the model. However, it also necessary to consider computation time and 
memory allocation when specifying Ax; an unnecessarily small value will be expensive 
in terms of computer resources. Thus it is normal to fix Dm and calculate the 
corresponding Ax.
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The usual choice is a value Dm = 0.45 [21] and Ax is calculated as
(4.7)
where D is the average diffusion coefficient
Dm = 0.45
and At calculated below (Section 4.4.2).
4.4.2 Calculation of At
The value of At is of paramount importance within the finite element model. It must 
reflect both the diffusion of the molecules and the reaction rates of the initial surface 
reactions, these being the fastest reactions within the system. The value of At used 
must be small enough so that when the free species arrive at the capture antibody 
surface the reactions that occur are within the physical constraints of the system.
In the case of the competitive assay, when the analyte and labelled analyte arrive at the 
surface, reactions 1 and 3 in Table 4.4 take place with the resulting concentrations
[ca] = Af£t[c][a] 
[cl] = Ar£3 [c][l]
These concentrations are constrained such that
ip J  = Art,[c] < 1
(4.8)
In the capillary fill cell the capture antibody concentration is given as a surface 
concentration and converted to a volumetric concentration for the purposes of reaction 
with other free species. Thus
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(4.9)
where Ai is the area of the surface covered by immobilised antibody
At is the total area of the lower surface of the cell 
Ax is the height of the finite elements calculated above (Section 4.4.1) 
and [c]surface is the surface concentration of c
Substituting for [c] (4.9) and Ax (4.7) in equation (4.8) and rearranging leads to
A similar formula, which includes the maximum forward rate constant of the four 
possible initial reactions, can be derived for a sandwich assay.
4.4.3 Diffusion coefficients within the cell
The diffusion process within the cell may be complicated by the presence of other 
chemicals, namely the humectant layer used to preserve the capture antibody. The 
humectant layer is an additional substance e.g. sucrose that is used to coat the capture 
antibody layer. This preserves the activity of the antibody and hence the shelf life of 
the device.
Dm A] [c\stlrfa(xM AX(ki, £ 3  )
(4.10)
where D is the average diffusion coefficient
Dm = 0.45
At is the total area of the lower surface of the cell
Ai is the area of the surface covered by immobilised antibody
[c]surface is the surface concentration of c
and MAX(£/,Aj) is the maximum forward rate constant.
Once the sample is added and the solution fills the capillary fill cell, the humectant 
layer will dissolve thus altering the viscosity of the solution and therefore the diffusion
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coefficients of the molecules. The diffusion of the humectant layer into the solution 
and the resulting effect on the diffusion coefficients of the molecules must therefore be 
accommodated within the model. The most time efficient method of considering the 
changes in diffusion coefficients was to write a set of two-dimensional look-up tables 
for each of the molecules concerned.
4.43.1 Diffusion coefficient lookup tables
The lookup tables provided the diffusion coefficients of the molecules within the assay 
as a function of elapsed time and distance from the surface. Values of At and Ax could 
be small and therefore a complete table, one including a value for all values of t and x, 
would be excessive. Also, for a given elapsed time large parts of the table would 
contain identical values. Thus the tables were written with varying values of elapsed 
time and distance which reflected the diffusion of the humectant layer into the whole 
capillary fill cell. A bicubic spline interpolation could then be used to determine the 
diffusion coefficients within a particular element at a particular elapsed time.
4.4.4 Calculation of concentrations
The concentrations of each species at a time T after addition of the sample containing 
the analyte are calculated as follows:
i) calculate At;
ii) calculate Ax;
iii) determine the transition probability matrix based on the reactions involved at 
the surface;
iv) determine the vector of initial concentrations at the surface;
v) determine the initial concentrations within each element;
4.4 Diffusion included within immunoassay module 79
vi) calculate the diffusion of the humectant layer into the solution and determine 
at which point in time equilibrium occurs (teq)
vii) calculate the diffusion coefficients of the analyte and labelled molecules (and
any complex of these) within each element as a function of time until teq
viii) iterate
a. if t  < teq calculate diffusion coefficients
b. calculate concentrations in each element resulting from diffusion
c. calculate concentrations in each element resulting from reactions
d. apply equation (4.4) to the surface reactions 
required number of times to reach time T.
The physical parameters of the system that may effect the resulting concentrations are:
i) the initial concentrations of capture, analyte and labelled molecule and
ii) the intrinsic association constants for the reactions.
4.5 Verification o f model
It is vital, with any model, to establish that the model is producing results that are an 
accurate representation of the system being modelled. In the case of the immunoassay 
module verification involves establishing that the concentrations returned by the 
model, given an initial set of concentrations and association constants for the reactions, 
are the concentrations that would be achieved by performing the immunoassay 
experimentally.
4.5.1 Optimisation model
In order to consider the accuracy of the optimisation model it was necessary to 
consider the composition of the optimisation function F  to determine which, if any, of 
the redundant equations should be ignored in order to produce a well-conditioned 
search surface.
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Initially the three classical regression procedures were applied to a competitive assay 
for the protein IgG. The initial concentrations for the assay were
[a] 0 = 20 x 10'9 M 
[c]0 = 12.5 x 10‘9 M 
[l]o = 45 x 10'9 M
the association constants were
capture -  analyte Kc = 5.67 x 109 M-1 
capture -  labelled analyte Kl = 2.63 x 108 M*1
and all steric hindrance values were set equal to 0 , i.e. steric hindrance was ignored.
Table 4.5 shows the association constants and forward and reverse rate constants used 
in the model. The association of the capture antibody with the analyte, IgG, was 
assumed to be diffusion controlled and thus the forward rate constants k\ were 
calculated by the standard procedure used for diffusion controlled chemical reactions
[22]. The association constants shown are derived statistically from the intrinsic values 
quoted above (see Appendix B).
Table 4.5: Values of the rate constants used in the competitive assay model.
Equilibrium Association Values used in model
equation constant
K iO vf1) k, ( M 1 s 1) k.i ( s1)
c + a ca 2Kc 3.23 x 107 2.85 x 104
ca + a 5* ca2 !/2Kc 1.83 x 107 6.43 x 104
c + 1  <± cl 2Kl 3.23 x 107 6.14 x 10'2
cl + 1  ch 'f&L 1.64x10* 1.25
ca + 1  «* cal Kl 6.57 x 10* 1.16x10 '
cl + a *±cal Kc 1.83 x 107 6.94 x 10'2
Forward rates calculated as diffusion limited rate
Backward rates from Kj = k*/k.i.
Kc = 5.67 x 109M '' and KL = 2.63 x 108 NT1.
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Figure 4.10 illustrates the results when all the equations are included within the 
optimisation. The differing results indicate that this search surface is ill-conditioned, as 
was the case for an optimisation function including all equations for the subsystem 
discussed in Section 4.2.1.3.
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Figure 4.10: Comparison of the concentration values returned by three classical regression
techniques applied to the optimisation of F (4.3) for a competitive assay
N = 6; M  =  3; L — 8 ; yf = le80 for all i and \ t -  Lagrangian multipliers
Initial analyte concentration = 20 nM,
effective capture antibody concentration = 12.5 nM,
initial labelled  analyte concentration = 45 nM.
Figure 4.11 illustrates the results achieved using the three different techniques in the 
case where one redundant equation has been removed from the optimisation function.
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Figure 4.11: Comparison of the concentration values returned by three classical regression 
techniques applied to the optimisation of Ffor the competitive assay described in Figure 4.10 
N = 6; M = 2; L = 8; yt = le80 for all i and f  -  Lagrangian multipliers
4.5 Verification o f model 82
It can be seen that the Nelder-Mead procedure and the Broyden procedure, despite its 
record of failure if started away from the global minimum, give consistent results for 
both approaches but that the Davidon-Fletcher-Powell procedure is unreliable with 
either approach. The Davidon-Fletcher-Powell is considered a robust procedure [8,9], 
however it can prove problematic in situations were the scaling of the data is variable; 
a situation which is evident in the case of an immunoassay.
Comparison of Figures 4.10 and 4.11 shows that in the case illustrated by Figure 4.11, 
i.e. with one redundant equation removed, the Broyden and Nelder-Mead methods 
converge to an identical solution. However, application of these procedures to the more 
complex sandwich assay failed to produce consistent results, with the optimisation 
remaining extremely sensitive to the initial estimates.
Extending the comparison to include the intelligent optimisation methods produced a 
similar result i.e. equilibrium values for the competitive assay could be established but 
those for the sandwich assay could not. As the calculation is to be included within a 
procedure to fit to experimental data the speed of the calculation was a vital factor in 
determining the optimisation method to be used. Table 4.6 shows the times taken by 
the different techniques and indicates that the Broyden regression procedure would be 
the most appropriate.
Table 4.6: Comparison of performance time and minimum achieved by
three types of optimisation procedure.
Procedure Time Taken Function value at minimum
Genetic algorithm1 7.91s 3.35 x 10' 13
Simulated annealing 16.20s 2.03 x 10' 16
Broyden < 1 ms 8.09 x 1 0 ‘23
No significant difference in performance on changing encoding procedure
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The failure of the genetic algorithm to produce a global minimum for the sandwich 
assay optimisation indicates that the surface is prone to local minima and as the 
equation describing the sandwich assay has at least 14 dimensions it would seem 
impossible to isolate and eliminate this problem.
4.5.2 Markov model
The modified Markov approach was applied to the competitive assay of IgG previously 
described. Figure 4.12 illustrates the concentration of each species as a function of time 
obtained by repeated application of equation (4.4) with a time interval, At, of 0.1 s, an 
initial vector p(0) = ([c]0 [a]0 [/]0 0 0 0 0 0) and Q(s) as in equation (4.5).
20 •
□ [ca] 0[ca2] ♦[cl] □  [c!2]
A[cal] * [a ] A[c]
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Figure 4.12: The transient response fo r  the competitive assay fo r  IgG calculated using 
the m odified M arkov approach.
Analyte concentration = 20 nM,
effective capture antibody concentration = 12.5 nM,
labelled analyte = 45 nM.
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4.5.2.1 Equilibrium values
Figure 4.13 shows the concentrations of the species for the competitive assay at 
equilibrium obtained using this modified Markov approach, i.e. after 7 minutes. The 
results are compared with those obtained from the classical regression procedures that 
were found to be reliable i.e. the Broyden and Nelder-Mead procedures and shows 
excellent agreement.
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Figure 4.13: The comparison o f  equilibrium values calculated using m odified M arkov  
approach and classical regression techniques fo r  the competitive assay fo r  IgG  
Analyte concentration = 20 nM, 
effective capture antibody concentration = 12.5 nM, 
labelled analyte = 45 nM.
4.5.2.2 Transient response
The advantage of the modified Markov approach to modelling the immunoassay is the 
fact that the search pathway to equilibrium appears to mimic the transient response of 
the reactions. Analytical solutions are not available for the full immunoassay reaction 
set but are available for subsets, e.g. the individual reactions in Tables 4.1 and 4.3. The 
transient concentrations of the species associated with any of these, e.g. c + a ^ ca, 
were calculated using the modified Markov approach. These were compared with the 
results of the analytical solution of this simpler reaction equation (see Appendix C):
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[ca]=
2K{(/3 + <i y k-'1' - f ]  + q )
[c] = [c]o- [ca]
[a] = [a]0-[ca]
where [X]0 is the initial concentration of species X
[X] is the concentration of species X at time t 
kj is the forward rate constant 
k.i is the backward rate constant
k
K  = — -  is the association constant
p = -(K[a]0 + K[c]0+ l) 
q = ^ r ^4 K ^) 
and y =  K[a]0[c]0
The results were found to be in agreement as shown in Figure 4.14.
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Figure 4.14: The transient response o f  the reaction c + a  t±ca  calculated both
analytically (continuous line) and using the m odified M arkov approach (symbols). 
Initial concentrations: [c]o = 12.5 nM  (circles), [ajo = 10 nM  (triangles), and  
[ca]o = 0 nM  (squares).
Rate constants: ki = 3.23 x 107 M 1 s'1 and k-j = 2.85 x 10 3 s'1.
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Variants of the Runge-Kutta method are commonly used to solve the differential 
equations describing the kinetics of a chemical reaction for which no analytical 
solution is available [23,8], Comparison of a fourth order Runge-Kutta solution with a 
solution determined using the modified Markov method for the competitive assay for 
IgG showed that both methods produced identical results. Whilst the Runge-Kutta 
method proved slightly more robust, producing accurate results for At < 0.16s 
compared to At < 0.13s for the modified Markov approach, it was computationally 
more expensive in terms of elapsed time (Table 4.7).
Table 4.7: Time taken to produce results for the transient concentration
values of the competitive assay for IgG using the two approaches
At (secs) Elapsed time (secs)
_____________Markov_____ Runge-Kutta
0 .1 < 1ms 0.06
0 .0 1 < 1 ms 0.16
0 .0 0 1 0.16 1.54
0 .0 0 0 1 1 .2 1 10.76
0 .0 0 0 0 1 7.91 102.98
Both techniques were then extended to the more complex sandwich assay described by 
Table 4.3. Similarly to the competitive assay results were in agreement and although 
the Runge-Kutta method was slightly more robust, producing results for At = 0.1 s, the 
modified Markov approach was again superior in terms of time taken (Table 4.8).
Table 4.8: Time taken to produce results for the transient concentration values of 
the sandwich assay for IgG using the two approaches________________
At (secs) Elapsed time (secs)
_______________Markov______Runge-Kutta
0.1 FAILED 0.06
0.01 0.06 0.33
0.001 0.33 2.15
0.0001 2.25 16.86
0.00001 17.52 163.73
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4.5.3 Finite element diffusion model
4.5.3.1 Humectant diffusion
The diffusion model was applied to a capillary fill cell with a sucrose humectant layer 
and the following initial values
CFD thickness = 97 x 10"6 m 
Humectant layer thickness = 10 x 1CT6 m 
Temperature = 293 K.
The concentration of the humectant within the elements as a function of time is shown 
in Figure 4.15. This verifies that the humectant is diffusing to a constant gradient as 
expected.
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Figure 4.15: The diffusion o f  the humectant through the capillary f il l  cell. Different 
lines relate to different elements within the fin ite  element analysis, ranging from  the 
element closest to the surface to that furthest away.
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4.5.3.2 Application to an immunoassay
The finite element diffusion model was applied to a capillary fill device that included 
the competitive assay for IgG described above. An equilibrium solution was 
determined and found to be in total agreement with the equilibrium achieved when 
considering the immunoassay without diffusion. A similar result was achieved for a 
sandwich assay. Obviously the amount of calculation involved when considering the 
diffusing system greatly extends the computation time involved. Table 4.9 shows the 
time taken to perform a full analysis of the immunoassay.
Table 4.9: Characteristics and time taken to perform the finite element
diffusion model of immunoassay
Assay At (s) No. finite elements Time taken (s)
Competitive 0.021978 56 59.26
Sandwich 0.002614 175 591.11
4.5.4 Results of verification
A review of the verification of the immunoassay model indicates that the equilibrium 
concentrations of the less complex competitive assay can be calculated using the 
standard optimisation technique of collapsing the equations to a single equation which 
is then minimised using an optimisation procedure. The most effective procedure in 
terms of computation time was the secant regression technique of Broyden. However 
optimisation failed to produce reliable results for the more complex sandwich assay.
Equilibrium concentrations for the competitive asgiy calculated using the modified 
Markov approach showed good agreement/those achieved using the regression 
technique. This approach also produced results for the equilibrium concentrations of 
the sandwich assay, not achieved using regression techniques. The advantage of this 
approach was that no initial estimates were needed.
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Comparison of the transient response calculated using the modified Markov approach 
with the analytical solution of a single reaction showed good agreement. The classic 
Runge-Kutta technique for solving differential equations was applied to the rate 
equations and the results were in agreement with those generated using the modified 
Markov approach. Although slightly less robust than the Runge-Kutta solution the 
modified Markov approach proved significantly superior in terms of computation time.
Inclusion of a finite element analysis of diffusion within the capillary fill cell provided 
a successful means of incorporating both the diffusion and the reactions within the 
model. Equilibrium concentrations calculated using this full model were in total 
agreement with those calculated using an analysis of the immunoassay only.
4.6 Comparison with experiment
The modified Markov approach was incorporated into a Nelder-Mead optimisation in 
order to fit a set of experimental data available from work previously undertaken 
within the group [24]. The assay was a sandwich assay for human chorionic 
gonadatrophin (hCG) with initial concentrations
[c]0 = 30.9 x 10'9 M
[l]o = 250 x 10'9 M
The variables used for fitting were the
i) capture-analyte intrinsic association constant
ii) analyte-label intrinsic association constant
iii) steric hindrance factor between capture antibody and analyte
iv) steric hindrance factor between labelled antibody and analyte
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Figure 4.16 illustrates the results of the fitting with the values for the factors shown in 
Table 4.10. The values established for the association constants indicate that the 
immobilisation process or the addition of a label alter the rates at which antibodies 
react within the immunoassay. Noting that hCG is a large molecule the steric hindrance 
factors were as expected i.e. total steric hindrance occurs, demonstrating the 
importance of the inclusion of this factor within the model.
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Figure 4.16: Results o f using the modified Markov approach to fit equilibrium data for 
the sandwich assay for hCG.
Squares -  experimental data points 
Smooth line -  fitted curve
Table 4.10: Values of factors determined using the modified Markov approach to fit 
experimental data for the sandwich assay of hCG_____________________________
F ac to r M anufac tu re rs value V alue established
Capture association constant 6 x 10'° M-1 2.2 x 10*' M '1
Label association constant 2 x 10" M '1 4.1 x 1010 M '1
Steric hindrance a - c 0.99
Steric hindrance a -1 1.0
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Chapter 5 
Light Module
5.1 Light within the immunosensor
In a fluorescence evanescent field immunosensor the output of the device depends on 
the excitation of fluorophores within the immunoassay element of the sensor. An 
accurate reading is one resulting from each bound fluorophore label, with no 
contribution from any of the unbound label. Two of the main factors that affect the 
resulting fluorescent output of the device are the evanescent field and scattering of light 
from the surface of the waveguide.
5.1.1 Evanescent field
An evanescent field is a time-varying electromagnetic field extending into a region 
where boundary conditions prevent it from propagating. The evanescent field decays 
exponentially with increased distance from the boundary. Light coupled into a 
waveguide causes an evanescent field to decay into the region on either side. In the 
case of an immunosensor this region contains the immunoassay that is immobilised on 
the upper surface of the waveguide, thus exciting those fluorophores that are bound 
near the surface (Figure 5.1).
SANDWICH IMMUNOASSAY
V  CAPTURE ANA, VTF LABELLEDANTIBODY ANALYIt fgf' ANTIBODY ANTIBODY-
SANDWICH
EVANESCENT
FIELD
WAVEGUIDE
INCIDENTS 
LIGHT i SUBSTRATE
[ e m i t t e d I l ig h t
Figure 5.1: Light propagating in the waveguide causes an evanescent f ie ld  to decay  
into the region above the waveguide that contains the immunoassay; thus exciting 
fluorophores bound within this field.
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In an evanescent field sensor the strength and depth of the field are crucial. Insufficient 
field depth may mean that some of the bound fluorophores are not excited whilst if the 
evanescent field penetrates too deeply unbound fluorophores may be excited. In either 
case the resulting reading from the device will be inaccurate. The incident light source 
and the coupling of this light into the waveguide are key factors in determining the 
evanescent field.
5.1.2 Coupling
The light module models the arrangement for the coupling of light into the waveguide 
and the resulting output fluorescence. Traditional methods of coupling into a 
waveguide, i.e. prism or grating coupling require phase matching, with the incident 
light being at a precise angle. One arrangement for an evanescent field immunosensor 
involves the capture antibody of the immunoassay immobilised onto a waveguide that 
has been deposited onto the lower glass surface of a capillary fill device (CFD). 
Coupling into the waveguide is achieved using a prism. The first light module, which 
models this arrangement, is referred to as Model A (Figure 5.2a).
The second light module, Model B (Figure 5.2b), involves the method of multilayer 
coupling devised by Pampapathi & Flanagan [1]. In this model coupling is achieved 
using a series of layers of appropriate thickness and refractive index, similar to the 
resonant mirror device.
MODEL A - PRISM COUPLING MODEL B - MULTILAYER COUPLING
UPPER SURFACE UPPER SURFACE
EVANESCENT
FIELD
100 A im  100 A im
■' ' » wave!
Lower surface
\ ■» WAVEGUIDE
, BUFFER
A  LOWER SURFACE
INCIDENT/ 
LIGHT
*REFLECTED 
LIGHT
Figure 5.2: Two arrangements fo r  coupling o f  light into the waveguide
a) M odel A - Light is coupled into the waveguide using a prism
b) M odel B - Light is coupled through multiple layers c .f  resonant mirror
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5.1.3 Scattering
In optical waveguides attenuation, i.e. loss of energy as the wave propagates along the 
waveguide is an important characteristic in determining the viability of the waveguide 
for the intended purpose. Loss can generally be attributed to three different 
mechanisms, absorption, radiation and scattering, with scattering being the 
predominant loss mechanism in dielectric waveguides [2],
In an evanescent field immunosensor based on a planar waveguide scattering of light 
from the top of the waveguide may cause unbound fluorophores in the cell beyond the 
evanescent field to be excited and thereby falsely produce a raised output signal. Thus 
scattering has been incorporated into the model. This will allow its effect on the output 
signal to be accurately studied for both Model A and Model B arrangements. The 
different approaches exemplified by these models than can be compared.
5.1.4 Modelling considerations
The objective of this aspect of the model is to calculate the amount of fluorescence that 
will be emitted as a result of the light incident on the sensor and the concentrations of 
the species within the immunoassay, i.e. the amount of label that is bound near the 
surface and the amount that is free in the solution within the cell. This module assumes 
that these concentrations are known. Thus the role of the light module is to
i) calculate the amount of light propagating in the waveguide;
ii) calculate the amount of light absorbed by the label both as a result of the 
evanescent field and of light scattered into the cell from the waveguide surface 
and
iii) determine the resulting fluorescence.
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5.2 Model A -  Prism coupling
The experimental set-up of Model A, illustrated by Figure 5.3, involves an indium 
phosphate waveguide which has been deposited onto the lower surface of a capillary 
fill device. The capture antibody has been immobilised onto the waveguide and the 
sample added to the space above the waveguide by means of capillary fill. The light 
source is a 0.2 mW Helium-Neon laser of wavelength 543.5 nm coupled into the 
waveguide by means of a prism. The CFD is masked to provide an observation length 
of 1 mm, this being the length from which output fluorescence will be detected [3].
Upper glass surface
He-Ne Laser 
0.2 mW 
543.5 nm
Incident light
Prism
Solution with analyte i 
; arid: labelled; antibody;
•^Waveguide with antibody
Lower glass surface
-*1 mm
Emitted fluorescence
Detection
Figure 5.3: Experimental arrangement fo r  an immunosensor with the light module 
m odelled as M odel A. Immunoassay takes p lace  on the surface o f  an indium phosphate 
waveguide deposited onto the lower glass surface o f  a  capillary f i l l  device. Light is 
coupled into the waveguide via a prism.
5.2.1 Light propagating in the waveguide
In order to determine the amount of light propagating in the waveguide the system was 
equated to a three-layer thin film dielectric slab waveguide and the standard equations 
for such a waveguide [4] outlined in Appendix D could then be applied. The equations 
and procedures detailed pertain to Transverse-Magnetic modes; however an analogous 
set of equations can be derived for Transverse-Electric mode propagation.
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The characteristic equation for the waveguide is given by
t e n ( M ) = 4 po± h )
b2 -PoP2
(5.1)
where d is the thickness of the waveguide
„ 2
nFP o = ~ T  P o­
ns
  nFPi = - f  P i ­
ne
* = V ( M o )2 - ^ 2)
Pa =V(^2 ~(ns kt t f )
P2 = VC°2- ( nc ko f ) 
kQ = co(£qHq )^ 2  = — is the wave number im vacuum
c
c is the velocity of light in vacuum.
<o = is the angular frequency of the light,
X is the wavelength of the light,
8o is the permittivity of free space,
po is the magnetic permeability of free space,
n is the refractive index of the medium,
subscripts S, F & C refer to substrate, film and cover respectively, 
and p is the longitudinal phase constant of the propagating wave.
Since the waveguide confines the wave then the value of p must lie within the range [5] 
k0ns < P < k0nF
Thus equation (5.1) can be solved iteratively to determine a value for p and hence b, po, 
P2, etc.
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The power propagating in the system is given by
 2 >
j, wp
4a>s0np b 2
where
"sPof^+Po2) nCPl{b2 +P2
is the effective thickness of the film due to Goos-Haenchen shift 
W ( »  d) is the width of waveguide in y-direction,
A is a constant, 
t| is the coupling efficiency, 
with the other symbols are as defined above.
Once p has been determined, a value for A can be established by putting P equal to the 
incident power in equation (5.2). Values of A and p can then be used to determine the 
surface power density S at any value of x within the system by applying the equation
s M = ~ r K ( * f  (5.3)2 (dSqu
/Ijcos(&<i) + sin(fo/) ^ePo ^x+d^  x < - d
where H y (x) = /fjcos(At) -  sin(ta)j -  d < x < 0
A e 'P2X 0 < x
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Tiefenthaler & Lukosz [6] considered the electromagnetic fields within a four-layer 
sensor system where the thin antibody layer immobilised to the waveguide surface had 
a thickness much shorter than the wavelength of the light and showed that it was 
acceptable to treat this as a three-layer system with the thickness of the waveguide 
increased by the factor
p
where
Ad =
2 2 
nA ~ nC 
2 2 
n F ~ nC
r , \2  1
N/  I - 1k / nA j
X J ~ \
n is the refractive index of the medium,
(5.4)
and
N -  —  is the effective refractive index of the system 
kQ
k0 = o)(£0juq)% = — is the wave number in vacuum 
c
c is the velocity of light in vacuum.
cd = l i t k  is the angular frequency of the light,
p is the longitudinal phase constant of the propagating wave
d is the thickness of the layer
subscripts denote layers as follows
S -  substrate, F -  film, C -  cover and A -  antibody layer.
5.2.2 Attenuation of light
Along the observation length in the sensor, light may be attenuated due to absorption 
by the bound label, absorption by the free label, scattering from the waveguide surface 
or absorption by the waveguide itself. In order to facilitate analysis of the sources of 
noise within the immunosensor it will be necessary to determine the contribution of 
each type of attenuation to the overall attenuation of light.
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Consider a length L along which light is attenuated by two different factors a and b. 
Assume that the length is divided into segments of thickness Az in which attenuation is 
due to either a or b and that segments attenuated by a and b occur alternately (see 
Figure 5.4).
< Az ►
Propagating
light ( a b a
1 e-aAz e-aAze-bAz e-2aAze-bAz
Intensity
Figure 5.4: Intensity o f light propagating in an attenuating medium where the 
attenuation is due alternately to segments containing a and b
Using Beer’s absorption law
l ( z ) = l ( 0>—  
where I is intensity
z is distance 
and a is the attenuation constant
Total light attenuated due to a is
Knenuated = ^  )+ e - * * * *  )+ (l - e ^ ) + . . .
that is
j a , -  (i -  P~aAz p-*(ate+bAz)
1 attenuated \A / / ,
;=0
Taking the sum of a geometric progression this becomes
I _ g-N{atsz+btsz) ^
I  attenuated ~ \ l e  ^ ! _ e ~(aAz+bAz)
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which, noting the NAz = L and rearranging becomes
-abz \ja  L C-L(a+J  l - e ~ aA*
1 attenuated V1 e ~(a+b)bz
Taking the limit as Az -» 0
IfLattenuated ~ \  ^  a \ X l ~ e ~L{a+b))( l - ( a  + 6)) 
and thus the light attenuated due to a is
b u r n e d  = -  e l M , )= ( ^ ) 7
A similar argument leads to the fraction of light attenuated due to b
jb  _ f  b  \jT ota l
1 attenuated ~  , , r attenuated\ a  + b j
Thus, for light within the immunosensor
nbound _ Si DTotal
r att ~  r att
Total
attenuated
g l+ g 2 + g 3 + S 4
S i
£l + S l  + &3 + &4
53
&1 + S l +S3 + S 4
54
Si +S2 + S3 + S 4
p free    pTotal
r att ~  r att
Dscattered _  S  pTotal
r att — r att
rtdbsorbed _  S  uTotal
r att — r att
(5.5)
where P*tt is the power attenuated due to X
pTotat _  ^_ e ~{g\+g2+g3+g4)y>
P is the power at the start of the observation length 
and gi are attenuating factors as derived below.
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5.2.2.1 Light absorbed by the fluorophore
Within the observation length light can be absorbed by fluorophores that have become 
bound close to the surface due to the immunoassay reactions and by those that are still 
free in the solution within the cell as illustrated by Figure 5.5.
Bound 
fluorophores 
Waveguide surface with capture antibodies
Figure 5.5: The bound and fre e  fluorophore labels above the waveguide surface 
fo llow ing immunoassay reactions where the capture antibody is immobilised onto the 
waveguide surface.
Using Beer’s law the amount of light absorbed across the observation length is
S a b s o r b e d  ~  ^ 0  ~  e x P ( — ^ 6 ^ ) }
where 8 is the extinction coefficient for the fluorophore (in M '1 m '1)
Cb is the concentration of the bound fluorophore (in M)
L is the observation length (in m) 
and So = S(0) the surface power density calculated using equation (5.3).
However, So refers to the power density at the waveguide surface and therefore does 
not take into account the decay of the evanescent field into the layer of bound 
fluorophores.
Y Y V Y Y m V V Y V m Y V V V m Y Y Y W m Y
Evanescent
I
fj e(d Free fluorophores
300 - 400 
nm
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By equation (5.3)
S{x) = S0e~2MC
and so the total power absorbed by the layer of bound fluorophores is
m
Pa\7nd = S0^{l -  exp(- echL)}\ e~2^ d x
0
= S0fr{l -  exp(- ecbL ) } ~  {l -  exp(- 2 p 2m)}
2p2
where multiplication by width W ensures that units are correct
and m is the thickness of the bound layer.
Assuming this to be the only source of attenuation i.e. g2 = g3 = g4 = 0 in (5.5) above 
and equating Pa™nd -  Patt*™* leads to
Si -  _ ln 1 _ M L  (l _ e-**L Yl _ e~2lV» j  2p2P A '
(5.6)
A similar argument to that used to establish the power absorbed by the bound 
fluorophores determines the power absorbed by the free fluorophores as
P f% rbei = S0^ { l -  exp(- fcf L%\ e -2pi*dx
m
= S0W {l -  exp(- ec fL % ^ ~  {exp(- 2 P im)~  exp(- 2 p 2-^)}
2/?2
where Cf is the concentration of free fluorophore
and H is the height of the capillary fill cell.
and thus
S i  = - ln 1 _  S0W L _ e-SCf L\ e-2P2m - e~2PlH) 2p2P y A ’
(5.7)
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5.2.2.2 Scattering at the waveguide surface
Scattering of light from dielectric interfaces within waveguides is difficult to model. 
Extensive theories exist, for example, a sophisticated theory for scattering in 
symmetrical slab waveguides was developed by Marcuse [7]. This theory treats surface 
scattering as a form of radiation loss in which the irregularities in the surface couple 
energy into radiation modes above the surface. However there is little developed theory 
that allows easy simulation of multimode waveguides. Walter & Houghton [8] 
considered a monomode waveguide and developed the theory of Marcuse to produce a 
formula for the scattering of TE mode light from the surfaces of asymmetric 
waveguides as illustrated in Figure 5.6. A strong correlation between theoretical results 
from their model and experimentally achieved measurements supported the theory, thus 
making it ideal for application to a biosensor simulation.
Radiation modes 
O s |f t^ k n c Field distribution of 
guided mode
Cover
FC
'FS
Film/Waveguide n.
Substrate
Walter 8c Houghton's formula:
Figure 5.6: Guided and radiation modes o f an asymmetrical planar optical waveguide 
(Diagram adaptedfrom Figure 1 o f Walter and Houghton [8]) with their formula for 
the calculation ofpower loss due to scattering at the Film-Cover interface for TE 
propagated light within the waveguide.
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Walter and Houghton [8] quote a formula that was derived for TE propagated light. 
Since the majority of the experimental work against which the current biosensor model 
is to be verified used TM propagated light it was necessary to adapt the formula 
accordingly. A similar procedure to that adopted by Walter and Houghton was used to 
produce the formula for calculating the amount of light lost through scattering at the 
surface of a dielectric waveguide for TM propagating light.
AP = A2 ~ « c fo  cosjbW pctf ( n j+ « c ) ..
LPt  B PnWeq „j.
ko "c „ „2
f
-k,/ic {P Pr) + / g l  -
 _^____________________________________cos2(sJVfc)__________________________________________
r l  f c  cos2(sfJfc)+ s2 sin2{sWpg)}+ f |  cos2(slVf s )+ s2 sin2(i#"r a ) |
. _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ sin2^ ) _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ '
r i f e s i n 2(s^ r e )+.s2 cos2(5 ^ ) } + r e f s  sin2(slVf s )+ s 2 cos2^ ^ ) }
(5.8)
where AP is the change in power
Pt is the total power guided by the waveguide 
L is the observation length 
d is the thickness of the waveguide
b = ijl(nFko)2 ~ f i2)
Po =-j(p2 -(»s*o)2)
p i  = V is 2 - M o ) 2)
k0 = a)(s0jU0 )K = — is the wave number in vacuum
c
c is the velocity of light in vacuum.
<0 = 2j is the angular frequency of the light,
X is the wavelength of the light,
80 is the permittivity of free space,
po is the magnetic permeability of free space,
n is the refractive index of the medium,
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subscripts S, F & C refer to substrate, film and cover respectively, 
p is the longitudinal phase constant of the propagating wave
d  1 1Won = —  + ——  +* 0 2 2 2  nF ns p 0 nc p 2
Wfc is the distance between the cover and the maximum of the 
propagating wave
Wfs is the distance between the substrate and the maximum of the 
propagating wave
s = l ( konF f - f l 1
rC ~  l ( k onc  f  ~  fir
= 'J(/cons f  -  fir 
A is the roughness parameter as a length 
and B is the correlation length of the surface profile.
The formula requires values for the roughness parameter i.e. a measure of the 
perturbations of the scattering surface and the correlation length i.e. the length over 
which these perturbations repeat. In an immunosensor perturbations at the surface of 
the waveguide will be primarily due to the immobilised capture antibody and 
biochemical complexes resulting from the immunoassay reactions. Sloper & Flanagan
[3] have previously considered scattering of TE light at the surface of a waveguide 
within an evanescent field immunosensor and applied Walter & Houghton’s formula to 
establish values for both the roughness parameter and correlation length, values that 
will apply for the TM light model currently being considered.
Application of equation (5.8) allows a value for AP, the power lost due to scattering to 
be calculated. Assuming that this is the only source of attenuation and equating to 
equation (5.5) gives
(5.9)
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S.2.2.3 Absorption in the waveguide
In developing the technique of using a thin film waveguide as the transducer for an 
immunosensor, Sloper & Flanagan conducted extensive investigations into the 
properties of the films being used [9]. Thus values for the absorption of the waveguide 
were available for the thin film waveguides being modelled. Thus
(5.10)
where Oabs is the attenuation due to waveguide absorption.
The attenuation of light across the observation length can be calculated as
pTotal
r att (l_g-fo+£2+g3+g4)jp 
where P is the power at the beginning of the length
g2 = _ i„  _ e-2
84  &absL
and all other symbols are as defined during the derivation.
The proportion of the power lost due to each of the four possible causes of attenuation 
can be established using equation (5.5).
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5.2.3 Fluorescence resulting from the model
Fluorophores are essentially coloured dyes that accept light energy at a given 
wavelength and re-emit it at a higher wavelength. Fluorescence occurs because the 
molecular structure of the fluorophore resonates or vibrates when excited by light at an 
appropriate wavelength. Excitation causes electrons to be raised to a higher energy 
state, which only exists for a short time (in the order of nanoseconds). The energy is 
then dissipated as electrons are transferred between the higher and lower energy state 
and as a result some of the excitation energy is emitted as fluorescence [10].
The amount of light absorbed by both the bound and free fluorophore above the 
waveguide is calculated using equations (5.5), (5.6) and (5.7). The fluorescence 
resulting from this absorbed light is found by multiplying by the quantum yield of the 
fluorophore, a factor that reflects the fact that not all of the energy absorbed by the 
fluorophore is emitted as fluorescence.
5.2.3.1 Fluorescence resulting from scattered tight
The amount of scattered light that is absorbed by the fluorophores in the cell above the 
waveguide is dependent on the path of the scattered light through the layers of bound 
and then free fluorophores. The path length of the light will depend on the angle at 
which light is scattered. Since the calculation of the amount of scattered light involves 
an integral over the range of possible angles, the calculation of the path length and 
therefore the amount of the scattered light absorbed can be included within an 
adaptation of this integral.
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Figure 5.7 shows the possible path lengths for light rays in a layer of height h.
4 d l  M-
h
Figure 5.7: The path length (I) o f light rays at angle 0  in a layer o f thickness h across 
an observation length L.
The trigonometry of the layer dictates that
/ — * -
cos#
di = hta.nO 
d2 = L-htanO
The average path length of a ray is
/ 0 < x < d2
~l = l  j— d2 < x < L  
2 2
and therefore the weighted average is
ld2 + - d l 
2 2 1
h
L cos#
L - hXanO
(5.11)
Thus within the integration of equation (5.8) the value of the angle with the positive x- 
axis is calculated as
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The angle with the normal is
and L is calculated using equation (5.11), which by symmetry is valid for all angles. 
The amount of scattered light absorbed by the bound layer is thus
The amount of light absorbed by the solution layer is slightly more complex, as there 
will refraction at the interface between the bound layer and solution layer. The 
possibility that a particular ray does not reach the solution layer must also be taken into 
account. The possibility of total internal reflection at this interface was considered, but 
due to the nature of the interface i.e. bound antibodies, it was decided that the 
modelling of this interface would be too time consuming given the small impact on the 
resulting fluorescence of reflection at this point.
Thus scattered light absorbed by the free fluorophores is
bound (5.12)
APwhere —  (fir ) is the integral function using equation (5.8)
LP
and L(o) is the average length calculated using equation (5.11)
Ffree = L P \ ^ { p ry a >l W \ \ - e - af m )<ipr (5.13)
where 0'= arcsin
nb, nf are the refractive indices of the bound and solution layers.
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S.2.3.2 Calculation offluorescence resulting from Model A
The calculation of fluorescence follows the stages shown.
i) use characteristic equation of waveguide (equation 5.1) to determine p;
ii) equate power propagating in the three-layer system (equation 5.2) with the 
input power and determine a value for the constant A;
iii) calculate waveguide surface power density (equation 5.3) using A;
iv) calculate the fraction of power scattered (equation 5.8);
v) calculate values for gi using equations (5.6), (5.7), (5.9) & (5.10);
vi) calculate the amount of power absorbed by the bound and free label using 
equation (5.5);
vii) calculate amount of scattered power absorbed by fluorophores within the 
immunoassay using equations (5.12) & (5.13);
viii) add all absorbed powers and multiply by fluorophore quantum yield.
The physical parameters of the system that may impact on the resulting fluorescence 
are therefore:
i) input power;
ii) coupling efficiency;
iii) waveguide thickness;
iv) width of the cell;
v) height of the capillary fill cell and
vi) the observation length.
5.3 Model B -  Multilayer coupling 112
5.3 Model B -  Multilayer coupling
The sensor employing multilayer coupling, modelled as Model B, involves a series of 
layers of appropriate thickness and refractive index. Coupling of light into the 
waveguide is achieved evanescently. Figure 5.8 illustrates the layers and the electric 
field within each layer resulting from light incident on the lower glass surface. 
Similarly to the resonant mirror device [11] at a particular angle of incidence, light 
coupled into the waveguide is at a maximum i.e. resonance is achieved. This resonance 
is reflected in the amount of emitted fluorescence resulting from a fluorophore labelled 
molecule involved in the immunoassay performed on the waveguide surface.
SOLUTION IN CFD 
(n = 1.34)
IMMUNOASSAY LAYERS
BUFFER 
(n= 1.44)
SUBSTRATE 
(n = 1.51)
out
Figure 5.8: The layers used to achieve evanescent coupling into the waveguide in the 
multilayer coupled M odel B immunosensor. The resulting electric f ie ld  within each 
layer is also illustrated.
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Calculation of the emitted fluorescence follows a similar technique to that determined 
for Model A although the analysis of the electromagnetic field values differs. The 
resulting calculation will be dependent on the angle of incidence of the light, thus 
allowing a series of calculations to be performed for a range of angles, matching the 
angle scan used to determine resonance. The analysis given is for the TM mode of 
propagation, a similar set of results can be derived for the TE mode.
5.3.1 Electromagnetic field profile
Consider a series of layers with TM polarised light incident at the first interface (Figure 
5.9). At each interface there will be an incident and a reflected component of light. 
Derivation of the fields in a multilayer system is a common technique in applied optics
[12] and has not been repeated here.
Layer 2: Waveguide
Layer 1: Buffer
Incident .Reflected Layer0: Glass x
Figure 5.9: Light incident at the firs t interface in a multilayer system
The fields in layer i can be written (following Appendix E)
E  = Aj X  o. - a
v*i ku
eJa‘x Bi — , 0, —
k,
,-jatX (5.14)
and
where
H = ^ L
Zo
4|(0, 1, 0)eJa'x 1 ,0  (5.15)
A t is the incident coefficient
B i is the reflected coefficient
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kz = &osin0
c
to is the angular frequency of the light 
c is the velocity of light in vacuum 
ni is the refractive index of layer i
a i
Zo is the characteristic impedance 
and i denotes the layer.
At each interface boundary conditions can be applied, i.e. the fields parallel to the 
interface must be continuous. Thus the electric field in the z-direction and the magnetic 
field in the y-direction must be. equal at each interface. Applying this to equations 
(5.14) and (5.15) leads to
and
\A,\eJa‘X
ki
' a '
*/
=  |4i+1 J aMx <*i+l 
&i+1 )
+ Aj+il -M+i* <*i+l 
V ^ /+1)  
(5.16)
! h . \A \e ^ x +— \e~JCCiX = | Ai+i \e^ai+lX + ^ \ B i+l\e-Ja^ x
Z q Z0 Z q z 0
Making the assumptions that the coefficient of the incident light is normalised and that 
there is no reflected component in the final layer i.e.
K l = i  
l5 « - i l = 0
implies that for m layers there are 2m-2 coefficients and a set of 2(m-l) linear 
equations from which the coefficients may be determined. Thus both the electric and 
magnetic fields can be established at any point within the multilayer for any given 
angle of incidence. Once the fields are known, equation (5.3) can be used to calculate 
the waveguide surface power density and the emitted fluorescence can be determined in 
the same manner as for Model A.
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5.3.2 Laser Beam Divergence
The calculations used to determine the coefficients of the electromagnetic fields 
derived above are sensitive to the angle of incidence of the light and are scaled to the 
input power. A perfectly collimated beam of light is not a realistic possibility [13] and 
laser beams are found to be Gaussian in nature. Moreover, the incident area of the beam 
at large angles will be significantly larger than the beam area at normal incidence 
(Figure 5.10). Light incident at the extremes of this area may vary significantly in 
power and angle of incidence from light incident at the centre. The corresponding 
electromagnetic fields will vary and the fluorescence calculation will return different 
values. Thus the divergence of the beam was considered.
PLANE OF INCIDENCE
Area 1 Area 2
LASER
Figure 5.10: Area o f  incidence o f  a diverging laser beam incident on a plane a t angles 
o f  incidence ( f  and 3 ( f  illustrating that the area o f  incidence fo r  3 ( f  incidence (area 2) 
is greater than that fo r  incidence at ( f  (area 1).
5.3.2.1 General laser beams
The wide variety of lasers currently available indicated that it would be difficult to find 
a simulation that would adequately model any laser. Thus it was decided to use the very 
general laser theory as a starting point in this model.
The variation in intensity from the centre of a laser beam diverges from a point at 
which the beam diameter is smallest, the beam waist wo [14]. The Rayleigh length is
the distance from the waist at which the diameter of the beam has increased to V2w0 
and this length defines the Rayleigh range. Within this range the beam varies with a 
small divergence given by
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where k  is the wavelength of light
and wo is the beam waist.
The variation of the diameter with distance along the direction of propagation, x, is
w(x)=w0 
where xo is the Rayleigh length.
, *2 
1 + —
*0
Within the Rayleigh range the beam is considered paraxial [15] and thus the paraxial 
solution to the wave equation for a light beam propagating in the x-direction [16] 
applies:
with
~P'
1 j k  Q 
w{jc)2 27?(jc) - M * )
(5.17)
where A is the normalisation constant 
wo is the beam waist diameter
w(*)=wo J l + 3
( 2 \  
i + *
X\  * J
r (x)=
0 (r)=  arctan
r \  x
*o)
cm .k -  —  is the wave vector in medium with refractive index n
c
co is the angular frequency of the light
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c is the velocity of light in vacuum 
n is the refractive index
and is the Rayleigh length.
5.3.2.2 Application to the model
In order to include the beam divergence within the model it was assumed that the beam 
is composed of a bundle of rays that each follow a straight-line path. A two- 
dimensional array of incident field elements was created for a range of y and z values 
describing the normal incident area of the beam (Figure 5.11).
Array of points that define area 
Figure 5.11: Illustrating the incident area o f  the light beam.
Initially the values of the electric field were calculated using equation (5.17) for each 
pair of y, z values with A = 1. The surface power density is given by
AREA OF INCIDENT LIGHT
a *  *  * * s
Replacing Hy with — ~
2
Ex this becomes
where n is refractive index
and Zo is the characteristic impedance.
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The total power incident on the surface is thus
-^ max zmax
B 2 — rj  j  E]dyz(5.18)
>n« Zmbi
where B is a factor scaling the electric field according to the power of the 
incident light.
A two dimensional Gaussian Quadrature was used to perform the integration. Values of 
Ex were calculated using a bi-cubic spline interpolation from the two dimensional array 
of initial electric field values. Equating the result to the known incident power of the 
laser enabled a value for B, the scaling factor, to be determined and the array of electric 
field values can be scaled accordingly. This provided a symmetric array of electric field 
values that reflects the Gaussian variation within the total incident power normally 
incident on a surface.
In order to consider variation within the immunosensor the model may be incorporated 
into a Monte Carlo procedure and thus any calculations must be performed at optimum 
speed. The number of points that need to be included within the Gaussian Quadrature 
was investigated (Figure 5.12) and it was concluded that a 10 point Gaussian 
Quadrature would be sufficient to provide fast results whilst not compromising the 
accuracy of the calculation.
0.57
0.56
055
0.54|
£ 0.53
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0.51
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049
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Number pants in Gaussian Quadrature 
>> _ max z max
Figure 5.12: Value o f  the integral J J Exdydz calculated using a Gaussian
y_ nun z_  min
Quadrature with varying number o f  points.
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A two dimensional array corresponding to the resulting angle of incidence for each of 
these rays was also determined by treating the laser as a point source. These values 
reflected the divergence of each ray from the normal and were subsequently used to 
adjust the angle of incidence in any power calculations.
At this point the arrays of electric field values and incident angles values reflect the 
divergence of the beam for normal incidence on a surface. Experiment showed that to 
interrogate a sensor based on a multilayer coupling technique the incident angle would 
need to range between 70° and 80° [1], Thus the model must incorporate the spread of 
the incident area resulting from incidence at any angle within this range.
Since the propagation of light is within the x-plane, the expansion of the incident area 
caused by incidence at an angle occurs in the z-direction only. Assuming that the 
electric field associated with a particular ray before the beam is incident on the surface 
remains constant, the value of z relating to each ray was adjusted according to the 
projection of the beam onto the surface at the particular angle of incidence (see Figure 
5.13 and Appendix F).
PLANE OF INCIDENCE
Figure 5.13: Projection o f  the values o f  the z  distance onto the area o f  incidence. A t 
normal incidence values z t correspond to electric f ie ld  values Et. After incidence a t an 
angle the electric f ie ld  values remain the same but their corresponding z values have 
been adjusted according to the projection o f  the ray onto the surface.
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Within Model B any calculation of power at a particular point becomes a two- 
dimensional integration of the power resulting from each of the incident rays i.e.
3Viax z max
P = \  \P(y,z)dydz
y  nun z mm
The integration is performed using a two-dimensional Gaussian Quadrature. A bi-cubic 
spline interpolation of the electric field array with respect to the y and z arrays and a 
cubic spline interpolation of the divergence angle array with respect to the z array are 
used to provide an incident field coefficient and angle of incidence for the equations 
describing the multilayer system (5.16), which can be solved using an LU 
decomposition for the incident and reflected coefficients within each layer. The electric 
and magnetic fields and hence the power at the point in question can be then calculated 
and returned to the integration.
Thus, prior to the calculating the fluorescence resulting from the system, it is necessary 
to establish the precise electric field and angle of incidence at each point of incidence 
(Figure 5.14).
AREA OF INCIDENT LIGHT
Array of points that define area RAYS
,NGLES
SOURCE
Figure 5.14: Illustration o f the incident area subtended by a normally incident beam of 
light with divergence in the incident light beam.
The steps necessary to establish the field and angles are
i) initialise a two-dimensional array of y and z values that define the area 
subtended by a normally incident light beam diverging from a point source;
ii) initialise an array of divergence angles relating to the z values in the area
array i.e. 0  = arctan in Figure 5.14;
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iii) establish a two dimensional array of electric field values corresponding to
each pair of y-z values using equation (5.17) and assuming A = 1
iv) calculate incident power using equation (5.18) and equate this to the known 
incident power to establish a value for A;
v) scale the electric field values accordingly;
vi) calculate the projection of the incident area resulting from incidence at the 
given angle and scale the z values to reflect the values within the new area.
The fluorescence emitted due to light incident at a particular angle is then calculated as 
detailed for Model A, replacing any power calculation with a two-dimensional 
integration as described above. Similarly to Model A, the physical parameters of the 
system that may impact on the resulting fluorescence are:
i) input power,
ii) coupling efficiency;
iii) waveguide thickness;
iv) width of the cell;
v) height of the capillaiy fill cell and
vi) the observation length.
5.4 Verification
Verification of the light module, i.e. ensuring that the output from the model reflects 
the output that would be achieved experimentally, is difficult to do analytically and will 
be best done by fitting results from the model to experimental results. However, it is 
possible to demonstrate that the equations used in the description of each model lead to 
physically real electric fields.
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5.4.1 Model A -  Prism coupling
Model A allows the electromagnetic fields in a three-layer system to be determined and 
used to calculate the power at any point in the system. The experimental arrangement 
simulated by this model (Figure 5.15) consisted of a substrate corresponding to the 
lower surface of the capillary fill cell which was constructed from Pilkington float glass 
with a refractive index of 1.5196.
The film was an indium phosphate waveguide with a layer of immobilised antibody on 
the surface, which had a thickness of 380.014 nm (being the deposited thickness, 380 
nm, plus the adjustment due to Tiefenthaler & Lukosz [6] for a four-layer sensor i.e. 
equation (5.4)). The thin film waveguide had a refractive index of 1.6 [9].
0.2 mW 
He-Ne 
543.5 nm 
LASER
SALINE WITH FREE MOLECULES n = 1.3424
MMUN0A55BV"
INDIUM PHOSPHATE WAVEGUIDE n = 1.6 380.014 nm
PILKINGTON FLOAT GLASS n = 1.5196
Figure 5.15: Values used in Model A, prism coupling arrangement, to verify the 
electric and magnetic field values calculated by the model.
The cover was a saline solution containing the analyte and the labelled antibody with a 
refractive index of 1.3424 calculated using the Clausius-Mossotti formula for refractive 
indices of compounds:
w2 _  1 M n 2 - 1
n j ' t  Z  | _ j  Uj +  Z
where n is refractive index,
V is molar volume, 
x is mole fraction
the subscript T denotes the total compound 
and subscript i refers to the each distinct component of which there are N [ 17].
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The light source was a 0.2 mW Helium-Neon laser of wavelength 543.5 nm coupled 
into the waveguide by means of a prism, with an assumed coupling efficiency of 0.81, 
this being the maximum coupling efficiency achievable using a prism [18]. The width 
of the waveguide was.O 4 m and the observation length for resulting fluorescence was 1 
mm.
The immunoassay layer was a sandwich assay for IgG with initial concentration values 
[analyte]o = 20 x 10'9 M 
[capture antibody]o = 30.9 x 10"9 M 
[labelled antibody]o = 250 x 10'9 M 
and association constants
capture -  analyte Kc = 5.67 x 109M_1 
analyte -  labelled antibody KL = 1.52 x 1010 M '1.
The modified Markov approach described in Chapter 4 was used to determine that the 
resulting equilibrium concentrations of bound and free labelled antibody were 
[bound label] = 2.99 xl0‘8 M 
and [free label] = 2.20 x 10'7 M.
Figure 5.16 illustrates the electric and magnetic field profiles across the three-layer 
model resulting from the application of the three-layer system of equations to the
Model A system described above. The fields correspond with those expected from a
dielectric slab waveguide, 
a) b)
Electric field
2000
-1000 -400 -200 0 200 400 -800 -400 -200 0 200 400-1000
Figure 5.16: Plot ofTMfields through the three-layers described by Model A
a) Electric field (E,)
b) Magnetic field (Hy)
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5.4.2 Model B -  Multilayer coupling
Model B modelled the fields through a multilayer system. Applying this to an 
immunoassay at a waveguide surface the model became a six-layer model as illustrated 
by Figure 5.7. The substrate was Pilkington float glass substrate with refractive index 
1.5196, a 750 nm layer of buffer, refractive index 1.44 was placed above the glass and 
a thin film waveguide of iron phosphate, thickness 150 nm, refractive index 1.7 was 
deposited onto the buffer layer.
The exciting light was a 5 mW Helium-Neon laser of wavelength 632.8 nm. The width 
of the waveguide was 0 4m  and the observation length for resulting fluorescence was 1 
mm.
The immunoassay, a sandwich assay for IgG as detailed above, was considered as a 
further three layers. The thickness of both the capture and bound layers were calculated 
by assuming that the molecules were spherical and hexagonally close packed at each 
surface as shown in Figure 5.17. The thickness of the capture layer was taken as the 
diameter of the capture antibody molecule and the thickness of the bound layer as the 
combined diameters of the analyte and labelled antibody. Thus for the sandwich assay 
for IgG, where the capture antibody is an anti-IgG antibody, the analyte is IgG and the 
labelled antibody is an allophycocyanin labelled anti-IgG antibody the thicknesses were 
7 nm for the capture layer and 15 nm for the bound layer.
Labelled antibody
Analyte
Capture antibody
Figure 5.17: Layers representing the capture antibody and the bound analyte and label 
layer. Thickness o f capture layer is the diameter o f the capture antibody and the 
thickness o f the bound layer is the combined diameters o f the analyte and labelled 
molecule.
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The real parts of the refractive indices were calculated using the Clausius-Mossotti 
formula assuming the saline solution will have diffused into all gaps and that the 
refractive index of an antibody is 1.5 [19]. The imaginary parts of the refractive index 
relating to the presence of the absorbing label were calculated [20] using
ci& lln(lO)
n im  ~  ~A 4 71
where nlm is the imaginary part of the refractive index
Ci is the concentration of the label 
8 is the extinction coefficient of the label 
and k  is the wavelength of the incident light.
The characteristics of the layers describing the system are shown in Table 5.1.
Table 5. 1: Characteristics of the multilayer system used in Model B.
Layer
Thickness
(nm)
Refractive Index 
Real part Imaginary part
Glass 1.51958 -
Buffer 750 1.44 -
FeP04 waveguide 150 1.7 -
Capture antibody 7.14 1.3428 -
Bound layer 15.47 1.34239 0.000959
Solution - 1.33284 1.45 x 10"6
The calculated power at the waveguide surface resulting from application Model B 
across a range of angles is illustrated in Figure 5.18, demonstrating the existence of the 
resonant peak expected.
I
03
75.8 7074 748 748 752 75.474 2 744 75 758
Figure 5.18: Normalised power at the waveguide surface calculated using Model B for 
a range o f incident angles
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5.5 Comparison with experiment
A Nelder-Mead optimisation procedure incorporating the algorithm for determining the 
fluorescence resulting from Model B, the multilayer coupled model, was used to fit 
existing experimental data [21]. The detection module, i.e. the module that determines 
the output voltage resulting from the sensor, was also incorporated into the algorithm as 
the experimental data available recorded output voltage for a range of incident angles.
The experimental data was produced using an immunoassay for hCG. The values for 
the equilibrium concentrations of the biochemical species resulting from the 
immunoassay were determined using the modified Markov method described in 
Chapter 4. Initial concentration values for the assay were
[analyte]o = 24.2 x 10‘9 M 
[capture antibody]o = 30.9 x 10'9 M 
[labelled antibody]o = 250 x 10'9 M
with association constants
capture -  analyte Kc = 2.2 x 109 M'1 
analyte -  labelled antibody Kl = 4.1 x 1010 M-1.
The immunoassay module produced equilibrium concentrations leading to 
concentrations for bound and free labelled antibodies
[bound labelled antibody] = 4.76 x 10-8 M 
[free labelled antibody] = 2.02 xlO-7 M
The optimisation assumed that the concentrations resulting from the immunoassay 
element of the model were fixed and thus the immunoassay element played no part in 
the optimisation procedure.
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Previous studies of the multilayer coupling method have shown that the thickness of the 
waveguiding layer impacts on the angle of resonance [21]. The coupling factor 
determines the amount of power entering the system and thus will affect the output 
voltage achieved. Therefore initial fitting was performed with waveguide thickness and 
coupling factor as the variables. Figure 5.19 and Table 5.2 illustrate the results of this 
fitting, indicating that the experimental values used were valid.
Table 5.2: Values of factors determined using the algorithm for the 
multilayer coupled Model B with the detection module to fit experimental 
data for the output voltage from a multilayer coupled CFD containing an
F ac to r E xperim en tal value Fitted  value
Waveguide thickness 150 nm 148.24 nm
Coupling factor 1.0 0.97
cn
0.4 -
76.573.5 74 74.5 75 75.5
Angle of incidence
Figure 5.19: Results o f  using the M odel B algorithm with the detection module to  f i t  
data resulting from  the detection o f  voltage output from  an immunoassay perform ed on 
the surface o f  the multilayer coupled CFD.
Squares -  experimental data Smooth line -  f it te d  curve
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Chapter 6 
Detection module
A fluorescence optical immunosensor involves three main elements, the immunoassay, 
the transducer, in this case the waveguide with prism coupling or the waveguide with 
multilayer coupling described previously, and the detection of the emitted fluorescence. 
The amount of fluorescence resulting from the sensor is small and therefore it is usual 
to use a device such as a photomultiplier tube (PMT) to amplify the signal into a 
detectable current or voltage.
6.1 Arrangement o f  detection system
Figure 6.1 shows the physical arrangement used to detect the fluorescence emitted from 
the capillary fill device. A collector lens, or arrangement of lenses, is used to focus the 
light through a longpass filter, a bandpass filter and onto the cathode of a PMT. The 
filters are used to limit the amount of stray light or breakthrough laser light reaching the 
PMT. Passing the output current from the PMT across a load resistor determines an 
output voltage.
CAPILLARY FILL
DEVICE
Figure 6.1: Arrangement o f  the system used to detect the em ittedfluorescence. The 
fluorescence em itted from  the CFD is focussed through a set o f  filters onto the cathode 
o f  a photom ultiplier tube.
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6.1.1 Modelling considerations
The efficiency of a PMT depends on the wavelength of incident light, as do the 
emission of the fluorophore and the transmission of the filters. Thus any calculation of 
current resulting from the PMT must be undertaken for the range of wavelengths that 
will be present.
The objective of the detection module of the model is to calculate the voltage and 
associated noise resulting from the incidence of the emitted fluorescence onto the 
detection system described
6.2 Model o f detection system
Extensive literature exists detailing the modelling of photoemmissive events, including 
major contributions on extending theories to the modelling of a PMT [1]. However, the 
majority of these theories are at a level of complexity that does not lend itself to 
incorporation into the simulation being considered in this thesis. Their use of moment 
generating functions and saddle point calculations would lead to unacceptable 
computation times when included within an iterative procedure. It may also lead to 
over parameterisation of the model. Consequently, the less complex equations for 
output signal and noise current resulting from a PMT derived by Kingston [2] have 
been applied.
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6.2.1 Photomultiplier Tube
A PMT contains a cathode, an anode and several intermediate dynodes within a high 
vacuum environment (Figure 6.2). The electric field applied to the dynodes accelerates 
the electrons released from the cathode towards the first dynode. The energy of the 
each incident electron causes the release of several electrons from the first dynode. 
These secondary electrons are then accelerated towards the second dynode where the 
process is repeated. The current resulting at the anode is a result of these 
multiplications and allows a tiny incident current to be magnified into a current large 
enough to be detected.
p m t ^  ~r<~ DYNODES h |
P M  I f j  „  j  ^  ^  J
SOCKET, 
PIN No
OUTPUTPOWER SUPPLY
CIRCUITRY WITHIN A PMT 
+2Vp +4Vp
+Vp +3Vp
•out
+nVp
SCHEMATIC DIAGRAM OF CURRENT AMPLIFICATION WITHIN A PMT
Figure 6.2: Highly schematic diagram illustrating the amplification o f  incident current 
by acceleration o f  electrons between successive dynodes within a photom ultiplier tube.
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6.2.1.1 Kingston’s derivation of signal current resulting from the PMT 
The current incident on the dynode due to the signal only is
i -  ^  m nlQ ~ ---- (0-1)hv
where r\ is the efficiency of the cathode
e is the charge on an electron 
Ps is the incident signal power 
h is Planck’s constant 
and v is the frequency of the incident light.
The mean-square current output from the PMT resulting from the signal is therefore
/ J = G w 2
h v
(6.2)
where G = m2n is the power gain of the PMT
m is the average gain per dynode 
and n is the number of dynodes.
6.2.1.2 Kingston’s derivation for noise current resulting from the PMT 
The mean-square noise current in a vacuum diode is
iff = 2 eiB
where e is the charge on an electron
i is the incident current 
and B is the bandwidth.
Defining P(k) as the probability of k secondary electrons being emitted by a particular 
dynode produces mean and mean-square values of k
00   00
k - m  -  y kP(k) and k 2 -  J],k2P(k)
k=o k=o
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Thus for the first dynode of the PMT the mean-square noise current is
ijf = 2ei0B k2
and the excess noise produced by the current from the first dynode is
=  2
V J excess \  J
which at the output will be
^  j  = m2n 22ei0B^k2 - m 2>j
since the current from the first dynode will be subject to a gain of m2(n_1)
Similarly the excess noise at the output due to the current from the second dynode will 
be
= m2n 42ei0B ^k2 - m 2^
At the output the total excess noise is
(*)v  / out -  2ei0B m2n + ^k2 - in 2 ] Y m 2n 2lm' 1
= 2 eiQBm2n 1 +
^ f=l
1 ” _ 1 Replacing the summation with —  r since Y jc 1 =    for n »  1, the
^  1— x
square output noise current is
f 't f ]  = 2  ei0BGT
v  1 out
mean-
where G = m2n is the power gain
and T = k - m  .
m(m-l) is the noise factor.
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The probability distribution P(k) is considered to Poissonian for a PMT [2,3] and thus 
k 2 =m2 +m 
and the noise factor can be reduced to T = m
m - 1
However, the signal at the output will also contain a noise element due to any 
background power incident on the cathode and due to the dark current of the PMT 
itself Thus the total noise signal at the output of the PMT, assuming the incident 
current given by equation (6.1) and a similar form for incident current resulting from 
background power, is
T  2rjTGe2B
lN ~ hv
huj_
ne JJ
+ " « H  (6.3)
R
where rj is the efficiency of the PMT
T = m is the noise factor. 
m - 1
G = m2n is the power gain of the PMT
m is the average gain per dynode
n is the number of dynodes.
e is the charge on an electron
B is bandwidth
h is Planck’s constant
v is the frequency of the incident light.
Ps is the incident signal power 
Pb is the incident background power 
id is the dark current
and — is the shot noise associated with the electrical circuit
R
where ke is Boltzmann’s constant
T is the temperature 
and R is the load resistance.
6.2 Model o f  detection system 136
It should be noted that equation (6.3) differs slightly from the formula quoted in 
Kingston’s book, which is dimensionally incorrect. However, the derivation is identical 
and it can only be assumed that the inaccuracy in the quoted formula is due to a type 
setting error.
6.2.1.3 Dark current
In the absence of any illumination a PMT will still produce a slight current, known as 
the dark current. This current is a result of thermionic emission from the cathode and is 
calculated according to the Richardson-Dushman equation [4], which relates the 
emission current to the work function and temperature of the cathode. Assuming that 
the work function and photoelectric threshold energy are equal; an assumption that is 
not totally accurate for the many materials used in electronics today as will be 
discussed later, the dark current is given by
hvc
id = 120T2Ae k«T (6.4)
where T is the temperature of the cathode
A is the area of the cathode in cm2 
h is Planck’s constant 
vc is the cut-off frequency of the PMT 
and kB is Boltzmann’s constant.
6.2.1.4 Gain o f the PMT
Hamamatsu [5] give the empirical formula for the average gain per diode, m, as
r
m = A
n + 1
where V is the applied voltage
n is the number of dynodes 
and A and a are constants dependent on the dynode material and geometry
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The current gain across a PMT having n dynodes is therefore
.np  -  m
A n
(«+i r
=  K V p
■Van
An
where K  =
(*+i r
and p = an are constants.
The logarithmic graph of voltage versus gain given by Hamamatsu for the R928 PMT 
device as used in the experimental arrangement of the immunosensor was used to 
determine values for K and p and therefore A and a. The average gain per diode could 
then be calculated as
/  T, \  0.750561
(6.5)m = 0.1691762
n + 1
6.2.2 Filters
Filters are used for isolating the band of light spectrum that is of interest [6]. A 
longpass filter allows light of longer wavelengths to be transmitted, whereas a bandpass 
filter passes a narrow region of wavelengths around a central wavelength. The filters 
used in the detection system will have a higher transmission at some wavelengths than 
at others. Values for the filter transmission as a function of frequency were determined 
from a typical transmission curve for the types of filter involved (Figure 6.3). 
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Figure 6.3: Transmission curves fo r  filters
a) bandpass f ilte r  a t 700 ± 40 nm
b) longpass at 640 nm
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6.2.3 Integration over frequency
Equations (6.2) and (6.3) both contain terms that are dependent on the frequency of the 
incident light. The fluorescence output from the capillary fill device may range over a 
number of frequencies with the emission of the fluorophore being dependent on the 
frequency. In order to account for the range of frequencies that may be present 
equations (6.2) and (6.3) are rewritten as
ij  = Ge2 (PF + P g f  
and (6.6)
4  = 2TGe2B(PF +PB)+ 2TGeBid + i M ®
R
p  v2
where Pv = "^°r f emm(y\j(v)filter{y)ci v
hvexc '
pB = n{vexc )f,lter(vexc )
Pfiuor is the fluorescence output from the capillary fill cell 
Pbreak is any laser light that has broken through the cell 
Vexc is the excitation frequency
emm(v) is the normalised emission intensity of the fluorophore at v 
rj(v) is the PMT efficiency at v
filter(v) is the normalised filter transmission intensity at v 
and Vi and Vi determine the range of frequencies.
The emission spectrum for a fluorophore output is normally measured as a function of 
wavelength and must be converted to a function of frequency for the above calculation.
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Given
«6 ,>
where Q is the energy of the fluorophore
K is a constant 
X is the wavelength 
and Ex are the emission values.
Let the emission value at the corresponding frequency v be
/
v Sv
Since c= \X
SQ SQ Sv _  c SQ   c_
“  A  ^ A •* 1
SX Sv SX x 2 Sv £
Putting this into equation (6.7) leads to
~ I y = K E X 
2r
Equation (6.6) must encompass the whole range of possible fluorescence, thus it 
requires
i
V1
I y d V = \
1^
Rewriting this in terms of A. leads to
1K =
ExdX
and thus a conversion factor
/  E ^Jv
c ^ E xdX
h
can be applied to the wavelength emission values to determine the appropriate values in 
terms of frequency.
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6.2.4 Calculation of output voltage
The calculation of the output voltage and associated noise follows the following stages.
i) calculate fluorescence resulting from the light module;
ii) calculate the signal and associated noise current using equation (6.6);
iii) apply V = iR where V is voltage and R the load resistance.
The physical parameters of the detection system that may impact on the value of the 
output voltage are
i) the dynode voltage;
ii) the bandwidth and
iii) the resistance.
6.3 Verification
Implementation of the detection system requires that the code accurately calculates the 
values of the current and hence voltage determined as a result of using the PMT system 
to detect the fluorescence resulting from the capillary fill device. Any comparison with 
experimental data that includes the detection system will also need to include the 
fluorescence modelling and has been considered in Chapter 5. However, it is possible 
to verify some of the internal calculations of the detection system against data existing 
for the PMT device employed.
6.3.1 Dark current
Equation (6.4)
hvc
id = \20T1Ae k*T
calculates the dark current of the PMT device. The specification for the R928 
Hamamatsu PMT gives values 
A = 1.92 cm2
and
vc= 3.33 x 10'14 s'1
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Equation (6.4) for T = 300 K gives the value id = 1.439 x 10'16 Amps whereas the 
specification quotes a typical dark current value of 3 nA. The disparity between these 
results warranted further investigation.
The Richardson-Dushman equation is based on the initial assumption that the work 
function and the photoelectric threshold energy of the cathode are equal. It is 
acknowledged that this assumption is not accurate for the materials currently used in 
electronics. Hamamatsu investigations have shown that dark current in a PMT is 
comprised, not only of thermionic emission, but also of ionisation of residual gases and 
leakage current from the glass stem base and socket [5], The latter dominates when the 
operating voltage of the PMT is below 800 V, which is the case in this instance. There 
is, as yet, no theoretical development in relation to these other dark current sources. 
The closest research is the work of Kharin et al on melted pools of zirconium oxide [7] 
which unfortunately does not apply. Thus, given the disparity between theory and 
practice, for the model being considered, it was decided to use the Hamamatsu quoted 
figure for dark current id = 3 x 109 A.
6.3,2 Gain of the PMT
Equation (6.5) was derived for calculating the value of the gain per dynode within the 
PMT. Figure 6.4 illustrates the comparison between the gain calculated using this 
equation and the gain chart illustrated by the PMT specification, showing good 
agreement.
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Figure 6.4: Current gain as a function o f  applied  voltage. 
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6.4 Calculation o f  sensitivity
“At such low levels of analyte even trace amounts of 
interferents can become significant.”
Foulds et al [8]
The accepted definition of sensitivity is the lowest detectable concentration of analyte 
distinguishable from measurements made with no analyte present. Figure 6.5 illustrates 
a typical calibration curve for a sandwich assay. Applying the definition of sensitivity 
to this figure the lowest concentration that can be determined from the graph occurs at 
an analyte concentration, s, such that the signal on the graph at the point s is equal to 
the signal at zero analyte plus the error in the zero analyte signal plus the error in the 
signal at s analyte i.e.
S0 + N 0 + N s = S s
where S refers to the signal
N refers to the noise or error in the signal 
the subscript refers to the analyte concentration 
and s is the sensitivity.
20 -
15-
Analyte concentration
5
Figure 6.5: Calibration curve fo r  a  sandwich assay showing the calculation o f  the 
sensitivity (s) o f  the curve illustrated.
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The calibration curve resembles a cubic polynomial and fitting data to such a curve 
proved successful. Thus the sensitivity of a set of data from the immunosensor 
model was calculated by
i) fitting the output signal to a cubic polynomial S;
ii) fitting the noise signal to a cubic polynomial N;
iii) solving the equation *S(o)+ N(o)+ N(s) = S(s) for s > 0.
The solution of the equation was established using a bisection to locate the root and a 
Newton-Raphson procedure to determine an accurate value.
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Chapter 7
Application of the model to the analysis of noise and variation within
an immunosensor
Once each of the component modules had been fully implemented, tested and the 
results generated verified against experimental data, a full model of an evanescent field 
immunosensor was constructed and used to study some of the sources of noise and 
variation within the system. Time restrictions dictated that the results of the preliminary 
investigations discussed here were not pursued beyond the initial stages. However, the 
results demonstrate the range of investigations that can be undertaken using this type of 
model and the variety of information that can be accumulated.
7.1 Noise
Noise is a generic term that refers to any unwanted component of a signal [1]. In the 
case of the evanescent field immunosensors modelled here, noise refers to any part of 
the output voltage that does not result from fluorescence of the bound labelled molecule 
within the immunoassay. Noise or variation may occur within a sensor or the variation 
may be between different instances of the same sensor. The model allows sources of 
both within sensor and between sensor noise to be considered and the resulting effects 
on sensitivity to be determined.
7.1.1 Between sensor noise
A degree of variation may occur between instances of the same sensor and this is 
known as between sensor noise. These errors may produce a variation or error into the 
output voltage and therefore have an impact on the reproducibility and reliability of the 
sensitivity that can be achieved.
In the immunoassay element variation in the concentrations of the initial species added 
and the association constants will produce between variations in the amount of bound 
label. This variation may occur due to measurement of the concentration of the added
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species or changes in the activity of the immobilised capture antibody. Previous fitting 
of experimental data (Section 4.6) showed that the values of the association constants 
could also be altered by immobilisation or labelling.
Within the light module both the physical dimensions of the system and the coupling 
and specifications of the power source may introduce between sensor error. The 
difference in value of the physical parameters of the system may be introduced due to 
manufacturing tolerance for example and variations in the incident power may occur in 
the progression from laboratory to field instrument. Similarly within the detector the 
applied voltage may impact on sensitivity. Table 7.1 lists the sources of between sensor 
noise, indicating those that have been considered in the current model of the 
immunosensor.
Table 7.1: Sources of “between sensor” noise indicating the appropriate module and 
whether the current model deals with the particular source_____________________
Module Considered within project Not considered as yet
Immunoassay Concentrations Cross reactivity
Association constants
Light Beam divergence Scattering*
Coupling
Incident power
Physical dimensions
Detection Dynode voltage
* has been considered as ‘within sensor’ noise
Given that the immunosensor model presented assumes a single immunoassay, i.e. one 
analyte, one capture antibody and one labelled molecule, cross-reactivity will not be a 
problem and need not be considered. However, future development of the model is 
likely to consider multianalyte detection. Obviously at this point cross-reactivity may 
become a significant source of noise and thus would be a vital factor to be included 
within the noise analysis.
7.1 Noise 147
7.1.2 Within sensor noise
Within sensor noise refers to variations in the output signal that occurs as a direct result 
of some element of the system. This may be due to electrical noise within the PMT or 
due to fluorescence excited by light scattering into the unbound labelled molecules. 
Noise resulting within the sensor is consistent for the sensor arrangement and may be 
difficult to eradicate. Thus, within sensor noise directly affects the sensitivity that can 
be achieved for a particular device. Table 7.2 lists the sources of within sensor noise, 
indicating those that have been considered in the current model of the immunosensor.
Table 7.2: Sources of “within sensor” noise indicating the appropriate module and 
whether the current model deals with the particular source___________________
Module Considered within project Not considered as yet
Immunoassay Non-specific binding
Light Scattering Stray ambient light
Breakthrough laser light
Detection PMT noise
The experimental data used to verify the model was generated using a system in which 
both non-specific binding and stray ambient light has been reduced to insignificant 
levels. Thus these factors were not a priority when determining the sources of noise to 
include within the original model. Further development of the model to encompass 
other systems would necessity their inclusion.
It should be noted that some of the physical parameters that define a sensor may also 
impact on the within sensor noise, for example the waveguide thickness is involved in 
the scattering calculation. Thus, there may be correlations between ‘between sensor’ 
and ‘within sensor’ noise. The current model has not considered this relationship as the 
possible complexity is beyond the scope of the preliminaiy investigations into noise.
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7.2 Between sensor noise
7.2.1 Immunoassay concentrations and constants
It is difficult to exactly replicate a set of immunoassay conditions. Fitting the model to 
experimental data as outlined in section 4.6 showed that the manufacturer’s values for 
the association constants of the reactions were altered by antibody immobilisation or 
the addition of a label. Immobilisation or labelling may also interfere with the active 
binding sites of the molecules and thus reduce the concentration available for reaction. 
It is therefore possible that there is a between sensor variation in the association 
constants and the initial concentrations of the capture and labelled species.
The modified Markov approach to simulating an immunoassay was incorporated into a 
Monte Carlo simulation to establish the variation in the output concentrations resulting 
from variations in the initial conditions. The assay was a sandwich assay for human 
chorionic gonadotrophin (hCG) with initial concentrations
[c]0 = 30.9 x 10'9 M 
[l]o = 250 x 10'9 M
and association constants
capture -  analyte Kc = 2.2 x 109 M'1 
analyte -  labelled antibody Kl = 4.1 x 1010 M'1.
The simulation assumed errors in the intrinsic association constants and initial 
concentrations and that there was no noise or errors associated with the remainder of 
the sensor. The number of simulations necessary to establish a reliable error is large 
and the runtime of the immunoassay module varies with the elapsed time assumed for 
the assay. Thus, a set of 100 simulations each allowing the assay module to run to an 
elapsed assay time of 1 minute was deemed sufficient to produce a realistic estimate of 
the mean and standard deviations involved.
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The procedure was performed for a range of initial analyte concentrations. The Monte 
Carlo simulation produced means and standard deviations for the resulting bound and 
unbound label concentrations. These values were used within the remainder of the 
immunosensor model using Model B, the multilayer coupling model (characteristics 
described in Table 7.3); with exciting light provided by a 5 mW Helium-Neon laser of 
wavelength 632.8 nm, a waveguide width of .0 4 m and an observation length for 
resulting fluorescence of 1 mm.
Table 7.3: Characteristics of the multilayer system used in Model B.
Layer
Thickness
(nm)
Refractive Index 
Real part Imaginary part
Glass 1.51958 -
Buffer 750 1.44 -
FePC>4 waveguide 150 1.7 -
Capture antibody 7.14 1.3428 -
Bound layer 15.47 1.34239* 0.000959*
Solution - 1.33284* 1.45x1 O'6*
* Values dependent on concentrations
Examples of the calibration curves for the assay are illustrated by Figure 7.1 showing 
the errors in the output introduced by including errors within the immunoassay 
variables.
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Figure 7.1: Output from  the immunosensor m odel showing the errors in the output 
signal introduced by variations in the initial concentrations o f  species within the 
immunoassay determ ined using a M onte Carlo simulation
a) 1% error in initial concentrations and 10% error in association constants
b) 10% error in initial concentrations and 10% error in association constants
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The sensitivities, the lowest concentration of analyte that can be detected, of the 
resulting sensors are shown in Table 7.4 and Figure 7.2. The results demonstrate that 
increasing the amount of error in the assay concentrations has an effect on the 
sensitivity of the device. An increase in the percentage error in the concentrations from 
1% to 5% decreases the sensitivity by 400%. However, further increasing the error in 
concentrations beyond 5% produces a slower decrease, a 25% decrease in sensitivity 
for each doubling of the percentage error.
Table 7.4: Sensitivities calculated for the immunosensor assuming variations in 
the parameters defining the immunoassay module
(determined using a Monte Carlo simulation of the sandwich assay for hCG) 
with no errors or variations within the remainder of the sensor.
% error in 
Association Initial 
constants concentrations
Sensitivity 
X 1011 M
10 1 1.103
10 5 4.024
10 10 5.040
10 20 6.377
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Figure 7.2: Sensitivity o f the multilayer coupled CFD immunosensor containing a 
sandwich assay for hCG assuming a percentage error in the initial concentrations o f 
the immunoassay module, a fixed 10% error in the association constants, and no 
variations within the remainder o f the system.
7.2 Between sensor noise 151
Errors of less than 1% in concentrations may be achievable by an expert but a viable 
biosensor will require no expert measurements and in the case of a CFD concentrations 
will be controlled by the physical dimensions of the device. However these results 
show that it is vital that the error in concentration be kept to a minimum if good 
sensitivity is to be achieved.
7.2.2 Physical parameters of Model A -  Prism Coupling
The physical parameters of the Model A immunosensor (Figure 7.3) that may impact 
on the resulting fluorescence are:
i) input power;
ii) coupling efficiency;
iii) waveguide thickness;
iv) width of the cell;
v) observation length.
SALINE WTTTI FREE MOLECULES n= 1.3424
380.014 nmRISM INDIUM PHOSPHATE WAVEGUIDE
n = l 5 1 0 6PILKINGTON FLOAT GLASS
0.2 mW 
He-Ne 
543.5 nm 
LASER
UPPER SURFACE
EMfTTED FLUORESCENCE
Figure 7.3: Experimental arrangement fo r Model A, the prism coupled model 
illustrating the values fo r the physical parameters that may impact on the resulting 
fluorescence.
A second Monte Carlo simulation was implemented. This procedure simulated output 
from the light module for variations in one of the physical parameters. The values of all 
other parameters were fixed, so the error in the output was due to variation in a single 
parameter only. The concentrations and variances of the species resulting from the 
immunoassay module were fixed as the values resulting from the Monte Carlo 
simulation of the immunoassay with a 1% error in initial concentrations described 
above.
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The percentage error in the output signal of Model A, the prism-coupling model, with 
no errors in the physical parameters of the light module was determined as 0.96% 
(Table 7.5). Figure 7.4 illustrates the percentage errors resulting from the inclusion of a 
1% error in each of the physical parameters listed.
Table 7.5: Percentage error in the output signal from a Model A (prism coupled) 
immunosensor caused by 1% error in the concentrations resulting from the 
immunoassay module with the addition of a 1% error in each of the physical 
parameters listed._______________________________________________________
Parameter with 1% associated error %  error in output signal
Concentrations ONLY 0.96
+ Incident power 1.96
+ Coupling factor 1.97
+ Cell width 0.96
+ Observation length 1.88
+ Waveguide thickness 1.40
Concentrations + Incident Power + Coupling + Width + Observation + W aveguide
efficiency length thickness
Param eter
Figure 7.4: Percentage error in the output signal from a prism coupled immunosensor 
caused by 1% error in the immunoassay concentrations with the addition o f a 1% error 
in each o f the physical parameters listed determined using a Monte Carlo simulation. 
The lighter area below the line is the error due to variation in the concentrations o f the 
immunoassay. The darker area above the line indicates the additional error resulting 
from error in the particular parameter.
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It can be seen that a 1% error in the incident power, the coupling efficiency and the 
observation length increased the error in the output signal by a similar percentage. 
However, a 1% error in the waveguide thickness had less effect and a 1% error in the 
width of the waveguide did not significantly increase the percentage error from that 
achieved with errors in the immunoassay only.
Analysis of this type is invaluable to a biosensor designer. The effect variation of the 
coupling efficiency and incident power demonstrate that the amount of light coupled 
into the waveguide is a crucial factor in the production of a sensitive device. In terms of 
the manufacture of the device the physical parameters of importance are the waveguide 
thickness and observation lengths.
Sloper & Flanagan [2] devised a spin coating technique that enabled them to deposit 
waveguides with accuracy in the deposited thickness of 3%. The Monte Carlo was 
adapted to allow variation in two of physical parameters and the impact of variation in 
both the waveguide thickness and the observation length on the output signal was 
determined (Figure 7.5). It can be seen that variations in the observation length produce 
a greater increase in output error than variations in the waveguide thickness.
% error in output signal
3
% error in 
observation length
% error in w aveguide thickness 4
Figure 7.5: The percentage error in the output signal as a function o f percentage 
errors in the waveguide thickness and observation length determined using a Monte 
Carlo simulation o f the Model A (prism coupled) light module.
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7.2.3 Physical parameters Model B -  Multilayer coupling
A similar analysis was made of the impact of errors within the physical parameters of 
the multilayer coupling model; Model B (layers and thicknesses as described in Table 
7.3). The exciting light was a 5 mW Helium-Neon laser of wavelength 632.7 nm. The 
width of the waveguide was J3 4 m and the observation length for resulting fluorescence 
was 1 mm.
A further Monte Carlo simulation was implemented to simulate output from the light 
module for variations in one of the physical parameters of Model B using values for the 
concentrations and variances of the species resulting from the Monte Carlo simulation 
of the immunoassay with a 1% error in initial concentrations previously discussed. 
Figure 7.6 illustrates the error in the output signal resulting from the separate inclusion 
of a 1% error in each of the parameters listed.
Concentrations + Incident Pow er + Coupling efficiency + Width + Observation
Figure 7.6: Percentage error in the output signal from  a multilayer coupled  
immunosensor caused by 1% error in the immunoassay concentrations with the 
addition o f  a  1% error in each o f  the physical param eters listed  determ ined using a 
Monte Carlo simulation.
The lighter area below the line is the error due to variation in the concentrations o f  the 
immunoassay. The darker area above the line indicates the additional error resulting  
from  error in the particu lar param eter.
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Analysis of this type enables the comparison of the effect of the different parameters in 
Models A and B. It can be seen that variations in the incident power and coupling 
efficiency have a similar impact in both models but that the width of the waveguide 
becomes a significant factor in Model B, the multilayer coupling. The impact of the 
observation length is less significant in Model B than in the prism coupled Model A.
7.2.3.1 Noise in the resonance curve
Model B, the multilayer coupling device, involves performing an angle scan to 
determine the resonance point at which the signal is at its maximum value. Noise in the 
output signal produced by Model B may blur the point at which resonance occurs. A 
biosensor is unlikely to involve an angle scan, however if multilayer coupling is used 
the angle at which a light enters the system will effect the resulting output.
Figure 7.7 (overleaf) illustrates the resonance curve produced using the Model B model 
defined above. Figure 7.7a shows the error bars in the output resulting from a 1% error 
in the initial immunoassay concentrations only, whilst Figure 7.7b represents the output 
produced with the addition of a 1% error in the observation length. It can be seen that 
the introduction of an error does extend the range at which resonance may appear to 
occur, i.e. the point of maximum voltage minus the possible error in the signal.
Resonance curves were drawn for the addition of a 1% error in each of the parameters 
considered in section 7.2.3 above. Table 7.6 shows the range of angles whose output 
signals fall within the error margin of the maximum output, i.e. the range of angles that 
may appear to be the resonant angle.
Table 7.6: Range of angles within the error margin of the maximum voltage minus
error in voltage for 1% errors in the parameters shown.
Parameter and error Range of angles Difference
1% error in immunoassay ONLY 75.38-75.41 0.03
+ 1% error in input power 75.37 - 75.42 0.05
+ 1% error in coupling efficiency 75.37 - 75.42 0.05
+ 1% error in width 75.37 - 75.42 0.05
+ 1% error in observation length 75.38-75.42 0.04
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Figure 7.7: Output from  the angle scan o f  the multilayer coupled device with error  
bars illustrating the error in the output signal at each poin t
a) Errors in immunoassay ONLY
b) Errors in assay p lus a 1% error in observation length
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7.2.3.2 Waveguide thickness
Previous research has shown that the angle of resonance varies with the thickness of the 
deposited waveguide [3], The Monte Carlo simulation used to determine the variation 
in the output caused by variations in the parameters illustrated by Figure 7.6 above 
assumed that the output signal was recorded at the known angle of resonance. 
Performing a Monte Carlo simulation with a 1% error in the waveguide thickness at a 
fixed angle returned an error in the output signal of 50%. This large variance is due to 
the fact that as the waveguide thickness varied within the simulation the angle at which 
the output signal was determined was no longer the resonant angle. Thus the mean and 
standard deviation of the output voltage calculated by the simulation were no longer 
realistic and waveguide thickness was not included in the comparison of the errors in 
the physical parameters (Figure 7.6).
Figure 7.8 shows the deviation of both the mean and standard deviation of the output 
voltage from the Monte Carlo simulation with increasing percentage errors in the 
waveguide thickness. It is clear that as the variations in the waveguide thickness 
increase the standard deviation of the output voltage become dominant. Therefore, if 
the waveguide thickness is not consistent, a multilayer coupled sensor using a fixed 
angle of incident light would not be viable.
250
200
_  150
100
520 1 3 4
% error in waveguide thickness
Figure 7.8: Variation in mean output voltage (dashed line m) and standard deviation  
(smooth line • )  resulting from  increasing percentage error in the waveguide thickness 
within a Monte Carlo simulation o f  a  M odel B (multilayer coupled) immunosensor 
assuming a fix ed  angle o f  incidence.
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The relationship between variation in the waveguide thickness and variation in the 
incident angle was investigated by adapting the Monte Carlo simulation to allow 
variations in these two parameters. Figure 7.9 shows the results of this simulation and 
illustrates that the relationship is non-linear. This confirms that if a multilayer coupled 
sensor is to be used waveguide thickness, incident angle and the trade-off between 
them need to be considered during the design process.
350
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% error in output signal
150
100
% error in 
incident angle% error in waveguide thickness
0
Figure 7.9: Percentage error in the output voltage o f  a M odel B immunosensor as a 
function o f  percentage errors in the waveguide thickness and angle o f  incident light.
7.2.3.3 Divergence in incident laser beam
Collimating optics would not be available within a small biosensor and thus the 
incident beam may diverge before it becomes incident on the sensing component. The 
impact of divergence in the incident beam on the resonance curve produced for the 
multilayer coupling device, Model B, was investigated. Resonance curves for the 
sandwich assay for 24.2 nM of hCG within a multilayer coupled CFD (as described in 
Section 7.2.1) were generated for a range of angles of divergence of the incident beam.
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Figure 7.10 illustrates the incongruities between the values that parameterise the 
resonance curves resulting from the model for variations in the angle of divergence of 
the incident beam. Increasing the divergence of the beam significantly decreases the 
maximum output voltage. Given that the 24.2 nM of analyte used to generate these 
curves is a relatively high concentration then the impact of this reduction in output 
voltage for lower analyte concentrations and hence sensitivity is significant.
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Figure 7.10: Variation in the maximum output voltage (smooth line) and the bandwidth 
(dashed line) o f  the resonance curve resulting from  a sandwich assay perform ed within 
a multilayer coupled CFD.
Typical values fo r  a Helium-Neon and semiconductor laser are marked.
The bandwidth of the resulting curve varies dramatically with increasing angle of 
divergence. The “natural” bandwidth of the resonance curve is 0.28°, which remains 
constant until the divergence in incident beam exceeds this value. It then becomes 
erratic with a sharp increase followed by a decrease before the divergence reaches 
twice the “natural” bandwidth. At this point the maximum output voltage also peaks 
briefly. Once divergence has reached three times the “natural” bandwidth the curves 
produced no longer resemble a resonance curve.
The typical divergences of a Helium-Neon and a semiconductor laser are marked on the 
curve in Figure 7.10. It can be seen that whilst both fall within the region where the 
bandwidth of the resonance curve is constant, the maximum output voltage achievable 
using the semiconductor laser is about 50% of that achievable using the Helium-Neon 
laser.
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7.2.4 Dynode voltage
Within the detection module one of the physical parameters that may vary between 
sensors is the dynode voltage applied to the PMT. A biosensor that is truly portable will 
not have the stable power supply that would be available under laboratory conditions 
and thus the impact on the sensitivity achieved with the inclusion of variation in the 
dynode voltage was considered.
A Monte Carlo simulation of the detection module was performed considering a 1% 
variation in the dynode voltage. Data transferred to this module was from the model 
with the sandwich assay for hCG performed within a multilayer coupled CFD (detailed 
in Section 7.2.1). This data included a 1% error in the initial concentrations but 
assumed that all other parameters were constant. Figure 7.11 shows the increased error 
and therefore reduced sensitivity with the inclusion of a 1% error associated with the 
dynode voltage.
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Figure 7.11: Output from  the multilayer coupled immunosensor m odel containing a 
sandwich assay fo r  hCG fo r
a) Errors in immunoassay ONLY
b) Errors in assay p lus a 1% error in dynode voltage
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7.3 Within sensor noise
7.3.1 Scattering
The constitution of fluorescence resulting from the sensor can arise from both bound 
and unbound labelled molecule, excited by either the evanescent field or light scattered 
from the waveguide surface. Applying the definition of noise used here, any 
fluorescence that does not result from the bound label excited by the evanescent field is 
an unwanted part of the signal.
Concentrations for bound and unbound labelled molecule were determined for a 10 
minute sandwich assay for IgG using the modified Markov approach. Initial 
concentrations were
[a]0 = 20 x 10‘9 M 
[c]0 = 30.9 x 10'9 M
[l]o = 250 x 10'9 M 
with association constants
capture -  analyte Kc = 5.67 x 109M_1 
analyte -  labelled antibody Kl = 1.52 x 1010 M '1.
These concentrations were then used within both a Model A (Section 7.2.2) and a 
Model B (Section 7.2.3) arrangement and the resulting output analysed (Figure 7.12).
M odel A Prism coupling Model B Multilayer coupling
U  E van escen t 
H H  S cattered
Figure 7.12: Percentage o f  fluorescence due to evanescent excitation and excitation 
due to scattered light fo r  M odel A -  prism  coupling and M odel B  -  multilayer coupling
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The amount of fluorescence resulting from evanescent excitation and excitation due to 
scattered light for both the prism and the multilayer coupled sensors is shown in Figure 
7.12 and indicates that scattered light contributes less to the output signal in the 
multilayer coupling device.
7.3.2 Breakthrough light
Breakthrough light, i.e. laser light that comes through the system and is incident at the 
photomultiplier tube cathode, adds an additional error to the output signal recorded by 
the sensor. The sandwich assay within the multilayer coupled CFD described above 
was used as the basis for analysing the impact of breakthrough light on the sensitivity 
of the device. Figure 7.13 illustrates the change in sensitivity of a device where an 
increasing amount of the laser light breakthroughs. It can be seen that the addition of 
breakthrough light lowers the sensitivity achieved, but that increasing the amount has 
little further impact. Since the breakthrough light will affect not only the output signal 
but also the PMT noise current, it seems likely that the increase in signal eliminates any 
further impact of the increased noise.
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Figure 7.13: Sensitivity o f  an immunosensor with increasing amount o f  
“breakthrough ” laser light incident at the detector.
7.4 Summary
Noise within an immunosensor refers to any part of the output voltage that does not 
result from the fluorescence of the bound labelled element of the immunoassay 
component of the sensor. Errors may occur within a particular instance of a sensor or
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between instances of the sensor and will affect the sensitivity and reliability of the 
resulting device. The model was used to consider the impact of various sources of noise 
and variation within the immunosensor.
7.4.1 Between sensor noise
Within the immunoassay between sensor errors may result from changes in the 
association constants of the reactions caused by labelling or immobilisation and 
differences in the initial concentrations caused by immobilisation and inaccurate 
measurement. Application of the model showed that errors in the immunoassay 
concentrations contribute to a lowering of the sensitivity of the device with a reduction 
in sensitivity by a factor of 4 on increasing the error from 5% to 10%. The rate of 
reduction slowed as errors increased with a reduction by a factor of 1.25 on increasing 
the error from 10% to 20%.
The physical parameters of the light module affected the error in the output to different 
degrees. In the prism-coupled model those that were most significant were identified as 
incident power/coupling efficiency and observation length. Waveguide thickness had a 
less significant effect. Comparing the effect of increasing the error in both the 
waveguide thickness and the observation length it could be seen that the more 
significant effect of the observation length remained dominant over the effect of 
variation in the waveguide thickness.
The multilayer coupled model was used to show that incident power/coupling 
efficiency and width were the most significant physical parameters in this arrangement. 
As this model uses an angle scan to establish the angle of resonance and therefore the 
maximum output voltage, it was used to demonstrate the fact that errors within the 
physical parameters of the model could cause noise within the resonance curve. The 
impact of waveguide thickness, which is directly related to the resonance angle, was 
investigated further and it was shown that errors in the waveguide thickness and angle 
of incident light have a serious impact on the sensitivity of the device.
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Analysis of the impact of divergence within the incident beam demonstrated that 
increased divergence reduced the maximum output voltage and within certain 
parameters increased the bandwidth of the resonance curve. Increasing the divergence 
beyond 0.9° reduced the output to virtually zero with an undetermined bandwidth.
The model was used to showr that the introduction of a 1% error in the dynode voltage 
of the PMT detector reduced the sensitivity achieved by a factor of 3.6.
7.4.2 Within sensor noise
Scattering at the waveguide surface was analysed and a profile of the scattered light 
was produced. It was shown that the contribution of scattered light to the detected 
fluorescence was negligible for the multilayer coupling model but amounted to 30.2% 
of the output for the prism coupled model.
Breakthrough light is laser light that comes through the capillary fill cell and becomes 
incident on the cathode of the PMT. The presence of breakthrough light lowered the 
sensitivity of the device but the effect stabilised for a breakthrough of 2%.
7.4.3 Potential of the model
The model can be used to study the impact on the output of a sensor for variations in a 
range of parameters. This enables a designer to identify which factors have the largest 
impact and to look at the trade-off in sensitivity that can be made between certain 
parameters. Studies of this type are difficult if not impossible to perform 
experimentally. Even if it were possible to vary the value of one parameter whilst 
maintaining the value of another, a comparison of the performance of two “runs” of the 
sensor may introduce between sensor noise from another source. Analysis of the 
composition of the resulting output, e.g. whether output results from the evanescent 
field or from scattered light could not be achieved experimentally. Thus, the model of 
the immunosensor adds a valuable tool to the resources available to anyone involved in 
biosensor design.
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Chapter 8 
Application of the model to biosensor development
The potential of biosensors has been recognised since the early seventies and initially 
attracted a large research effort. Unfortunately success in the area has been limited and 
as a consequence the research effort has declined [1]. However despite a number of 
unresolved design issues, the potential for biosensors remains. The computer-based 
model of a biosensor described here has been developed in such a way as to facilitate 
its use in the research and development of biosensors and can be used to consider some 
of the issues that remain undecided in this arena.
8.1 Comparison o f assay protocols
Initial immunoassay techniques, introduced by Yalow & Berson [2] and developed 
through the seventies used radio-isotope labels. Experimentally produced results 
indicated that the sandwich assay was more sensitive than the competitive assay and it 
is generally accepted that this was the case [3]. There was little theoretical evidence to 
support the hypothesis, but given that the factors limiting the performance of an assay 
were practical, Davies [4] reports that there was little incentive to resort to complex 
mathematics when experiments could achieve the desired result.
Ekins [5] disputed the lack of need for a theoretical model and produced several 
detailed theoretical examinations of the immunoassay, becoming acknowledged as a 
source of reliable, accurate theory in this area. Ekins applied his model to the radio­
isotope labelled assays and verified that for this arrangement the sandwich assay 
proved more sensitive than the competitive assay.
However, a comparison of the sensitivity achieved using different assay protocols has 
not been repeated for the fluorescent techniques used in immunoassays today or for the 
different formats employed by biosensors. Unfortunately the amount of experimental 
data relating to biosensors is insufficient to allow the comparison to be made
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experimentally or to directly apply the theory developed by Ekins. However the model 
developed here was used to produce a theoretical comparison between competitive and 
sandwich assay protocols within an evanescent field immunosensor.
8.1.1 Application of the model to the comparison of assay protocols
The modified Markov approach was applied to simulate a competitive assay for the 
protein IgG for a range of initial analyte concentrations. Other initial concentrations for 
the assay were
[c]0 -  30.9 x 10'9 M 
[l]o = 45 x 10‘9 M 
and the association constants were
capture -  analyte Kc = 5.67 x 109M'1 
capture -  labelled analyte Kl = 2.63 x 108 M~\
The resulting concentrations were determined for elapsed times of 1, 2, 5 and 10 
minutes from the addition of the analyte. These values were then used to determine the 
output voltage assuming that the assay were being performed within a CFD with 
multilayer coupling (layers and thicknesses as described in Table 8.1). The exciting 
light was a 5 mW Helium-Neon laser of wavelength 632.8 nm. The width of the 
waveguide was .0.4 m and the observation length for resulting fluorescence was 1 mm.
Table 8.1: Characteristics of the multilayer system used in Model B.
Layer
Thickness
(nm)
Refractive Index 
Real part Imaginary part
Glass - 1.51958 -
Buffer 750 1.44 -
FeP04 waveguide 150 1.7 -
Capture antibody 7.14 1.3428 -
Bound layer 15.47 1.34239* 0.000959*
Solution - 1.33284* 1.45 xlO-6*
* Values dependent on concentrations
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The immunoassay module of the model was replaced with a sandwich assay for IgG. 
The initial labelled antibody concentration for the sandwich assay was
[l]o = 250 x 10'9 M 
and the association constant for the analyte - labelled antibody reaction
Kl = 1.52 x 1010 M-1
whilst all other parameters of the model remained identical to those described above. 
Concentrations and the resulting output voltages were again determined at elapsed 
times of 1,2,5 and 10 minutes from addition of the analyte.
Table 8.2 shows the resulting sensitivities for both the competitive and sandwich assays 
at each elapsed time and clearly demonstrates that, even with the potentially different 
sources of noise presented within the evanescent field immunosensor modelled here, 
the sandwich assay still produces a more sensitive device.
Table 8.2: Sensitivity calculated after elapsed time from addition of analyte shown for 
both a sandwich and competitive assay for IgG._______________________________
Sensitivity calculated after elapsed time 
(PM )
1 min 2 min 5 min 10 min
Competitive (Sense) 23100 14800 11500 10500
Sandwich (Senss) 140 80 30 30
Difference Factor 
Sensc/Senss
165 180 410 397
8.2 Transient response
Ideally a biosensor would be available for use in a doctor’s surgery, ambulance or even 
at home. Laboratory immunoassay techniques that involve removing any unbound 
molecules prior to measurement, allow the immunoassay reactions to come to 
equilibrium before the washing step. In some assays this may take in excess of 10 
minutes, not a reasonable time for a test to be performed during a routine visit to a 
doctor. A viable biosensor should return a result in 2 -  3 minutes. The time taken for 
the result to be determined is therefore a crucial design factor [6]. The biosensor 
modelled provides the ideal vehicle with which to undertake studies of the sensitivity of
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an immunosensor during the transient phase of the immunoassay, i.e. results recorded 
before the reactions have come to equilibrium (as seen in Table 8.2). The nature of the 
model also allows further analysis of the resulting output.
Visualising comparisons of assay protocols at different elapsed times across a range of 
analyte values proved difficult. The most satisfactory method found is illustrated by 
Figure 8.1 (overleaf) which shows calibration curves for both the competitive and 
sandwich assays for IgG described above. Noting the difference in scale on the y axis it 
is immediately obvious that the sandwich assay produces the more sensitive device.
8.2.1 Competitive assay
Figure 8.1a illustrates the calibration curves for the competitive assay for IgG at 
different elapsed times from the addition of the analyte. It is clear that after an elapsed 
time of 1 minute the gradient and the amount of noise do not produce a curve from 
which a small amount of analyte could be determined. Also, at this elapsed time the 
difference in the output between a sample with no analyte and one with 25 nM of 
analyte (-200 ± 90mV) has a large percentage error (45%) compared to the difference 
as the elapsed time of the assay increases (-650 ± 75 mV, 11.5% error, for a 10 minute 
assay).
8.2.2 Sandwich assay
Figure 8.1b shows the resulting calibration curves for the sandwich assay for IgG, 
demonstrating that with a sandwich assay the difference in output voltage between a 
sample with no analyte and one with analyte present greatly exceeds the differences 
produced with a competitive assay. For example, the presence of 25 nM analyte in a 
sandwich assay sample produces a difference in output voltage of -1200 ±120 mV 
from a sample with no analyte after 1 minute of elapsed time compared with a 
difference of 200 mV for equivalent analyte concentrations in a competitive assay. The 
percentage error (i.e. noise) in the output signal for the sandwich assay is 10%, more 
than double the 4% error in the output signal for the competitive assay. However, the 
lower voltages produced by the sandwich assay lessens the impact of this noise on the 
resulting sensitivity.
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Figure 8.1: Calibration curves produ ced  using a simulation o f  assays fo r  IgG within a  
m ultilayer coupled CFD at different elapsed times from  the addition o f  the analyte.
1 minute (triangles); 2 minutes (diamonds); 5 minutes (circles); 10 minutes (squares).
a) competitive assay
b) sandwich assay
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8.2.3 Sensitivity as a function of elapsed time
Ultimately the sensitivity that can be achieved dictates the superiority of any particular 
biosensor arrangement. Figure 8.2 illustrates the sensitivities of both the competitive 
and sandwich assays described above. It is clear that the immunosensor is at its most 
sensitive once the immunoassay has come to equilibrium. In the particular case 
illustrated it takes approximately 5 minutes for the competitive assay and 8 minutes for 
the sandwich assay to reach equilibrium. It can be seen from Figure 8.2 that 
measurements taken at half the equilibrium time would not greatly reduce the 
sensitivity achieved, although for the sandwich assay this has still not reached the 
desired time of 2 -  3 minutes. However, the ability to make these comparisons at 
various elapsed times from the introduction of the analyte is an additional benefit of the 
model. Ekin’s work in this area was restricted to comparison of results established once 
the assay had reached equilibrium.
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Figure 8.2: Sensitivity o f  a  com petitive (smooth line) and sandwich assay (dashed line) 
fo r  IgG as a function o f  elapsed time from  the addition o f  analyte determ ined using a 
simulation o f  the assays within a  multilayer coupled capillary f i l l  device.
8.3 Scattering in planar waveguide sensors
Optical immunosensors in which the evanescent field interrogates the immunoassay 
offer a means of producing a sensor which eliminates the washing step used in standard 
immunoassay techniques, thus providing a more user-friendly interface. Planar 
waveguides [7] have been used as the transducer in evanescent field fluorescence
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immunosensors. However, it has been suggested that scattering of light at the 
waveguide surface may contribute to noise in the output signal by exciting unbound 
fluorescent labels and thus decrease the sensitivity of the device [8]. The modular 
design of the model allows data from a particular aspect of the model to be determined 
independently of the remainder of the model. Thus it can be used to facilitate the 
analysis of the impact of a particular phenomenon, e.g. scattering at the waveguide 
surface, on the sensitivity of the sensor under investigation.
8.3.1 Scattering in the model
Scattering of light from dielectric interfaces is a difficult phenomenon to simulate. 
However, the theory developed from that of Walter & Houghton [9] (outlined in detail 
in Section 5.2.2.2) allows the proportion of light scattered from the surface of a 
monomode waveguide to be incorporated within the model. As the experimental work 
of this group is based on monomode waveguides the use of this element of the model to 
further analyse the profile of the scattered light and its contribution to the resulting 
output signal was beneficial.
83.2 Profile of scattered light
The formula (Equation (5.8))
AP_= A2 { n l - n ^ lc o s ip W p c ^  (nj+«c)..
LPt B PnWeq np
Me _ J2f rc rs
___________________________________________C O S  \ s W p c ) ________________________________________________
r£ f c  C0S2(sWF€)+s2 sin2(sWpc)}+ r £ c o s 2(sWFS)+s2 sin2^ ^ ) }
__________________________s in 2( s y r c ) _____________________________
rife  s in 2( s r jFC) + s 2 c o s 2( i f r / c ) } + r c f i  s i n ^ s P F ^ + i 2 c o s 2( s # ^ ) } _
dp ,
(8.1)
calculates the proportion of propagated light that is scattered from the surface of a 
planar waveguide.
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The formula involves integration over the range of radiation modes i.e. [-konc, koiic]. It 
is obvious, considering Figure 8.3, that this range of constants is equivalent to the range 
of angles at which the light is scattered.
Radiation modes 
CU|pr|« knc
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Film/Waveguide n,
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yA— >z
Figure 8.3: Radiation modes o f  an asymm etrical planar optical waveguide (Diagram  
adapted  from  Figure 1 o f  Walter and Houghton [9])
The integration from formula (8.1) was performed for a number of small steps and the 
contribution of each to the whole integral enabled a profile of the scattered light to be 
determined. Figure 8.4 illustrates the normalised values of the integral function and the 
resulting profile of the scattered light, which shows that the majority of the light is 
scattered forward with a peak at approximately 20°.
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Figure 8.4: Norm alised value o f  the integral o f  equation (8.1) as a function o f  angle o f  
scatter. Profile o f  the light sca ttered  a t the waveguide surface where the length o f  line 
indicates the percentage o f  light scattered in the corresponding direction.
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In the capillary fill device any light within the cell that has not been absorbed by a 
fluorophore may reflect from the upper surface and potentially excite further unwanted 
fluorescence (Figure 8.5). An observation length of 1mm is used to limit the amount of 
fluorescence detected and thus limit the impact of reflected light on the signal. The 
profile of the scattered light determined using the model indicates that the peak of the 
scattered light occurs at 20°. Considering the geometry of the cell it can be determined 
that at this angle the scattered light will be reflected 0.3 mm (100pm/tan 20°) beyond 
the point of scattering and thus may contribute to the detected signal in an observation 
length of 1 mm. Such analysis, that is determination of the amount of reflected light 
and its impact on the output fluorescence, is virtually impossible to do experimentally 
and yet calculating the amount of scattered light that may be reflected within the 
observation length has obvious consequences for the physical design of the sensor.
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Figure 8.5: Scale drawing o f  capillary f i l l  cell illustrating the reflection o f  scattered  
light a t the upper surface and the observation length used to limit unwanted 
fluorescence being detected.
8.3.3 Constitution of resulting fluorescence
The fluorescence excited and detected at the output of an immunosensor can arise from 
two sources, the bound labelled molecule near the surface of the waveguide and any 
unbound labelled molecules free in the solution within the capillary fill cell. Excitation 
can occur due to the evanescent field or due to light scattered from the waveguide 
surface. The output for the 10 minute sandwich assay for IgG described above (section 
8.1.1) was analysed in order to determine the percentage of the fluorescence resulting 
from the different sources.
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Table 8.3 illustrates the results of the analysis and shows that for this particular 
configuration (multilayer coupling) less than 0.5% of the total signal is due to 
fluorescence excited by scattered light but that the evanescent field is such that 2.5 % 
of the fluorescence results from evanescent excitation of unbound label.
Table 8.3: Analysis of the origins of the output signal from the immunosensor
Excitation source Label Percentage of output
Evanescent field Bound 97.15
Unbound 2.50
Scattered light Bound 0.01
Unbound 0.34
8.4 Application to a reverse symmetry waveguide
Horvath et al. [10] recently published an article detailing their analysis of a reverse 
symmetry waveguide, a waveguide where the refractive index of the substrate layer is 
lower than that of the cover layer (Figure 8.6), in which they suggested that this 
configuration would have a potential application as a biosensor. They demonstrated 
that the change in refractive index that could be detected in the cover layer of a reverse 
symmetry waveguide was superior to that that can be detected in the cover layer of a 
normal waveguide, i.e. one in which the refractive index of the cover is greater than 
that of the substrate.
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Figure 8.6: Evanescent field  profile in normal and reverse symmetry waveguides
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8.4.1 Application of the model
Although Horvath et al did not consider fluorescence evanescent field sensors they 
suggest sensors as one of the applications of their theory and the argument that the 
increased penetration depth of the evanescent field would be beneficial may apply to 
the optical immunosensors considered in this project. In order to consider the effect of a 
reverse symmetry waveguide the Model A - prism coupling module was used to 
simulate the output from a sensor in which the immunoassay is performed on the 
surface of a reverse symmetry waveguide (Figure 8.7).
SALINE WITH FREE MOLECULES n = 1.3424
380.014 nm‘RISM INDIUM PHOSPHATE WAVEGUIDE n = 1.6
0.2 mW 
He-Ne 
543.5 nm 
LASER
VARIABLE SUBSTRATE
Figure 8.7: Values used in Model A to consider reverse symmetry waveguides.
The film was an indium phosphate waveguide with a layer of immobilised antibody on 
the surface, which had a thickness of 380.014 nm (being the deposited thickness, 380 
nm, plus the adjustment due to Tiefenthaler & Lukosz [11] for a four-layer sensor i.e. 
equation (5.4)). The thin film waveguide had a refractive index of 1.6 [12].
The cover was a saline solution containing the analyte and the labelled antibody with a 
refractive index of 1.3424 calculated using the Clausius-Mossotti formula [13] for 
refractive indices of compounds. The immunoassay was a sandwich assay for IgG as 
described above. The light source was a 0.2 mW Helium-Neon laser of wavelength
543.5 nm coupled into the waveguide by means of a prism, with an assumed coupling 
efficiency of 0.81, this being the maximum coupling efficiency achievable using a 
prism [14]. The width of the waveguide was .0 4 m and the observation length for 
resulting fluorescence was 1 mm.
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Figure 8.8 shows the output from the immunosensor where the waveguide substrate is 
either air, a low refractive index polymer or glass and demonstrates that the reverse 
symmetry waveguide would indeed enhance the signal. However, the corresponding 
sensitivities (Table 8.4) are of a similar order, indicating that the noise within the signal 
is also enhanced by use of the reverse symmetry waveguide.
Table 8.4 Waveguide substrates and the sensitivity achieved using these
configurations within the prism coupling model.
Substrate Refractive index Sensitivity
Glass (Normal symmetry) 1.5 7.71 x 10 “ M
Polymer (Reverse symmetry) 1.2 8.27 x 10 "  M
Air (Reverse symmetry) 1.0 8.43 x 10 "  M
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Figure 8.8: Output voltage determ ined using the m odel o f  a prism  coupled  
immunosensor fo r  a waveguide with different substrates Air (m) Polym er (+) Glass ( • )
It is possible that a reverse symmetry waveguide may produce a more sensitive device 
in the context of the larger scale gas sensor. However the application of the detailed 
model presented in this project showed that this was not necessarily the case for 
biosensors, thus demonstrating one of the potential pitfalls of extrapolating from 
chemical sensing to biosensing without thorough investigation.
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Chapter 9 
Application of the model as a design tool
Early computer models of biosensors received only limited application, which Ekins 
[1] ascribed to the experimentalists reluctance to dissect their assay systems in order to 
identify the sources of error. However the author of this thesis would suggest that the 
increase in computing power over the last decade has significantly facilitated the 
development of this project and that lack of computing power was a major deterrent to 
early modelling.
The implementation of the model presented here provides the facility to perform a 
number of evaluations of the immunosensor being modelled, such as comparison of 
protocols, optimisation and data analysis, which would be beneficial to research and 
thus feature in a design tool for biosensors. This chapter outlines the application of 
these features and demonstrates their benefit to a biosensor design strategy. The use of 
the model in this fashion would allow a designer to identify key experiments and thus 
eliminate some of the routine experimental work involved in biosensor development.
9.1 Comparison o f different protocols
The model was developed to enable the comparison of different protocols within the 
immunosensor system. The modular nature of the model allows one component of the 
model to be replaced with another variant of the same component, and the difference in 
resulting output and sensitivity to be compared. Experimentally such comparison is 
difficult to achieve. Between sensor noise, discussed in Chapter 7, means that it is 
virtually impossible to guarantee that any differences observed between two instances 
of a sensor result only from a single changed component.
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Figure 9.1 illustrates the modules within the model and lists some of the possible 
variants for each module. Not all of the variants listed have been modelled but a 
complete design tool would allow any combination of protocols to be simulated and 
compared.
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Displacement
IMMUNOASSAY
Laser
LEDLIGHT SOURCE
Planar 
Fibre optic.WaveguideSPRTRANSDUCER
PMT
•APDDETECTION
CALCULATE SENSITIVITY
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Figure 9.1: (Repeat o f Figure 3.3) The blocks denote each module representing a 
component o f the sensor, with the module variants listed to the right.
9.1.1 Assay protocols
The assay protocol employed within a sensor is a critical design factor, and as such was 
discussed at length in chapter 8. Comparisons of a competitive and a sandwich assay 
were made at both equilibrium and during the transient phase of the assay and the 
sandwich assay proved superior in both instances.
9.1.2 Coupling techniques
In biosensors, components other than the immunoassay may play a significant role in 
decreasing the sensitivity of the device and therefore become important considerations. 
Coupling of light becomes an issue in many applications of optics [2]. In an optical 
immunosensor coupling of light plays a major role in producing a detectable output 
signal that can be used to determine the amount of analyte in a sample. In any particular 
arrangement the design involves compromises between the amount of light that is 
coupled into the system and the practicality of the arrangement.
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Development of the capillary fill device (CFD) on which the model is based involved a 
progression of techniques that refined the coupling of light to produce the most viable 
arrangement. Initially the CFD developed by Professor Shanks at Unilever used the 
lower glass surface as a collecting waveguide rather than an exciting waveguide. The 
cell was flood illuminated from below (Figure 9.3a). Emission close to the lower 
surface, i.e. within what would be the evanescent field of a wave guided in a multimode 
planar waveguide, will according to reciprocity be coupled into the waveguide 
provided emission is at the appropriate angle. Thus a small amount of the fluorescence 
emitted is coupled into the lower glass surface and the possibility of using a slit to 
distinguish between this and any stray light that has become coupled into the 
waveguide was explored.
b) UPPER SURFACEUPPER SURFACE
INCIDENT
LIGHT
EVANESCENT
FIELDEVANESCENT
COUPLING IM M U N O iIMMUNI
DETECTOR
LOWER SURFACE LOWER SURFACE OUTPUT
INCIDENT
LIGHT
Figure 9.3: Initial arrangement of capillary fill device
a) Light shone into cell and resulting fluorescence coupled into lower glass surface
b) Light coupled into lower glass surface and resulting fluorescence excited by 
evanescent field
Upon acquisition of the CFD patent Sereno approached the UCL group with a view to 
adapting the technique to include coupling via a prism into the lower glass surface of 
the cell (Figure 9.3b). Fluorescence was then excited by the resulting evanescent field
[3], thus eliminating a percentage of the unwanted signal. However the width of the 
lower glass surface of the cell produced multimode coupling of the light and the 
resulting fluorescence was weak.
Flanagan with the support of Sereno examined alternative techniques in part use of the 
lower surface to produce evanescent excitation. At this point the method of depositing a 
thin film waveguide onto the lower surface was developed [4]. Coupling into this 
waveguide, whilst more difficult to achieve, produced a single propagation mode which 
resulted in a stronger evanescent field and greater output signal.
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The compromise between the ease of coupling light into the sensor and the overall 
design is not restricted to the capillary fill device. It is a design consideration for any 
optical immunosensor. Sensors with the immunoassay element immobilised on an 
adiabatically tapered optical fibres [5] have attempted to address the issue of coupling. 
This design allows easy coupling from the multimode fibre into the tapered region 
which supports only a single mode of propagating light. However, the resulting sensor 
is extremely fragile and once again a compromise has been made between sensor 
design and the coupling of light into the sensor.
In considering the arrangement in Figure 9.3b Flanagan has examined both grating 
coupling [4] and base plate coupling as alternatives to the prism coupling shown. It is 
clear that coupling is a major design issue in any optical immunosensor. Thus a 
biosensor design tool would need to allow the simulation and comparison of different 
coupling arrangements.
9.1.2.1 Application of the model to the comparison o f coupling protocols
The light component of the model deals with the coupling and propagation of light into 
the system. Two different experimental arrangements were modelled (Figure 9.4); 
Model A involving prism coupling and Model B involving the multilayer coupling 
technique devised by Pampapathi [6], This enabled a direct comparison between these 
two coupling techniques to be made.
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Figure 9.4: Two arrangements for coupling o f light into the waveguide 
Model A - Light is coupled into the waveguide using a prism 
Model B - Light is coupled through multiple layers c.f. resonant mirror
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The concentrations resulting from the sandwich assay for IgG described in section 8.1.1 
were used within both a Model A and a Model B arrangement with exciting light 
provided by a 5 mW Helium-Neon laser of wavelength 632.8 nm, a waveguide width 
of .0 4 m and an observation length for resulting fluorescence of 1 mm. Figure 9.5 
shows the calibration curves produced for the sandwich assay using these two different 
arrangements. The straight line produced for Model A, the prism coupling model is due 
to the fact that this model does not perform an angle scan to establish the best coupling, 
a reflection of the difficulty of performing such a scan experimentally for a prism 
coupled sensor. The less pronounced curve for Model B (the multilayer coupling) than 
those seen in Chapter 8, is due to the fact that the angle of incidence of the exciting 
light was fixed; as would be the case in a portable sensor; and thus the output will not 
have been at resonance for all of the readings.
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Figure 9.5: Calibration curves for a sandwich immunoassay for IgG placed into two 
different immunosensor system models. Model A (dashed line) involves coupling using 
a prism whilst Model B (smooth line) involves coupling through a thin film multilayer.
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The calculated sensitivities (Table 9.1) demonstrate that ; changing the coupling 
technique did not produce a significant change in the sensitivity of the device. This 
application of the model was a genuine use of the model as a design tool. The 
multilayer coupling technique was devised as an adaptation of prism coupling that 
would be easier to achieve using external instrumentation. Coupling with a prism 
involves evanescent coupling through the very thin layer of air between the prism and 
the waveguide and consequently requires the angle of incidence to be highly accurate
[2]. In the multilayer coupling into the waveguide also occurs evanescently, through the 
buffer layer, but is not so dependent on the angle of incidence. Theoretically it was 
impossible to determine whether this ease of coupling reduced the sensitivity of the 
resulting device and between sensor noise issues meant experimental comparison was 
invalid. Thus the model provided the only accurate means of making this assessment.
Table 9.1: Sensitivities of a sandwich assay calculated using different
experimental arrangements of the light propagation module______
Model Sensitivity
A Prism coupling tS> 26.9 pM
B Multilayer coupling V 15.9 pM
9.2 Optimisation of an immunosensor
The model presented provides the ideal vehicle for the optimisation of immunosensor 
performance. A single parameter can be varied, whilst the remainder of the system 
remains identical -  a situation that is difficult to achieve experimentally. Thus the 
effect on sensitivity of a single parameter can be studied and used to optimise the 
performance of the sensor.
9.2.1 Amount of labelled complex
Ekins applied his modelling to the optimisation of biosensors and in particular the 
immunoassay element. He used his experimental data to produce precision profiles that 
could be used to identify the optimal characteristics of an immunoassay. This approach 
was adopted by the few practitioners that considered modelling an asset in the 
development of immunoassays [7].
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Ekins determined that the amount of labelled complex used within an immunoassay 
effects the resulting sensitivity to such an extent that he used the terms ‘excess reagent’ 
and ‘limited reagent’ assays to categorise types of immunoassay. The model was used 
to consider the optimisation of an immunoassay with reference to the amount of 
labelled molecule, exemplified for the competitive assay for IgG with initial 
concentrations
[c]0 = 30.9 x 10'9 M 
and association constants
capture -  analyte Kc = 5.67 x K^Nf1 
capture -  labelled analyte Kl = 2.63 x 108 M~].
The modified Markov method was used to determine the resulting concentrations for an 
elapsed time of 10 minutes from addition of sample for a range of initial analyte 
concentrations. These values were then used to determine the output voltage assuming 
that the assay w$s being performed within a CFD with multilayer coupling (layers and 
thicknesses previously described in Table 8.1). The exciting light was a 5 mW Helium- 
Neon laser of wavelength 632.8 nm. The width of the waveguide was .0 4 m and the 
observation length for resulting fluorescence was 1 mm.
In a competitive assay the labelled analyte competes with the unknown quantity of 
analyte for the binding sites on the capture antibody surface. If the amount of unbound 
labelled analyte is too small the output signal will reach a maximum value and no 
longer indicate the amount of analyte present. However, if the amount is too large the 
labelled analyte will dominate the competitive reaction and the output signal may not 
be proportional to the amount of analyte present.
9.3 Data analysis 186
The model was used to calculate the sensitivity resulting from a range of initial labelled 
analyte concentrations with a view to finding the optimum concentration for the assay 
concerned. Figure 9.6 illustrates the results and shows that for this particular assay the 
optimum concentration of labelled analyte is approximately 40 nM.
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Figure 9.6: Sensitivity o f  an immunosensor containing a com petitive assay fo r  IgG as a 
function o f  the amount o f  initial labelled analyte within the immunoassay.
Figure 9.7 shows the precision profiles, corresponding to those employed by Ekins, 
produced using the data obtained from the model illustrating the result determined 
using the Figure 9.6, i.e. that a 40 nM initial concentration of labelled analyte produces 
the optimal assay.
100
Figure 9.7: Precision profiles follow ing Ekins determ ined using the model fo r  the 
com petitive assay fo r  IgG with initial concentration o f  labelled analyte 20 nM  (•), 40 
nM  (m) and 70 nM  (A ) .
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It should be noted that each data point on Ekins profiles was the result of a large 
number of repetitions of each experiments, repetitions intended to eliminate the effect 
of any variations not under consideration. The model presented in this thesis can be 
usecj(a faster means of identifying optimal values for many of the parameters involved 
and thus establish guidelines for subsequent experimental investigation.
9.2.2 Dy node voltage of the PMT
Most applications in opto-electronics use avalanche photodiodes or semiconductor 
detection devices. Nevertheless, the progressive miniaturisation of the PMT [8] and the 
low light levels emitted by the fluorophores mean that the PMT is still a serious 
contender for the detection element of a biosensor. However, an immunosensor that is 
to be used on location may not have the stable high voltage power supply available in a 
laboratory environment. The multilayer coupled sensor containing a sandwich assay for 
hCG as previously described was used to investigate the effect of reducing the dynode 
voltage of the PMT. Figure 9.8 shows that there is little effect on the sensitivity until 
below 300 V where PMT noise becomes dominant.
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Figure 9.8: The sensitivity o f  a  m ultilayer coupled immunosensor containing a 
sandwich assay fo r  hCG as a function o f  the dynode voltage o f  the PM T used to detect 
the fluorescence (smooth line) with the signal to noise ratio o f  the PM T (dashed line).
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The output signal and noise current resulting from the photomultiplier were calculated 
according to equation (6.6), i.e.
i s = q*f + ?b y
and
ij, = 2TGe2B(PF +PB )+2TGeBid + bTB
R.
where variables are defined in Section 6.2.1. The signal to noise ratio for the PMT is 
thus
which was calculated as a function of dynode voltage and superimposed on Figure 9.8, 
confirming that below 300 V noise dominates the PMT. However, as dynode voltage 
increases beyond this point the signal to noise ratio remains constant whereas the 
sensor become gradually more sensitive, indicating that the dynode voltage alone 
cannot be used to optimise an immunosensor; as would be expected given the multiple 
noise sources within the system.
9.3 Data Analysis
Sensitivity, that is the lowest detectable concentration of an analyte distinguishable 
from measurements made with no analyte present, is of prime importance in 
determining the viability of a biosensor, as limited sensitivity has been a major block to 
the commercialisation of many biosensor applications. A design tool should allow the 
calculation of sensitivity in addition to the analysis of the key aspects of the simulated 
sensor determining that sensitivity. The modular nature of the model presented allows 
data from any part of the model to be analysed independently. This facilitates the 
comparison of different protocols, not only in terms of the sensitivity of the resulting 
device, but also in terms of the sources of noise contributing to the resulting sensitivity.
Chapter 7 presented an analysis of noise within an immunosensor and employed a 
variety of visualisation techniques to illustrate the results; line graphs, 2D “nets”, bar 
charts and pie charts. Each technique was chosen as the appropriate means to
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accurately represent the data involved. However, in a design tool, there are applications 
in which the user may not be sufficiently familiar with a particular protocol to be 
concerned with accurately determined values but need a means of easily identifying 
problematic areas. After consideration of the data and different visualisation techniques 
a means of representing the data as a series of pie charts illustrating the relative impact 
of noise sources was devised (Figure 9.9). This allows the user to instantly identify the 
major sources of noise at a particular instant.
□  Concentrations 
01 Incident Power
□  Coupling efficiency 
■  Observation length
0  W aveguide thickness
□  Concentrations
l l  Incident Power 
3 Coupling efficiency 
■  Width
■  Observation length
Model A: Prism coupling Model B Multilayer coupling
Figure 9.9: Relative proportions o f  the noise sources within the signal o f  the M odel A 
(prism coupling) and M odel B (multilayer coupling) immunosensor fo r  the 
determination o f  IgG where the immunoassay has been allow ed to reach equilibrium.
Figure 9.9, representing a snapshot of an assay, illustrates the fact that impact of errors 
within the observation length is much more significant in Model A than in Model B. A 
good design tool should provide a user with the means to make such instant 
comparisons as well as the ability to analyse the numerical data in detail.
9.4 Summary
The application of the model to a number of features of a computer aided biosensor 
design tool has been demonstrated. The comparison of different protocols was 
illustrated using a comparison of assays and a comparison of coupling techniques. This 
comparison confirmed that the sandwich assay proves more sensitive than the 
competitive assay in a fluorescent evanescent field immunosensor. It also demonstrated 
that the multilayer coupling technique did not produce a significantly more sensitive 
device than the prism coupled device.
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Ekins [1] advocated the use of modelling to facilitate the optimisation of a biosensor. 
Two examples, optimisation of the amount of labelled complex in a competitive assay 
and optimisation of the dynode voltage of the PMT within the detection element of the 
sensor, were illustrated here to demonstrate the range of parameters that can be 
optimised with ease using the model presented
Whilst repeated experiments could have been used to both compare protocols and 
perform optimisation, the model was free from sources of noise that may occur 
between experiments and thus provided a more accurate as well as a quicker, cheaper 
means of doing the comparisons.
The use of the model for data analysis was considered and it has been demonstrated 
that the model could be used to produce data from parts of the sensor independently 
(Chapters 7 & 8) as well as being used to produce a measure of the sensitivity of the 
sensor modelled. Presentation of data as a visual means of identifying problematic 
areas within the model was illustrated.
It should be noted that the design of a biosensor is dictated by available instrumentation 
and thus the results that can be achieved are to some extent constrained by the 
limitations of the instrumentation chosen. The value of a design tool such as the model 
described here is that it can be used to perform initial comparisons and data analysis 
and thus provide the biosensor developer with an indication of the most productive 
direction in which to pursue the necessary experimental research.
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Chapter 10
Application o f the model to the investigation o f the effect of a
humectant layer
10.1 Humectant layer
The humectant layer is a layer deposited over the immobilised capture antibody in 
order to preserve it. Once the solution containing the analyte has been added the 
humectant dissolves, leaving the capture antibody available for binding. Several 
materials have been used as humectants. Protein sugar combinations were once 
common, for example, sucrose-casein. More recently it has been found that single 
sugars, e.g. trehalose or sucrose, are just as effective. Trehalose now appears to be the 
most effective. However, as the experimental data used to verify the model produced 
here was generated using an immunoassay with sucrose as the humectant, the initial 
modelling has considered the effectiv^o? a sucrose humectant layer.
The impact of the humectant layer on the sensitivity of the device is a matter of some 
debate. The sucrose layer dissolves in approximately 13 seconds (Figure 10.1 
reproduced from Section 4.5.3.1) but it has been reported that the presence of a 
humectant layer can cause perturbations during and in some cases beyond the first 
minute of the assay [1]. This may indicate that the dissolution model is too simplistic 
or that the early masking of the surface has a prolonged effect on the kinetics.
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Figure 10.1: (Repeat o f  Figure 4.15) Diffusion o f  the humectant through the capillary  
f i l l  cell. Different lines relate to different elements within the fin ite  element analysis.
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A humectant is necessary if a device is to have a realistic shelf life [2], but any impact 
on the timescale with which a result can be achieved must be resolved if the aim of a 
outcome within 2 minutes is to be achieved Consequently, the model was used to 
produce a detailed examination of the effect of the humectant layer on the 
immunoassay and the sensitivity of the resulting sensor.
10.2 Effect o f humectant on sensitivity
10.2.1 Application of the model
The modified Markov method was applied to the sandwich assay for hCG both with 
and without a humectant layer for a range of initial analyte concentrations. Other initial 
concentrations for the assay were
[c]0 = 30.9 x 10'9 M 
P]o = 250 x 10'5 M 
and the association constants were
capture -  analyte Kc = 2.2 x 109 M'1 
analyte -  labelled antibody Kl = 4.1 x 1010 M"1.
The output voltages were determined using the resulting concentrations assuming that 
the assay was being performed within a CFD with multilayer coupling (layers and 
thicknesses as described in Table 10.1). The exciting light was a 5 mW Helium-Neon 
laser of wavelength 632.8 nm. The width of the waveguide was 0.4 m and the 
observation length for resulting fluorescence was 1 mm.
Table 10.1: Characteristics of the multilayer coupling system.
Layer
Thickness
(nm)
Refractive Index 
Real part Imaginary part
Glass 1.51958 -
Buffer 750 1.44 -
FeP04 waveguide 150 1.7 -
Capture antibody 7.14 1.3428 -
Bound layer 15.47 1.34239* 0.000959*
Solution - 1.33284* 1.45 xlO -6*
* Values dependent on concentrations
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10.2.2 Calibration curves
Figure 10.2 illustrates the resulting calibration curves for the device with and without 
humectant layer determined at an elapsed time of 1 minute from addition of the analyte. 
It is interesting to note that the assay with a humectant layer produces higher output 
voltages than the assay without humectant. The calculated sensitivities of 139.6 pM 
with the humectant layer and 171.1 pM without showed that the device without the 
humectant layer was slightly more sensitive, a result that is difficult to explain 
intuitively given that the sucrose diffuses to an equilibrium within 15 seconds from the 
addition of the sample.
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Figure 10.2: Calibration curves fo r  a sandwich assay fo r  hCG perform ed within a 
capillary f il l  cell with multilayer coupling produced  a t an elapsed time o f  1 minute 
with a humectant layer (smooth line) and without a humectant layer (dashed line).
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10.2.3 Sensitivity
The sensitivity of the device with and without humectant was calculated for very short 
periods of elapsed time (Table 10.2). At an elapsed time of just 15 seconds the device 
with the humectant layer proved more sensitive. However by 30 seconds this had 
changed and the device without humectant was superior, remaining more sensitive until 
5 minutes where the difference in sensitivities between the device with and without 
humectant was no longer significant.
Table 10.2: Sensitivities of immunosensor with and without a humectant layer
Elapsed time Sensitivity
+ humectant layer - humectant layer Difference
(+h) (-h) (+ h )-(-h )
15 seconds 289.3 pM 262.4 pM 26.9
30 seconds 216.1 pM 246.9 pM -30.8
1 minute 139.6 pM 171.1 pM -31.5
2 minutes 78.6 pM 93.7 pM -15.1
Investigation of the layers above the waveguide showed that the presence of the 
humectant layer reduced the penetration depth of the evanescent field by less than 2 
nm, not sufficient to significantly alter the resulting output voltage. The variations in 
the sensitivities indicated that the amount of bound label was perturbed by the addition 
of the humectant layer. Thus, a comparison was made between the transient response of 
the immunoassay reactions in the presence of a humectant layer and the response when 
no humectant layer was present.
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10.3 Analysis o f transient response
10.3.1 Bound labelled antibody
The complexity and structure of the model are such that it is possible to output data at 
various points within a module. Thus it was possible to consider the amount of labelled 
antibody that had become bound at the surface as the assay progressed for both the 
device with and without a humectant layer. Figure 10.3 illustrates the results and shows 
that the amount of label bound was greater for the device with no humectant layer in 
the early stages of the assay, which is consistent with what was expected. However, 
between approximately 1 and 4 minutes the concentration of bound label was greater 
for the device with a humectant layer. Subsequently the amount bound for a device 
with no humectant layer become dominant, reaching an equilibrium value consistent 
with the increased concentration of labelled antibody within the cell in absence of a 
humectant layer i.e. the concentration occupying the additional volume left available by 
this absence.
25
2
1
c2o
jO
c
o
czOO
io
0.5
9 100 1 2 3 4 5 6 7 8
Time (mins)
Figure 10.3: Concentration o f  bound labelled antibody as a function o f  the elapsed  
time from  the addition o f  the sample fo r  a sandwich assay fo r  hCG perform ed within a  
capillary f i l l  cell with a humectant layer (smooth line) and without a  humectant layer 
(dashed line).
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This phenomenon immediately suggests that within the complex network of reactions 
that occur during a sandwich immunoassay there are steps in which transiently a 
kinetically controlled species may appear which with time decays as the true 
thermodynamic equilibrium is established.
10.3.1.1 Kinetic and thermodynamic control
Kinetic and thermodynamic control are well illustrated in many organic reactions. 
Figure 10.4 illustrates the example of the bromination of a diene [3] with the 
corresponding energies for the two alternate products. This shows that at low 
temperatures the reaction is under kinetic control forming the products in the ratio 
81:19, whilst at room temperature thermodynamic control produces 56% of the more 
stable form of the product.
19%HBr 81%
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Figure 10.4: Distribution o f  products depending on temperature fo r  the bromination o f  
a diene with the energy diagram  fo r  the two alternatives shown
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10.3.2 Species within the sandwich assay
There are several routes to many of the species in the sandwich assay (Figure 10.5) and 
it is very possible that such a kinetically controlled situation may occur. The addition of 
the humectant will increase the viscosity of the solution and this may selectively alter 
the reaction rates in a similar manner to the change in temperature in the simple 
example above. However, the complexity of the sandwich assay, as illustrated by 
Figure 10.5, and the fact that the diffusing humectant will have a continuous effect on 
the viscosity indicate that it may not be particularly easy to identify such kinetic control 
steps.
ca cal
a2l
ca
Figure 10.5: A network diagram illustrating the species that may occur during a  
sandwich assay and the possib le  interactions between them. A ll species that may occur 
within the sandwich assay are shown in boxes. The lines indicate reaction pathways  
and the nodes (dots) indicate the combination o f  two species, 
c -  capture antibody; a  -  analyte; I -  labelled antibody.
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10.3.2.1 Initial reactions
In order to begin the analysis the initial stages of the assay were considered. Within the 
bulk of the solution, i.e. at a distance from the capture antibody at the surface, the 
reactions occurring between the analyte, a, and the labelled antibody, 1, are:
a + 1 al
al + a a2l
Thus within the first few seconds after addition of the sample the capture antibody, c, in 
the absence of a humectant layer will ‘see’ predominantly a and 1, whilst in the 
presence of a humectant the first species that the capture antibody will ‘see’ are al and 
a2l. Therefore the initial reactions occurring to bind 1 at the surface will be
c + a ^  ca
ca + 1 cal
in the absence of a humectant layer and
c + al ^  cal
c + a j  ^  ca2l(2 )
when the humectant layer is present. Consequently the build up of ca, cal and ca2l(2) in 
the early stages of the assay were examined and are illustrated in Figure 10.6 
(overleaf). In all cases the build up is initially greater in the absence of a humectant 
layer, which is as expected, although the cross over to the situation where the 
concentration is greater when the humectant layer is present occurs at different times 
i.e. about 55 seconds for ca, 60 seconds for cal but only 12 seconds for ca2l(2).
The shape of the transience of each species is clearly different with and without 
humectant. At about 7 seconds species ca2l(2) begins to deplete when there is no 
humectant, however the presence of the humectant delays the beginning of the 
depleting reactions which then occur at a reduced rate. In both species ca and cal there 
is a change in the rate at about 7 seconds in the absence of humectant, suggesting that a 
subsequent reaction begins to affect the production of the species in this case; a 
reaction that is prohibited in the case when the humectant layer is present. It is 
therefore likely that the perturbing step is in an intermediate species.
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10.3.2.2 Intermediate species
The bound label concentration consists predominantly of cal (70%) and ca2h  (15%). 
Examination of the transient concentrations of the species that deplete cal and ca2h 
suggested ca3l and ca3b as the species likely to cause the perturbation (Figure 10.7). In 
both cases the initial production of the species is delayed slightly by the presence of the 
humectant. However, the decay and subsequent reformation experienced in the absence 
of humectant is significantly perturbed by the presence of a humectant layer.
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Figure 10.7: Concentration o f  species as a  function o f  elapsed time from  the addition  
o f  sample with a humectant layer (smooth line) and without a humectant layer (dashed  
line). a) ca3l b) cash
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Very early work reported by Sereno & Flanagan [4] on CFD immunosensors 
commonly showed an overall response not dissimilar to that shown in Figure 10.7. An 
example of the transient response of a sandwich assay for hCG is illustrated by Figure 
10.8. The major difference between these early experiments and those on which the 
simulation presented here is based is the fluorescent label used. In this early work the 
fluorescent label was XRITC, a small dye, whilst later experiments used 
allophycocyanin (APC), a large protein. The latter is expected to cause strong steric 
hindrance, as was demonstrated in the fitting of the model to experimental data 
described in Section 4.6. Fitting to an immunoassay for hCG determined the steric 
hindrance factor between the analyte and the APC labelled antibody as 1.0 i.e. total 
steric hindrance. A consequence of such hindrance is that the pathways that lead to the 
formation of ca3l and ca^b will not be dominant. However in the case of the early work, 
where the label was a small dye, steric hindrance is likely to be significantly smaller 
and thus such pathways will play a more significant role in establishing the equilibrium 
of the assay.
KINETIC MEASUREMENT
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Figure 10.8: Kinetic response fo r  a sandwich assay fo r  hCG (Reproduced from  [4])
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10.3.3 Further analysis
The analysis performed indicates the likelihood of a kinetically controlled species 
contributing to the difference in the build up of the bound label on the surface between 
an assay with a humectant layer and one without and suggests candidate species. Such 
analysis, using results that cannot be produced experimentally, demonstrates the 
advantage of this type of modelling. However, in order to further pursue the cause of 
the differences shown, the model presented requires the addition of a module that will 
calculate the correlations between each pair of species and thus facilitate further 
statistical analysis.
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Chapter 11 
Discussion
11.1 Biosensor design
Biosensors have only succeeded in a very narrow medical niche, i.e. blood sugar 
monitoring in diabetics [1]. Several factors affect the viability of biosensor design: 
sensitivity; reproducibility; calibration and compliance with regulatory authorities; 
practicality and cost of the mass production of a part disposable device and ease of use. 
The complexity and interplay of these factors has contributed to the lack of progress in 
this field. Noise within the sensor and monitoring elements, non-specific binding 
contributions and the reproducibility of biomolecular immobilisations all contribute to 
this failing. In particular, the reduction of a standard bioassay procedure to a pseudo- 
reagentless small sensor has often been made at the expense of the required sensitivity.
The underlying aim of this project was to develop a computer model of an evanescent 
field immunosensor, which could be used to study the various design criteria and 
analyse data generated from the model in order to facilitate the future development of 
biosensors. In order to achieve this aim the three main objectives of the project were 
defined as being
i) to model the components of an evanescent field immunosensor;
ii) to implement a full model and use it to study the sensor implemented and
iii) to demonstrate the potential of the model as a design tool.
11.2 Overview o f model
11.2.1 Modules
The model was implemented as a series of modules, each representing one aspect of the 
sensor, i.e. immunoassay; propagation of light and detection. This allowed each 
component to be tested independently and provided the potential for analysis of data 
from within a particular element of the sensor. The modules could be linked together to
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produce a model of the whole sensor. This approach greatly facilitated the comparison 
of different protocols within the sensor as a single module could be replaced with an 
alternative variant of the component, whilst the remainder of the system remained the 
same.
The model presented was based on the evanescent field immunosensors previously 
developed by the UCL group for which experimental data was available. This 
facilitated the testing and verification of the model.
The immunoassay module determines the concentrations of the biochemical species 
within the immunoassay that takes place on the surface of the waveguide within the 
capillary fill device (CFD). These concentrations allow the amount of the fluorophore 
that is bound at the surface and the amount that is free in the solution within the cell to 
be calculated. Two variants of the immunoassay, sandwich and competitive assay are 
presented.
The light module calculates the amount of fluorescence excited when laser light is 
incident on a CFD containing an immunoassay in which one of the species has been 
labelled with a fluorophore. Two different models are presented; one in which coupling 
into the waveguide on the lower glass surface of the CFD is achieved using traditional 
prism coupling and the other in which the coupling is via a series of base layers of 
appropriate thickness and refractive index.
The detection module converts the fluorescence output from the CFD into a detectable 
voltage and calculates its associated noise. The experimental system modelled focuses 
the output fluorescence through two filters onto the cathode of a photomultiplier tube 
(PMT). The current resulting from the PMT is detected as a voltage across a resistor.
11.2.2 Implementation
The modules presented can be linked together to form a complete simulation of an 
evanescent field immunosensor or used independently to study the particular aspect of 
the sensor. Prior to the commencement of this project no complete model of an
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evanescent field immunosensor has been developed, although within the lifetime of this 
project Holt et al [2] acknowledged the potential benefit of simulation to biosensor 
design and produced a limited model of a continuous flow displacement 
immunosensor.
Several aspects of the model are based on standard well established mathematical 
models of the components involved. The calculation of the laser output within the 
Rayleigh range [3] is one such example. However, the ideal portable biosensor may not 
have a stable light source or collimating optics and thus the facility to study the impact 
of beam divergence on the sensor would be an advantage. In order to fully encompass 
the effect of the beam divergence, particularly on the multilayer coupling system, it was 
necessary to produce a profile of the incident angle and electric fields which could be 
used as part of an integration to determine the response of the system to an incident 
light beam. The inclusion of beam divergence as a variable produced a sophisticated 
model of the incident light that allowed the impact of beam divergence to be analysed, 
an analysis as yet unreported within the biosensor community.
The model for the output and associated noise from a PMT was based on Kingston’s 
derivation [4], with a minor correction of what was considered to be a type setting 
error. However, investigation showed that modem materials and fabrication processes 
mean that the assumptions made by the Richardson-Dushman formula for the 
calculation of dark current are no longer valid [5] and thus the Hamamatsu quoted 
figure was used. Although this component of the model is quite simplistic, even the 
most complex of biosensor models previously reported (Holt et al [2]) neglected any 
modelling of the detection element of their system
The fluorescence output from the model was calculated by determining the power at the 
waveguide surface following either prism (Model A) or multilayer (Model B) coupling 
and determining the percentage reduction by any of the possible means of attenuation 
e.g. absorption by the bound label, absorption by the free label, scattering from the 
waveguide surface or absorption by the waveguide itself. The amount of light absorbed 
by either bound or free label was then used to determine the output fluorescence. In 
order to apply the standard calculation of the surface power density of a dielectric
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waveguide to the sensor it was necessary to adapt the formula to take into account that 
the arrangement could be considered to be a four-layer system with a very thin sensing 
layer. Tiefenthaler & Lukosz [6] had previously considered this adaptation in the 
context of sensors but focussed their modelling on the resulting surface power density 
and did not extend their model to include other components of the sensor.
It is acknowledged that scattering at the surface of a waveguide in an evanescent field 
immunosensor may have an impact on the resulting sensitivity of the device [7]. 
However it is often neglected when considering sources of noise within an optical 
biosensor. Modelling the scattering of light from dielectric interfaces within 
waveguides is difficult. The inclusion of scattering in the model presented here 
involved the adaptation of the theoiy developed by Walter & Houghton [8] for the 
scattering of TE mode light from the surfaces of asymmetric monomode waveguides to 
produce a formula that would be applicable to the TM model light used in the 
experimental models on which the simulation is based. Thus, the contribution of 
scattered light to the fluorescence output can be calculated and the resulting impact on 
sensitivity of the immunosensor determined. Inclusion of scattering also facilitates the 
analysis of the scattered light, i.e. amount and direction, and the physical design of the 
sensor can be evaluated accordingly.
Ekins’ [9] early modelling established that the signal to noise ratio was the dominant 
factor affecting the sensitivity of the device. However, the complexity and interplay of 
the factors that determine the output and associated noise within a biosensor are such 
that the model presented here is the first simulation of an immunosensor that includes 
the possible sources of noise; e.g. scattering of light, PMT noise; and that has been 
developed in a style that allows Monte Carlo procedures to be applied to different 
components of the model in order to establish the impact of variations in the physical 
parameters that define the system.
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Although several authors have acknowledged the potential of modelling to 
immunoassay and biosensor research [2, 9, 10, 11] the tendency in any such modelling 
is to simplify the assay. The immunoassay module presented here represents a 
significant advance on any previous analysis of an immunoassay or indeed of any set of 
complex multiple equilibria.
11.3 Aspects o f  the model
11.3.1 Immunoassay
Traditionally attempts to model immunoassay reactions have been very simplistic. 
Initially the Scatchard plot, a method commonly used to characterise molecular binding 
events throughout biology [12], was used to plot the ratio of bound to unbound analyte 
against the bound analyte to produce a straight line from which the association constant 
could be determined. However, if the capture antibody is bivalent, a more complex 
Scatchard plot is obtained which requires non-linear regression in order to extract the 
value of any constants (Figure 11.1). It is clear that the complexity of the sandwich 
assay is such that it would be difficult to produces Scatchard plots for the assay that 
could be easily analysed.
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The Sips plot developed the methodology of plotting binding data and using the 
resulting graphs to determine constants relating to the reactions. Figure 11.2 shows a 
number of variants of the Sips plot that can again be used to calculate association 
constants. However, any early research with antibodies used antibodies that were 
polyclonal, i.e. their affinity with a particular antigen was not constant. Attempts were 
made to approximate this variation by formulating a distribution of the affinities of the 
antibody and Pauling et al [13] developed the mathematically tractable Sipsian 
distribution, based on the logarithmic Sips plot. This enabled an average value for the 
association constant and its distribution to be determined, however this is still 
insufficient data for a full analysis of the immunoassay.
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Figure 11.2: Sips plots for an immunoassay taken from Dougan et al [14] 
r -  number o f antigen binding sites 
rc -  number bound antigen per antibody 
c -  molar concentration o f free antigen 
n -  valency o f the antibody
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Other early modelling techniques that advanced the techniques illustrated above 
include the four parameter log-logistic (4PL) and the logit-log method [15], both of 
which use regression techniques to fit to the calibration curve of the immunoassay. 
However, these methods are fits to arbitrary functions and thus the estimated 
parameters cannot be related to the underlying physical constants, e.g. association 
constants.
Thus, the analysis potential of these methods is limited. One of the aims of this project 
was to model the full complexity of the immunoassay so that the model could be 
applied to considering issues such as the impact of variations within the immunoassay 
itself, the possibility of producing measurements from the immunosensor during the 
transient phase of the immunoassay reactions and performing a full analysis of the 
effect of a humectant layer on the reactions. Obviously the methods discussed above 
would not facilitate this level of analysis and therefore it was necessary to determine an 
alternative means of modelling the immunoassay.
Initial literature searching established that there were a number of computer programs 
available for studying multiple equilibrium amongst which were RAMESES [16], 
HySS [17], and ES4EC [18]. These, along with several others, were reviewed. The 
common feature of these models was their application to titrations, allowing the 
inclusion of pH as an additional variable within the set of simultaneous equations that 
described the reactions and the mass conservation of the system being modelled. The 
simultaneous equations were solved using classic regression techniques, in two cases 
the method of Newton Raphson, a method that was considered and discarded when 
applying regression techniques to the immunoassay equations due to the tendency for 
this procedure to become trapped within a false minimum. It is possible that the over 
parameterisation introduced by the inclusion of pH as an additional variable produced 
search pathways that were less complex. • ;; pH is not a/factor in an
immunoassay.
In addition these programs solved reactions for their equilibrium concentrations, an
,be
inevitability if one is using a regression technique and thus could not easily(adapted for 
the more rigorous kinetic analysis required. The complexity of the examples illustrated
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was minor compared with the complexity of a sandwich immunoassay and it was 
concluded that the systems being modelled were well conditioned and were thus 
suitable for regression procedures.
The initial modelling of the immunoassay presented here did follow the approaches 
outlined in the publications mentioned above i.e. applying optimisation techniques to 
the equilibrium equations describing the assay and investigating the performance of a 
range of classic regression procedures in addition to the “intelligent” genetic algorithm 
and simulated annealing techniques. Some analysis of the search surfaces produced by 
this approach revealed the complexity of the assay, even in two dimensions. The 
comparison of the different approaches implemented enabled the appropriate procedure 
for inclusion within an iterative calculation to be made. However, whilst optimisation 
was being applied to the immunoassay further investigation, with a view to modelling 
the transient response of the assay, was being undertaken.
The technique developed by Too et al [19] and Antia & Lee [20] for solving the 
chemical concentrations in continuous flow reactors provided a viable solution. Their 
approach was applied to the rate equations describing the assay reactions and used to 
produce an modified Markov chain that could be solved for the concentration values at 
any given time from the addition of the analyte. Thus this approach allowed both the 
transient and equilibrium concentrations of the immunoassay to be calculated.
It has been suggested that Markov chains could be used to solve sets of differential 
equations [21]. This application provides an example where a Markov chain is used to 
solve a set of differential equations. As part of the verification process the transient data 
produced by the modified Markov method was compared with that produced using a 
fourth order Runge-Kutta technique [22]; a standard method for solving sets of 
differential equations. The data from the two methods was found to be in total 
agreement, although the Markov approach was significantly faster in terms of 
computation time. Analysis of the implementation of the modified Markov approach 
indicated that it was essentially a zero order Runge-Kutta. It is therefore possible that 
the adaptive steps employed by procedures such as Runge-Kutta, which evolved to
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facilitate computations, are no longer necessary given the vast improvement in 
computer performance over the last decades.
11.3.2 Aspects of a design tool
In order to demonstrate the potential for this type of modelling to become part of a 
biosensor design tool, the model was used to compare different protocols within the 
sensor arrangement. At the time when Ekins demonstrated the superiority of the 
sandwich assay over the competitive assay in radioimmunoassay [9] lack of computing 
power hindered the development of a totally theoretical model and his models were 
derived from a large number of experiments. The ease and speed with which the 
superiority of the sandwich assay over the competitive assay for an optical 
immunosensor was established highlights the advancement of computer performance 
over the last decades. This advancement supports the benefits of developing the type of 
model presented here.
The model was used to compare the two types of coupling implemented, Model A 
prism coupling and Model B multilayer coupling. The multilayer coupling technique 
had been developed experimentally as it proved easier to construct and use the 
instrumentation necessary. However, experimentally there was no way to determine 
whether this ease of coupling affected the sensitivity of the resulting device, as in any 
experimental work such a comparison could introduce between sensor errors that may 
bias the result. Using the model it was possible to demonstrate that there was no 
significant change in the sensitivity of the immunosensor when prism coupling was 
replaced with multilayer coupling, thus establishing that the ease of this method of 
coupling was not detrimental to the device.
It has been noted that performing repeated experiments with an immunosensor may 
introduce between sensor noise that biases any comparison between results and that one 
of the benefits of the model is that a single parameter can be changed whilst the 
remainder of the system remains identical. This allows the model to be used to optimise 
the value for any of the physical parameters that define the sensor, another potential 
function of a design tool.
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Parameter estimation using data fitting techniques is an established means of
determining values for parameters that cannot be determined experimentally.
Immobilisation of the capture antibody in the immunoassay and the labelling of a
second molecule can cause alterations to the value of the association constants and the
steric hindrance that may occur once the assay has began. Once immobilisation or
labelling has occurred it is impossible to determine the new values. The immunoassay
module of the model presented encompasses the full complexity of both a competitive
and a sandwich assay and thus provides the basis for parameter estimation of those 
frtc
values that can/be determined experimentally.
11.3.3 Aspects of biosensor development
Ideally a biosensor will produce a result in 2 minutes. Thus it will be necessary for the 
sensor to perform measurements before the immunoassay has reached equilibrium. The 
immunoassay module of the model presented allows a full analysis of the transient 
response of the assay from the time of the addition of sample. Thus it was possible, 
using the model, to determine the sensitivity of a immunosensor as a function of the 
elapsed time from the addition of sample and thus provide information regarding the 
elapsed time necessary to produce results at the required sensitivity.
Another design factor that is a cause of debate is the use of a humectant layer, 
deposited onto the immobilised capture antibody in order to preserve it and thus 
produce a device with a realistic shelf life. The model was applied to the comparison of 
a sensor with and without a humectant layer, producing results that could not be 
intuitively explained. The full complexity of the immunoassay module facilitated the 
preliminary analysis of the effects of the humectant layer on the build up of the 
different species within the assay, establishing that initially the amount of bound label 
was greater without a humectant layer than in the presence of a humectant but that this 
trend reversed for a period before being re-established. This suggested the existence of 
a kinetically controlled intermediate species and the analysis of the composition of the 
bound label, an analysis that is only possible with a full theoretical model of the 
immunoassay, identified two possible candidates.
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11.4 Project in current context
Modelling of evanescent field immunosensors is not a well established area of research. 
Early computer models of biosensors received only limited application [9]. It has been 
suggested that this lack of exploitation of computer models is due to the fact that such 
models are complex, do not easily take into account common features of assays or 
information on assay parameters and thus do not reflect reality [11], The potential 
benefit of modelling to biosensor design is beginning to be recognised and Holt et al [2] 
produced a model of a continuous flow displacement immunosensor that was used to 
optimise certain parameters. However, the immunoassay element of their model was a 
gross simplification of this aspect of the sensor. The model presented in this thesis has 
modelled an evanescent field immunosensor with a more complex analysis of the 
immunoassay element than any model previously published. Table 11.1 indicates both 
the strengths and limitations of the resulting model.
Table 11.1: Strengths and limitations of the model presented
Strengths Limitations
Immunoassay
module
Equilibrium data available
Kinetic data available
Two immunoassay modules 
implemented 
Diffusion within the cell 
considered
Non specific binding not yet 
included
Fitting to kinetic data not yet 
available
Horizontal transport of 
molecules within cell not yet 
included
Light module Two coupling methods 
implemented 
Scattering at waveguide 
considered
Divergence of incident beam 
considered
Only one light source 
implemented
Detection module Algorithm for calculating 
sensitivity
Only one detection module 
implemented
Overall model Modular nature No user interface as yet
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Non-specific binding (nsb) within an immunoassay i.e. the binding of the analyte or 
label to the surface without binding to a capture antibody can be a major source of 
unwanted signal in many assays. Initially nsb was not included within the assay module 
as the added complexity slowed the development; modelling the complexity of the 
immunoassay being one of the most difficult aspects within the project. Verification of 
the assay data without nsb was valid, since the experimental data used was generated 
using a system in which nsb had been reduced to an insignificant level. However, now 
a technique for modelling the complexity of the assay has been produced it would be a 
trivial exercise to include non-specific binding within the immunoassay module and, 
given the importance of nsb in immunoassays in general, an essential one.
Attempts to fit transient data from an immunoassay using the modified Markov 
approach within an optimisation procedure were initially abandoned due to the 
unacceptable computation times involved. The excessive computation times relate to 
the fact that the time interval, At, used in the immunoassay module is calculated to be 
small enough so that when the free species arrive at the capture antibody surface the 
reactions that occur are within the physical constraints of the system. This value is then 
used as the time step throughout the entire model, i.e. for both the reactions and the 
diffusion. Since the diffusion rates are slower than the reaction rates, the value for At is 
smaller than necessary within the majority of the cell. It is common practice in these 
types of situations to allow the value of At to vary. However for the purposes of this 
model it was decided that the development of other aspects of the sensor was a more 
critical use of the author’s time. At this stage this adaptation could be made to the 
immunoassay module and would greatly facilitate the application of the model to the 
fitting of kinetic data.
Inclusion of the horizontal transport of molecules within the cell is not trivial. The 
present model considered only one analyte and one label. The experimental aim of the 
UCL group, along with many others, is to produce multi-analyte sensors. In this case 
different capture antibodies would be immobilised onto different areas of the lower 
surface of the capillary fill device. The corresponding labelled antibody would be inkjet 
printed onto the upper surface opposite. The sample may then contain several analytes 
that will each react with the appropriate antibodies. The FDA requirement for a
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commercial biosensor is that internal calibration is necessary, calibration that may be 
achieved by including a separate calibration channel within the sensor [23]. Preliminary 
experiments on such systems indicated that in this type of device cross-talk will be a 
serious problem. There are procedures for extending a one dimensional finite element 
approach to two dimensions. It is clear that the complex dynamics of the capillary fill 
device will need to be incorporated in such a model if the benefits of the model 
presented are to be extended to the consideration of multi-analyte devices.
The model as it stands does not benefit from the type of graphical user interface 
common to many applications these days. However the classes implemented to 
describe each component of the sensor provide a suitable platform from which such an 
interface may easily be constructed.
11.5 Conclusion
It was stated in the introduction that ‘The complexity and interactions of the factors 
affecting the practicality of a biosensor have hindered their development in the 
traditional experimental environment.’ and the development of the model presented 
would provide the basis for a design tool that could facilitate biosensor research and 
development.
Evanescent field sensors were initially proposed as a means of drawing a precise 
distinction between the bound and unbound label present in the immunoassay [24]. The 
analysis of the scattering at the waveguide surface presented in this thesis, analysis that 
could only be achieved with a computer model, demonstrated that the distinction is not 
as precise as expected, vital information for the future development of evanescent field 
immunosensors.
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Appendix A
A.1 Finite element analysis of diffusion
Fick’s 1st Law of Diffusion
dx
where J is the flux
D is the diffusion coefficient 
C is the concentration 
x is distance 
and t is time.
Recasting this becomes
t(' lim {C(jc -f Ax, t) C(x, t)}
■/ ^ - A x _ > 0  U  t o
The finite element technique assumes that Ax can be made small enough to allow the
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Fick’s 2nd Law of Diffusion
dC(x,t) _ dj{x9t) 
dt dx
written in it’s finite difference form becomes
C(x,t + A t)-C (x ,t) _ 
At
J '  Ax 'X  +  A
v 2 '  j
- J
Ax
Substituting for J(x,t) from (A. 1) this becomes
DAtC(x,t + A/) = C(x,t)+ -—— {c(x + Ax,r) -  2 C(x,t)+ C(x -  Ax,f)} 
(A rf
A successive application of this formula allows the concentration in a particular 
element to be calculated for each time period.
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Appendix B
BA Diffusion limited rate constants
Fick’s 1st Law of Diffusion
D is the diffusion coefficient 
VC is the concentration gradient
If the gradient is spherically symmetrical (B. 1) becomes
Consider a reaction between spherical molecules A and B with reaction rate K
Figure BA: Spherical molecules A andB. B is diffusing towards A.
Assume
1) when A & B are in contact they react
2) B is diffusing towards A
3) r is the distance from A
4) neither molecule is charged
J t = -D/VC, (B.l)
where Ji is the flux
and i refers to the particular molecule.
(B.2)
A + B — ^—*AB
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The rate of diffusion of B towards A is 
-{A ^ n r1 pfJ B
where p is the proportional of the sphere that is surrounded by B
f  is the fraction of the surface that might bind with B
and the flux is derived from equation (B.2) as
J B =-(D A +Ob ) ^ -  (B.3)
dr
where D a  + D b  takes account of the motion of both molecules
and [B]r is the concentration of B at a distance r from A.
The total rate of reaction is
- ^  = K[A\B] 
which in the diffusion limited case is equal to the diffusion rate
- ^  = K[A\B] = -[AYnr2pfJB
at
Substituting (B.3)
K[B]=4m-2pf(D A +DB) ^
dr
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rearranging
d r j  *Rf{pA +DB) 
r 2 £ [ s ]  V
Integrating from R (the radius of contact of A & B) to oo
R r  R (B.4)
l=MBrfij([sL"[sLt)
Noting that as r -> oo [ B l  -> [b] equation (B.4) becomes
= M i ­
x'
4nRpf(DA +Db )
(B.5)
Assume that A and B in contact react with rate Kr 
i.e.
4b ] _
dt
= k [a \ b ]= k r [a \ b]r
Substituting (B.5) and eliminating [A][B]
K = KR 1 -
K
4xRpf(DA +DB)
4xRpf(DA +DB)
4 *Rpf(DAT D j  
K r
K  = KD
1 +
K i
K
(B.6)
where KD = 4 7tRpfipA +DB)
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Examination of (B.6) shows that
k < k d
and thus Kd is the maximum rate constant applicable i.e. the diffusion limited rate 
constant.
Note on units:
The units of Kd derived above are [Length]3 [molecule] '1 [sec]'1 
To convert to NT1 s'1 multiply the above formula by 1000 * NAvagadro
Thus the diffusion limited rate constant for the reaction is
Kd = 4izRpf(DA + Db )Na x 1000
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B.2 Statistical allocation o f association constant value
Given a set of chemical reactions
c + a 5=* ca 
ca + a ca2
where the intrinsic association constant for c-a bond is Kc and c is bivalent.
Forward reaction has 2 possible routes
Backward reaction has 1 possible route
Association constant for reaction: 2Kc
Figure B.2: Reaction: c + a ^  ca
Forward reaction has 1 possible route
Backward reaction has 2 possible routes
Association constant for reaction: V£Kc
Figure B.3: Reaction: ca + a ca2
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Appendix C
C.1 Analytical solution o f the transient response o f a single chemical reaction
Consider the reaction
kf
a+b<— c
kb
where kf is the forward rate constant
and kb is the backward rate constant
The association constant for the reaction is given by
k r
K  = - f  (C.l)
*b
Assume that at time t = 0
concentration of a is [a]o 
concentration of b is [b]o 
concentration of c is 0
and that at time t
concentration of c is [c] 
concentration of a is [a] = [a]o -  [c] 
concentration of b is [b] = [b]0 -  [c]
The rate of change of [c] is given by
^ k f [a\b]-kb[c\
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Substituting for [a] and [b]
^ = * / M o M o  - f c / H o +kA h\o+kt>Xc\+ kA cY
Dividing by kb and substituting (C. 1) this becomes
1 d[c] _
kb dt =4»]»M> -(44+44+4c]+44
Making the substitutions
P = -(K[a]0 + K[b]0 +1) 
y = K[a]0[b]o
and rearranging leads to
h dt =
4c]
K [ c f+ p [ c ] + r
Integrating this becomes
kbqt = In 2K[c \+P~q \ 
2 4 c ] + /? + <?.
+ C (C.2)
where
and C is a constant
Using the assumption that at t = 0, [c] = 0
C = In
r 0 , \P+q
P-qy
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Substituting into (C.2) and rearranging leads to the equation for the concentration of c 
and thus the concentration of a and b, at any time t:
e -h vU _  {P + 9 \ P - l k -
2K\l/} + q)e~kbq!- f i  + q
[a] = [a]0-[c ]
[b] = [b]0 -  [c]
(C.3)
where p = -(K[a]o + K[b]o +1)
q = yl{p2 -4 K r )  
and y = K[a]0[b]o
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A ppendix D
D .l Maxwell9s equations fo r light propagating within a waveguide
Maxwell’s equations for a perfect dielectric (i.e. 8  = n 80, p = po and o = 0) are
V x E  = -  jcojuqH  (D.l)
V x H  = jcosQn2 E  (P-2)
where E represents the electric field vector,
H the magnetic field vector,
j=V=T
po is the magnetic permeability of free space,
8o is the permittivity of free space, 
n is the refractive index of the medium 
and co is the angular frequency of the guided light.
For a slab waveguide, unconfined in the y-direction, the field components for a wave 
propagating along the waveguide in the z-direction can be expressed as
F(x,y,r.t)-F0(x y l" -* )
where x, y & z are the spatial coordinates,
t is time
and p is the longitudinal phase constant.
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Suppressing the exponential component and expanding Maxwell’s equations for fields 
of this form produces the following equations:
fiE oy ~  Ox
dEnr
J 0x + dx = JO>Uo °y
dEiOy
dx
■>- from Equation (D. 1)
/3H0y =(Q£0n E0x
  d H  a, i „
j W 0x + — = -  j<o£0n E0y
dx
from Equation (D.2)
dH
dx
O y 2 1 7'  = JODSqU EQz
Inspection of these equations shows that they can be divided into two groups each 
representing either the Transverse-Electric (TE) or Transverse-Magnetic (TM) mode of 
propagation.
TE modes are described by
< ® 0 y  ^
=  -JG>tl0H Qz
dx
  dHn- 9 _
0x + dx = ~J0)£°n °y 
PE<)y  =  -C O /JqH qx
and TM by
dE
jPEdx + —f  = J'WoHoy (D-3)
PH0y =O)e0n2E0x (D.4)
dH 0i> <5
— ^  = j(D£0n EQz (D.5)
dx
The following derivation of the fields and resulting power has been confined to the TM 
mode, however analogous equations may be derived for TE propagating waves.
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Rearranging, equation (D.5) becomes
- j  dH0y
Eqz ~ 2 (°-6)r OX(OSqU
and equation (D.4) becomes
E0x= - ^ H 0y (D.7)
(D€qn
Substituting equations (D.6) and (D.7) into equation (D.3) gives
P 2 „  1 d 2H 0y   ^
2 0  y j  2 ^M o ^O y
cosqU one 0n dx
which becomes
d 2_  
dx2
+ ^ 0)2 - /82] U 0y = 0  (D.8)
where k0 = a}(e0ju0)% =— is the wave number in vacuum
c
and c is the velocity of light in vacuum.
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D.2 Fields in a dielectric thin film  waveguide
In the three layer dielectric slab waveguide illustrated in Figure D.l equation (D.8) 
should represent a standing wave in the film and an evanescent wave in the substrate 
and cover regions.
COVER 
x = 0 ---------------------------
FILM 
x = d -----------
SUBSTRATE 
Figure D.l: Dielectric slab waveguide
Establishing fields that represent the appropriate type of waveform and using the 
continuity of Hoy across the substrate-film and film-cover boundaries the magnetic field 
in the y-direction is given by
Hgy (x)= {A cos(bd) -  B sin(W)3e p<> ^  x < - d
H Qy (jc) =  A cos(Ajr) + #  sin(&x) - d  < x < 0
Hoy (x)= Ae~PlX 0 < x
where S, F & C denote the substrate, film and cover respectively,
A & B are constants, 
d is the thickness of the film
b = ^i(nFk0)2 -  /?2) is the transverse phase constant in the film
and po = - (n s k0f  )
Pi = f y 2 - ( nc ko ? )  are the transverse attenuation constants in the
substrate and cover respectively.
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Applying equation (D.6) produces the equations for the electric field in the z-direction, 
namely
E 0z(x ) =  ^ j P 0 H 0y(x ) x < ~ d(os0 ns
Eqz (jc) = --------- {- bA sin(&x) + bB cos(&t)} - d < x <  0
co€QnF
E 0z(x ) = — ^ r ( “ P l ^ Q y l * )  0 < x
0*0 nc
Continuity of Ez across the film-cover boundary 
*£(<>)= *£(<>)
implies
which leads to
- ^ LY bB = ^ T ( - p 2)A
(D£tflp (OSqUq
B = - ^ A  (D.9)
where P 2 = ^ f / ?2 - 
nc
Continuity of Ez across the film-substrate boundary 
E g ( - d ) = E l ( - d )
implies
^ {bA sin(bd )+bB cos(bd )} =  p Q (<4cos(fc/)- Z?sin(fo/)}
a)eQnp
which leads to
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Substituting equation (D.9) and rearranging leads to
05.10)
b - P 0 P2
where P o = %  P o­
ns
Equation 10 is the characteristic equation of the waveguide and can be used to 
determine the value of p.
D.3 Guided power within the waveguide
The guided power in the waveguide is given by
oo
-ao
where W ( »  d) is the width in the y-direction
and Sz is the longtitudinal component of the Poynting vector
For a TM wave
Substituting for Ex from equation (D.7)
2cosQn
Thus equation (D. 11) becomes
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i.e.
P = WJ3 
4cos0np
1 +
---2>
Pi
b 2 y
A 2d,Cff (D.12)
»sPo(*2 + Po 2 j  nc P l{b2 + P i 2 j
is the effective thickness of the film resulting from the small penetration of the guided 
wave into the medium on either side. The value of A can be calculated from equation 
(D. 12) if the total power in the system is known and thus the field and hence the power 
at any value of x can be determined.
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A ppendix E
E .l Electromagnetic fie ld  equations
I
Figure E.l: Transverse-Magnetic f ie ld  with propagation  vector k
Consider the transverse magnetic wave with propagation vector k as illustrated by 
Figure E. 1. The propagation vector k can be written
k = {kx, 0, (E.l)
where
and
kz = k sin 6
k =
con
to is the angular frequency of the light
c is the velocity of light in vacuum
n is the refractive index of the propagation medium
k x = - J k 2 ~ k z  (= «)
The electric field vector can be written
E = Eej{k' r-M)
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Expanding this becomes
E = Ee-JO,eJk* e Jk**
Confining the direction of interest to the x direction this can be written as
E  = AeJC0C
Expanding this vector
Zs=|z|(sin#, 0, -cos0)eJax (E.2)
k  (XNoting that sin# = —  and cos# = — equation (E.2) can be rewritten as 
k k
E = o , - - V “k k )
(E.3)
Maxwell’s equations imply
H  = — k x E
COJU
Substituting equations (E. 1) and (E.2) this becomes
h = ~ -\a |(o, i, (E.4)
IjUq
where Z0 = —  is the characteristic impedance 
\  £o
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A ppendix  F
F .l Projection o f  a beam incident at an angle
H D  G
NOTE: Exaggerated scale (w « d )
Figure FA: Projection o f  a beam o f  tight o f  width w with angle o f divergence <p 
incident at an angle 6  on a surface AF at a distance d  from the source o f  the tight beam
d e \ \DE\
sini f - H cos (0  + (/>)
Applying the sine rule to triangle DEF
M
sin^
In the right angle triangle DEG
\d e \ = -A —
1 1 C O S0
Combining (F. 1) and (F.2) gives 
rfsin^
(F.l)
(F.2)
\EF\ =
cos#cos(# + ^ )
(F.3)
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Applying the sine rule to triangle ABC:
sin^ . f n  cos#
|AB| _ [AC\ _ \AC\
cin /h f  t r  'N rno (FA)
s in  0
U  J
In the right angle triangle CDH 
\CH\ = wsin 0
In the right angle triangle ACK 
L t d -  ^  _ d - p i \  d -w sm B
sin(f? -  (/>') sin(f? -  </>) sin((9 -  <f)
Combining (F.4) and (F.5) gives
. . _ |yfC|sin^ _ ( j-w sin # )s in ^
cos# sin(#-^)cos#
In right angle triangle BEJ
Thus the total length subtended by the beam on the interface, from (F.3), (F.6) and
(F.7) is
\AE\ + \BE\ + \EF\ = ( j-u 's in # )s in ^  w
sin(# -  ^ )cos # cos # cos # cos(# + ^ )
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Non-refereed conferences
Keating S M, O’Reilly J J & Flanagan M T, Proceedings of the Third Conference on 
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